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Abstract
Evidence relating salt and blood pressure is critically reviewed including the 
problems of bias and confounding in the epidemiological studies. Overviews of 
controlled trials of sodium reduction and within-population epidemiological studies 
give similar estimates of effect. In the trials, average blood pressure was lowered by 
2.9/1.6 mm Hg systolic/diastolic for daily sodium excretion less by 70-75 mmol, 
whereas the epidemiological studies gave a regression estimate (corrected for 
reliability) of 3.7/2.0 mm Hg systolic/diastolic per 100 mmol sodium.
INTERSALT is an international co-operative study of the relation of salt and other 
factors to blood pressure in 10,079 men and women from 52 centres and 32 countries; 
field methods, and procedures of the Coordinating Centre are specified. The analysis 
of multicentre studies is illustrated using INTERSALT data relating systolic pressure 
to body weight. There was significant heterogeneity of systolic pressure-weight 
regression coefficients which is explored. Implications for the design and analysis of 
future studies are discussed.
In INTERSALT, the corrected pooled within-centre regression estimate, adjusted for 
age and sex, was 3.5/1.5 mm Hg systolic/diastolic per 100 mmol, reducing to 2.2/0.1 
with adjustment for confounders. Age and sex specific results suggested a stronger 
relation at older ages, and for women compared with men. Across the centres, 
average sodium excretion was positively related to slope of blood pressure with age, 
such that 100 mmol/day lower sodium was associated with a 9 mm Hg lower rise in 
systolic pressure from age 25 to age 55. In the three United Kingdom centres, there 
was relatively high urinary sodium excretion (average 152 mmol/24-hour), 
sodium/potassium ratio, body mass index and prevalence of heavy alcohol drinking in 
men. These findings are used to illustrate the potential for non-pharmacological 
control of blood pressure in the community, and recommendations are made on more 
desirable levels of sodium intake.
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Aims and Scope of the Thesis
INTERSALT provides a wealth of data on the relation of electrolyte excretion, body 
weight, alcohol intake and other factors to blood pressure in the 10,079 individuals in 
52 centres worldwide. The thesis could not attempt a comprehensive account of the 
study, its results and implications; rather, the emphasis is on a critical assessment of 
the evidence on salt and blood pressure, and on methodological issues.
Thus the laboratory, clinical and epidemiological evidence on salt and blood pressure 
is reviewed including discussion of confounding and bias in epidemiological studies 
across and within populations; overviews (meta-analyses) are presented of 
randomised controlled trials of sodium reduction and of within-population studies 
(Chapter 1). Detailed INTERSALT field methods and methods of the Coordinating 
Centre and Central Laboratory are described (Chapter 2 and Appendix 1), and 
methodological issues arising out of the multicentre study design are explored 
(Chapter 3).
Results included from INTERSALT are age and sex specific findings relating sodium 
and potassium excretion to blood pressure, and results for the three United Kingdom 
centres (Chapter 4). These results are discussed, and some of the public health 
implications of the study illustrated using data from the United Kingdom centres 
(Chapter 5).
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Chapter 1
Evidence Relating Sodium And Blood Pressure
Evidence relating sodium and blood pressure (BP) has been extensively reviewed 
elsewhere (Battarbee & Meneely, 1978; Bartter, 1982; Brown et al., 1984; Dahl, 
1958; Denton, 1982; Elliott & Marmot, 1984; Final Report of the Subcommittee on 
Nonpharmacological Therapy, 1986; Grimm & Prineas, 1987; Laragh, 1983; 
MacGregor, 1983, 1985; National Research Council, 1989; Page, 1976; Pickering, 
1981; Simpson, 1979, 1984; Swales, 1980; Tobian, 1979). The evidence derives 
from animal studies, clinical observations, human experimental studies, and 
epidemiological studies. In this chapter, after a brief review of the animal work, the 
clinical and epidemiological evidence in man (excluding INTERSALT) is critically 
assessed and a judgment made as to causality.
This review is timely in the sense that, in addition to INTERSALT, a number of new 
studies have recently been reported which add importantly to the literature. In 
particular, the evidence from randomised controlled trials of sodium restriction is re­
evaluated in the light of recent data (including an overview analysis of all eligible 
studies published to date), studies of sodium restriction in populations are discussed, 
and an overview is presented of published within-population studies relating 24-hour 
sodium excretion to BP.
1.1 Animal Studies
Experimental hypertension in association with high sodium intake has been induced 
in several species including the dog (Coleman & Guyton, 1969; Vogel, 1966), the 
chicken (Lenel, Katz & Rodbard, 1948) and the baboon (Cherchovich et al., 1976). 
However, most investigation of sodium and BP in animals has been concentrated on 
the rat; for example, Meneely et al. (1953) were able to induce hypertension in rats by 
mixing salt with the food and allowing ad libitum consumption o f food as well as 
water.
Several strains of rat have been bred which develop hypertension and stroke when fed 
high doses of salt. Dahl (1967) fed unselected Sprague-Dawley rats with chow 
containing 8% sodium chloride. About 75% of the rats developed hypertension 
within 6 to 9 months, and a few developed severe hypertension with death in one or 
two months, but the remaining 25% were "resistant" to salt induced hypertension. 
The rats that had been "sensitive" ("S" strain) or "resistant" ("R" strain) were then 
selectively in-bred. After 5 to 7 generations o f such in-breeding, marked differences
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in BP response to a high salt diet were observed (Dahl, 1972). Many of the "S" strain 
rats died of fulminating hypertension within one to two months, whereas all "R” 
strain rats remained alive and in good health after 10 to 12 months on the same 
regimen. When "R" strain rats were crossed with "S" strain, the BP response of the 
progeny was unpredictable (Dahl, 1972). It is likely that the BP response of ”S" 
strain rats is related to a defect of renal sodium excretion (Tobian, 1979).
A W i s tar-derived strain of spontaneously hypertensive rat (SHR) was described by 
Okamoto and Aoki (1963). Louis, Tabei & Spector (1971) showed that SHR rats 
developed and maintained hypertension in the virtual absence of salt in the diet, but 
hypertension was induced earlier and became more severe in animals fed extra 
sodium. Other studies showed that salt restricdon could attenuate the development of 
severe hypertension in the SHR rat (Yamori, 1982), and also that the adverse effect of 
a high salt diet could be offset to some extent by adding either 2% (Yamori, 1982) or 
4% potassium chloride to the feeds (Louis, Tabei & Spector, 1971). This latter 
finding is consistent with previous observations of Meneely, Ball and Youmans 
(1957), who described increased survival in rats fed a high potassium in addition to a 
high salt diet.
The animal studies suggest a model of sodium-induced hypertension, particularly in 
genetically susceptible individuals. It is possible that the chloride ion accompanying 
sodium is also necessary (Kurtz & Morris, 1983; Luft et al., 1988; Whitescarver et 
al., 1983). Within this model, BP appears to be further influenced by the moderating 
effects of dietary potassium (Meneely & Battarbee, 1976). To what extent the animal 
model translates to human essential hypertension remains an open question (Denton, 
1982 p.612; Swales, 1980), but at the very least it provides experimental backing for 
the concept of a sodium-BP relation, and is supportive of and consistent with the 
evidence from human studies.
1.2 Clinical and Human Experimental Studies
1.2.1 Sodium Reduction
Sodium reduction was advocated in the treatment of hypertension early this century 
(Allen, 1920; Ambard & Beaujard, 1904) but did not gain favour until the 1940's, 
when in the absence of effective pharmacological therapy, Kempner (1944) treated 
severe hypertension (often associated with renal disease) using a low-sodium rice and 
fruit diet. Although the diet was effective in lowering BP, its low sodium content 
(approximately 10 mmol daily) and bland and restricted nature proved unpalatable
and unacceptable to many patients (Watkin et al., 1950). The advent of diuretic 
therapy, which promotes sodium as well as water loss, revolutionised the 
management of hypertension, and added support to the concept that sodium was 
important in the development of high BP.
A number of open and uncontrolled studies have suggested that moderate sodium 
reduction can lower BP both in children (Ellison et al., 1989; Liu et al., 1987) and in 
adults (Fujita et al., 1980; Gillum et al., 1983; Kawasaki et al., 1978; Miller et al., 
1983, 1987; Shibata & Hatano, 1979; Weinberger et al., 1988). Recently, several 
controlled trials of sodium reduction have been published; these have been reviewed 
(Cutler et al., 1988; Final Report of the Subcommittee on Nonpharmacological 
Therapy, 1986; Grimm & Prineas, 1987; Grobbee & Hofman, 1986; Kaplan, 1985). 
For example, in each of the 13 studies cited by Grobbee and Hofman (1986) a fall in 
systolic (though not diastolic) BP was recorded during the low-sodium phase. 
Reductions in systolic pressure were on average 3-4 mm Hg for an 80 mmol 
reduction in 24-hour urinary sodium excretion, and tended to be greater at older ages, 
and with higher initial BPs. Most of these trials were small and hence of limited 
statistical power, and the effects on BP were significant in only three studies.
Four of the sodium restriction trials reported by Grobbee and Hofman (1986) were 
conducted in double-blind fashion using a randomised cross-over study design 
(Grobbee et al., 1987; MacGregor et al., 1982; Watt et al., 1983, 1985). This design 
ensured that nutritional advice was given equally in both arms of the trial (i.e., normal 
sodium and low sodium) since all participants were required to restrict dietary sodium 
prior to interventon. The first of these trials was reported by MacGregor et al. in 
1982. Nineteen patients with "mild” hypertension were put on a low salt diet and 
then randomised to receive either placebo or slow-sodium tablets for four week 
periods whilst on the diet. BPs were then compared between the period on placebo 
(low salt) and that on salt tablets (control). An average difference in 24-hour urinary 
sodium excretion of 76 mmol between low salt and control periods was accompanied 
by statistically significant BP differences of 10 mm Hg systolic and 6 mm Hg 
diastolic.
Subsequent trials of similar design were less conclusive. Watt et al. (1983) found 
almost no difference in BP in a trial of 13 patients with mild hypertension who had 
successfully reduced 24-hour urinary sodium excretion by an average of 79 mmol, 
although the statistical power of the study was limited and confidence intervals were 
wide. Further studies in young people with either normal (Watt et al., 1985) or mild
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elevations of BP (Grobbee et al., 1987) also found no significant effect on BP of 
moderate sodium reduction.
A double-blind randomised trial of sodium restriction in newborn infants has also 
been reported (Hofman, Hazebroek & Valkenburg, 1983). Four hundred and 
seventy-six newborn infants were randomly assigned to either a low-sodium or a 
normal-sodium diet during the first six months of life. The average amount of 
sodium consumed by the low-sodium group over six months was approximately one- 
third that consumed by the normal-sodium group: 0.89 mole sodium (sd 0.26) vs 2.50 
(0.95); and, on comparing the two groups, BP (systolic) at 25 weeks was significantly 
lower in the low-sodium group by 2.1 mm Hg.
More recently, a number of other well designed randomised controlled studies of 
sodium reduction have been reported, which were not included in the earlier review 
of Grobbee and Hofman (1986). Using a modification of the randomised cross-over 
design, Macgregor et al. (1989) studied the effects on BP of differing degrees of 
sodium restriction. Patients were randomised to receive various combinations of 
slow-sodium and placebo tablets, again in double-blind fashion. Twenty patients 
with primary hypertension were studied on sodium regimens (estimated from urinary 
excretion) averaging 49 mmol, 108 mmol and 190 mmol per day. Mean BPs in the 3 
periods were 147/91 mm Hg (SE 4/2), 155/95 mm Hg (SE 3/2) and 163/100 mm Hg 
(SE 4/2) respectively, and a significant trend of lower BPs at lower sodium intakes 
was observed. O f the 19 patients followed up for over a year, 16 had adequate BP 
control with sodium restriction alone, without resource to anti-hypertensive therapy.
The Australian National Health and Medical Research Council Dietary Salt Study 
Management Committee (1989) studied 108 people with untreated diastolic pressures 
between 90 and 100 mm Hg who were randomised into two groups, both of which 
were advised to reduce sodium intake to below 80 mmol per day. The "normal" 
sodium group was then given 80 mmol of sodium as slow-release sodium tablets, 
whereas the "low" sodium group was given matching placebo tablets only. This 
intervention perod lasted 8 weeks. On comparing the "low" and "normal" sodium 
groups during intervention, average daily sodium excretion was lower by 71 mmol, 
and average BPs were lower by 5.5 mm Hg systolic and 2.8 mm Hg diastolic 
(p<0.001, for the difference between the two groups). The study was extended to 
include a randomised cross-over component (using the slow-sodium/placebo design) 
which was undertaken by 88 of the participants who had taken part in the parallel 
group study (Australian National Health and Medical Research Council Dietary Salt 
Study Management Committee, 1989a). For a mean change in daily sodium
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excretion of 67 mmol/day (SE 4), BPs were lower in the low sodium phase by 3.6 
mm Hg (SE 0.7) systolic and 2.1 mm Hg (SE 0.4) diastolic, (p<0.001).
In a study of type II diabetics with mild hypertension, 34 patients were randomly 
allocated to either three months of moderate sodium restriction or to usual diabetic 
diet (Dodson et al., 1989). Compared with the control group, mean daily urinary 
sodium excretion fell by 60 mmol in the sodium restriction group, and mean supine 
systolic pressure by 12.9 mm Hg (p<0.05). There were no significant differences 
between the groups in diastolic pressure, although statistical power was limited given 
the small sample size. In an extension of the study, nine of the sodium restriction 
group completed a double-blind randomised cross-over study in which 4 weeks' 
placebo was compared to 4 weeks’ supplementation by 80 mmol sodium per day. 
During the supplementation phase, mean supine systolic pressure was significantly 
higher than baseline by 11.9 mm Hg; and during the randomised part of the study, 
comparing sodium supplementation and placebo, BP was significantly lower by 9.7 
mm Hg during the placebo (low-sodium) phase.
The studies described above were mostly of short duration and were conducted in 
subjects with mild to moderate hypertension. A parallel group study lasting three 
years has recently been reported. It was carried out in normotensive individuals 
(Hypertension Prevention Trial Research Group, 1990) at two levels of body mass 
index, and included among the interventions, reduced calorie intake, reduced sodium, 
and reduced sodium/increased potassium intake. In the lower body mass group at 
three years, there was only a small difference in 24-hour urinary sodium excretion (16 
mmol, estimated from overnight urine collections) between the reduced-sodium and 
control groups, which was associated with a small non-significant difference in BP 
(0.1 and 0.2 mm Hg higher systolic and diastolic BPs respectively in the lower 
sodium group); at six months, however, BPs were non-significantly lower in the 
reduced-sodium compared to the control group, by 1.7 mm Hg systolic and 0.4 mm 
Hg diastolic. In the higher body mass group, results of sodium reduction were 
similar.
A further randomised trial, reported by R. Stamler et al. (1989) tested the use of 
combined nutritional therapy (reduction in sodium, in overweight and in excess 
alcohol) in the primary prevention of hypertension. Two hundred young adults with 
high-normal pressure (diastolic between 80 and 89 mm Hg) were randomised either 
to nutritional therapy or to a control group. In the nutritional therapy group compared 
to controls, average 24-hour urinary sodium excretion was lower by 30 mmol, weight
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by 2.7 kg and the incidence of hypertension after 5 years was reduced by half (9% in 
the intervention group compared with 19% in the controls).
The review of Grab bee and Hofman (1986) was not comprehensive. For example, 
randomised controlled studies of sodium excretion compared with weight loss 
(Fagerburg et al., 1984) or a low fat diet (Puska et al., 1983) were not included. 
Furthermore, no attempt was made to differentiate between results from parallel 
group studies and cross-over studies. Both study designs have advantages and 
disadvantages. The parallel group study directly tests the effects of sodium 
restriction versus usual sodium, but valid interpretation depends on sufficient sample 
size to ensure similar groups at baseline; in addition, statistical power for an 
equivalent sample size is lower than in cross-over studies. The cross-over design 
enables two "treatments" to be compared in double-blind fashion; placebo (low 
sodium) and sodium supplementation (usual sodium), and it is statistically efficient 
since each participant acts as his or her own control. However, the cross-over study 
is prone to "period" and "carry-over” effects which may confound the analysis and 
interpretation, and the effect under study depends on which "treatment" was taken 
first. For participants randomised first to placebo, the contrast of interest measures 
the effect of sodium supplementation in those on a low-sodium diet; whereas if 
sodium is taken first (and assuming an adequate lead in period on the low-sodium 
diet), the contrast is between short term sodium supplementation (tablets) compared 
with sodium restriction (placebo).
Overview analysis
To overcome the difficulties with previous reviews, and to take account of recent 
additions to the literature summarised above, the evidence from randomised 
controlled trials of sodium restriction was re-evaluated in a comprehensive overview 
(meta-analysis) of all eligible randomised controlled studies of sodium reduction 
through to January 1990 (Cutler et al., 1991)*. Trials were identified by the present 
author and a co-author (J. Cutler, National Heart, Lung, and Blood Institute) from a 
previous review (Cutler et al., 1986), reference lists in original articles and reviews, 
computer searches and information from colleagues. Only published trials were 
considered eligible for inclusion. Data were analysed separately for trials in 
hypertensive and those in normotensive subjects and then combined across all trials. 8
8 The overview analysis was undertaken by the present author in collaboration with Drs. Jef Cutler
and I Soh, and Mr. Dean l-ollman. National Heart, Lung and Blood Institute (NHLBI), Bcthesda,
Maryland, USA. The results were presented at a workshop on salt and BP organised by NHLBI,
November 1-2, 1989.
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The main criteria for inclusion were: random allocation of participants to sodium 
reduction or a control condition; trial design unconfounded by other interventions 
(mainly anti-hypertensive drugs or potassium supplementation), and reporting of 
systolic and/or diasatolic BP (in contrast to mean arterial pressure). Trials in infants 
and young children were excluded, as were two trials which assigned control subjects 
to a supplemented level of sodium well beyond usual intake (Parfrey et al., 1981; 
Sagnella et al., 1987); also in the study of Parfrey e t al., some of the data were later 
withdrawn with re-publication in graphical form only (Holly et al., 1981). One 
further otherwise eligible trial was excluded because data on mean arterial pressure 
only could be obtained despite communication with the investigator (Tuck et al., 
1981). Finally, in the study of Macgregor et al. (1989) discussed above, only data 
from the high and medium intake arms were used, to make the levels of sodium 
intake compared most similar to the other studies and to avoid double-counting of the 
data from the medium intake arm in the pooled analysis.
Information from each paper was abstracted onto a standard form by the present 
author, and independently by a co-author (I. Suh, National Heart, Lung, and Blood 
Institute), and any differences were reconciled. Design features noted included 
parallel group or cross-over study, BP eligibility criteria, extent of blinding of 
intervention and BP measurement, and duration o f intervention. Sample size and 
outcome data were from the last follow-up visit unless only means of all visits were 
given. The main outcome measures were changes from baseline (parallel group 
studies) or differences between treatment phases (cross-over studies) in BP and 24- 
hour urinary sodium excretion. Means, standard deviations, standard errors, t-values 
and p-values were recorded for each measure when reported. In a few instances, 
values had to be estimated from figures. Where possible, information for potentially 
confounding factors was also recorded, including body weight, urinary potassium 
excretion and alcohol intake.
For each trial, an attempt was made to estimate the variance of the treatment effect 
for the outcome measures, i.e., systolic and diastolic BP. Ideally, these values should 
be obtained from standard deviations of paired differences, between baseline and end 
of follow up for each group (parallel groups) or between each of the two treatment 
periods (cross-over design); or, if these statistics are not given, from exact t-values or 
p-values. If an exact variance of paired differences could not be derived, then one 
was imputed, either by inverting a boundary p-value (e.g., p<.05 became p=.05) or
If possible, changes in potentially confounding variables were noted, e.g., potassium
and alcohol intake.
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assuming a correlation of 0.5 between initial and final BP. (These figures are the 
basis for the standard errors shown in Tables 1 and 2.) Since only nine trials provided 
adequate data to derive an exact variance for BP changes, and 14 required variance 
imputation as described, results were pooled weighting simply by sample size 
(Demets, 1987) thereby assuming that all the trials which were pooled had the same 
underlying variance for changes in the outcome measures. (The sample size weights 
are n for cross-over trials, and ntn(/h t+nc for parallel trials, where nt and nc are 
sample sizes for the treatment and control groups). Pooling was also carried out 
weighting each trial by the inverse of the variance (Demets, 1987), derived or 
imputed. The overall variance of BP change, which is required to calculate the 
standard error o f the pooled mean, was estimated by the average of those exact 
variances of paired differences that could be derived.
Tables 1 and 2 summarise details of individual trials, including whether or not the 
study was placebo controlled, blinding of BP observers, duration of study, difference 
in urinary sodium excretion and change in BP between intervention and control, and 
data on confounding variables. Twenty-three trials met the selection criteria 
(Australian National Health and Medical Research Council Dietary Salt Study 
Management Committee, 1989, 1989a; Chalmers e t al., 1986; Cooper et al., 1984; 
Costa et al., 1981; Dodson et al., 1989; Erwteman et al., 1984; Fagerberg et al., 1984; 
Grobbee et al., 1987; Hypertension Prevention Trial Research Group, 1990; Logan, 
1986; MacGregor et al., 1982, 1989; Maxwell et al., 1984; Morgan et al., 1978; 
Morgan & Myers, 1981; Myers, 1989; Parijs et al., 1973; Puska et al., 1983; Richards 
et al., 1984; Silman et al., 1983; Skrabal, Aubock & Hortnagl, 1981; Wan et al., 
1983, 1985). Five of these trials were reported as two strata or two phases so that 
there are 28 entries in the tables (Australian National Health and Medical Research 
Council Dietary Salt Study Management Committee, 1989, 1989a; Dodson et al., 
1989; Morgan & Myers, 1981; Puska et al., 1983; W att et al., 1985). Overall, there 
were 18 trials in hypertensive and 6 in normotensive individuals, giving data on a 
total of 1,536 people (one trial, Puska et al., 1983, reported on both hypertensive and 
normotensive individuals).
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Table 1
Randomised trials of sodium reduction in hypertensive individuals
Author
year
Sample
size1
Blinding
Study
length
(m onths)
Urinary 
N a change 
(m m ol/day)
B P change 
(mm Hg) (SE) 
SBP D BP
Reported
confounding
factors2
Crossover studies
Parijs 15 NR i -98 -6.7 + 3.2 (W t)
1973 (3 7 6 ) (3.47)
M acGregor 19 Placebo i -76 -10 -5 W t (K)
1982 BP Obs (3.06) (1.78)
Watt 18 Placebo i -56 -0.5 -0.3 (W t) (K)
1983 0 .5 0 ) (0.80)
Richards 12 NR i- -105 -5.2 -1.8 (W t) (K)
1984 1.5 (4.10) (3.55)
Grobbee 40 Placebo 1.5 -72 -0.8 -0.8 (W t) (K)
1987 BP Obs(RZ) (1.80) (1.55)
M acGregor 20 Placebo 1 -82 -8.0 -5.0 (W t) (K)
1989 BP Obs (2.60) (1 6 2 )
Dodson 9 Placebo 1 -76 -9.7 -5.1 (W t) (K)
1989 BP O bs(RZ) (4.33) (2.94)
ANHMRC 88 Placebo 2 -67 -3.6 -2.1 (K)
1989 (0.70) (0.40)
Parallel s tudies
Morgan 31/31 BP obs 24 -27 -1.5 -6.9 NR
1978 (4.60) (2.12)
Costa 20/21 NR 12 NR -18.3 -5.9 NR
1981 (4.35) (2.91)
Morgan 6/6 BP obs 2 -98 NR -6.0 K
1981 (male) (4.08)
Morgan 6/6 BP obs 2 -78 NR -4.0 K
1981 (female) (3.30)
Sii man 10/15 BP obs(RZ) 12 -53 -8.7 -6.3 (W t) (K)
1983 (10.23) (4.41)
Puska 15/19 BP obs 1.5 -117 +1.8 +0.5 W t K
1983 (4.14) (2.37) A le (P/S)
Fagerberg 15/15 NR 2.3 -89 -13.3 -6.7 (W t) (K)
1984 (5.46) (3.07) (A le)
Maxwell 18/12 NR 3 -171 -2.0 +2.0 W t
1984 (4.96) (2.84)
Erwteman 44/50 BP obs(RZ) 6 -58 -2.7 -3.4 NR
1984 (2.20) (1 7 0 )
Chalmers 48/52 NR 3 -54 -5.1 -4.2 (K)
1986 (1-42) (0.90)
Logan 37/38 BP obs 6 -32 -1.1 -0.2 W t(K )
1986 (2.15) (1 4 1 )
Dodson 17/17 BP obs 3 -59 -13.0 -1.8 (W t) (K)
1989 (5.99) (3.48)
ANHMRC 50/53 Placebo 2 -71 -5.5 -2.8 (A le)
1989 (1 4 8 ) (0.85)
1 ■ In parallel study"/" denotes treatm ent group/conlrol group.
2. Parentheses denote controlled factors, and no parentheses denote possible con iounders.
Abbreviations: A le, Alcohol; ANHM RC, A ustralian National Health and M edical Research C ouncil; NR, N ot 
reported; O bs, observer; P/S, Polyunsaturated fatty acid/saturated fatty acid ratio; RZ, Random -zero 
sphygmanom eter; Wt, Weight.
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Table 2
Randomised trials of sodium reduction in normotensive individuals
Author
year
Sample
size1
Blinding
Study Urinary 
length Na change 
(monlhsXmmol/day)
BP change 
(mm Hg) (SE) 
SBP DBP
Reported
confoundi
factors2
Crossover studies
Skrabal 20 NR 0.5 -170 -2.7 -3.0 Wt (K)
1981 (2.36) (2.03)
Cooper 113 BP obs 2 -69 -0.6 -1.4 Wt (K)
1984 (0.84) (107)
Watt 35 Placebo 0.9 -74 -1.4 + 1.2 (Wl) K
1985(HH) BPobs(RZ) (0.74) (0.93)
Watt 31 Placebo 1 -60 -0.5 + 1.4 (Wt) (K)
1985(LL) BP obs(RZ) (0.82) (0.90)
Myers 172 BP obs 1 -130 -3.5 -1.9 (Wt) (K)
1989 0 .2 5 ) (0.90)
Parallel studies
Puska 19/19 BP obs 0.5 -117 -1.5 -1.1 Wl K
1983 (3.32) (2.03) Ale (P/S)
HPTRG 174/177 BP obs 36 -16 +0.1 +0.2 (Wt) K
1990 (1.00) (0.80)
1. In parallel study"/" denotes treatment group/control group.
2. Parentheses denote controlled factors, and no parentheses denote possible confounders.
Abbreviations: A le, A lcoho l; NR, N ot reported; Obs, observer; P /S, P o lyunsatura ted  fatty acid /saturated  fatty acid 
ratio; RZ, R andom -zero sphygm om anom eter; Wt, W eight; HH, sub jec ts  w ith parents in the top third o f  the ir age- 
specific BP distribu tion ; LL, subjects w ith parents in the bottom  th ird  o f  their age-specific B P  distribution; 
HPTRG, H ypertension Prevention Trial Research Group.
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In hypertensive individuals, eight of the trials were cross-over, entirely or in part, 
with an aggregate of 221 subjects. Treatment periods were one to two months, with 
median sodium reduction of 76 mmol (range 56 to 105 mmol). The pooled estimate 
of BP change in hypertensive individuals from cross-over trials was, for systolic and 
diastolic BP, -4.33 (SE 0.73V-1.98 (SE 0.33) mm Hg. Twelve trials reported results 
for hypertensive subjects from parallel designs. In two of these studies, the parallel 
group trial preceded a cross-over study included above (Dodson et al., 1989; 
Australian National Health and Medical Research Council Dietary Salt Study 
Management Committee, 1989). A total o f 652 subjects were studied including these 
two trials. Median follow-up was 3 months, and median sodium reduction, net of 
controls, was 65 mmol (range 27 to 171 mmol). One trial did not report urinary data 
(Costa et al., 1981), but intracellular sodium concentration was lower in the 
intervention group by 22.8% after 12 months follow-up. The pooled estimate of BP 
change in hypertensive subjects from parallel group trials was -5.28 (SE 0.89)/-3.36 
(SE 0.56) mm Hg, systolic/diastolic BP. When inverse variance weights were used, 
the BP effects were slightly smaller (Cuder et al., 1991). There were only two 
parallel group studies in normotensive subjects, so that results by type of study are 
not given separately.
The pooled results (cross-over and parallel group studies) for both hypertensive and 
normotensive individuals are summarised in Table 3. In the studies of hypertensive 
subjects, median sodium reduction of 72 mmol was associated on average with BP 
lower by 4.9 mm Hg systolic and 2.6 mm Hg diastolic. In the normotensive subjects, 
sodium reductions ranging from 16 to 170 mmol (median 74 mmol) were associated 
with BPs lower by 1.7 mm Hg systolic and 1.0 mm Hg diastolic. Over all studies, 
pooled BP reductions of 2.9 mm Hg systolic and 1.6 mm Hg diastolic were observed. 
All these BP changes were highly significant. There was also some evidence for a 
dose response with a tendency for larger falls in BP to be associated with greater 
reductions in sodium intake (Cutler et al., 1991).
Since this overview was completed, results of a further randomised cross-over study 
in normotensive individuals have been published (Mascioloi et al., 1991). Forty-eight 
individuals with average BP 131/84 mm Hg were put on a reduced sodium diet and, 
after a run-in period of 10 weeks, were randomised to receive either sodium 
supplementaion of 96 mmol/day or placebo for periods of four weeks each. At the 
end of the sodium supplementation period, BPs were higher by 3.6 (SE 0.9) mm Hg 
systolic (p<.001) and 2.3 mm Hg (SE 0.8) diastolic (p=.005). These results are 
consistent with the findings from the overview analysis above.
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Table 3
An overview of randomised controlled trials of sodium reduction and blood
pressuret
BP Change (SE) (mm Hg)
SBP DBP
Trials in hypertensive -4.92** -2.64**
subjects (N=18 trials) (0.65) (0.42)
Trials in normotensive -1.70** -0.97*
subjects (N=6 trials) (0.50) (0.33)
All trials -2.91** -1.60**
(n=l,536 people) (0.39) (0.25)
+ Pooled estimates were obtained by weighting according to sample size.
* p<0.01 ** p<0.001
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In summary, randomised controlled trials have shown that sodium reduction is 
associated with reductions in BP; this association is likely to be causal as generally 
issues of bias and confounding were adequately addressed. The size of effect was 
larger in parallel group than cross-over studies, and in hypertensive than in 
normotensive individuals.
1.2.2 Sodium Reduction and Drug Therapy
Several investigators have studied the treatment of hypertension by a combination of 
drug therapy and sodium reduction (Beard et al., 1982; Bulpitt et al, 1984; Dodson, 
Pacy & Cox, 1985; Kristinsson et al, 1988; Luft & Weinberger, 1988; Macgregor et 
al, 1987; Weinberger et al., 1988). In general, these studies have shown an additive 
effect between sodium restriction and drug therapy, although the use of sodium 
reduction with calcium antagonists may be an exception (Luft & Weinberger, 1988; 
Cappuccio, et al., 1990) so that lower doses of drugs can be used by some patients 
whilst still achieving adequate control of BP (Beard et al., 1982; Dodson et al., 1985; 
Weinberger et al., 1988). For example, in the study of Beard et al. (1982) in which 
patients on medication for "mild" hypertension were randomly allocated to a reduced 
sodium or usual diet, about one third of the intervention group were without drug 
therapy at 12 weeks and a further 50% were managed on a reduced dose of drugs. By 
contrast, no reduction in therapy was recorded by two thirds of the control group 
(p<0.001, for the difference between the two groups).
Two major controlled trials (both in participants who had been enrolled in the 
Hypertension Detection and Follow-up Program - HDFP) have reported on the 
efficacy of nutritional advice in maintaining BP control without drug therapy 
(Langford et al., 1985; Stamler et al., 1987). In the Dietary Intervention Study in 
Hypertension (DISH) (Langford et al., 1985) participants who were taking anti­
hypertensive medication were randomly allocated either to continue or to stop 
therapy. Of those randomised to the "no medication" group, participants were further 
randomised to a control group (no nutritional advice), a sodium reduction group or 
(for overweight individuals) a weight reduction group. The trial lasted 56 weeks. 
Overall, 33% lower sodium intake (reduced by about 50 mmol per day) was achieved 
in the sodium reduction groups. By the end of the trial, 44.9% of overweight 
individuals who were reducing sodium remained off medication, as did 53.4% o f 
those who were not overweight, compared with 35.3% and 45.0% respectively in the 
control groups. In multiple logistic regression, compared with controls, sodium 
reduction was associated with a more than two-fold relative odds of remaining 
without medication (p<0.05).
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In the Hypertension Control Program (HCP) (Stamler et al., 1987) participants with 
mild hypertension which was well controlled on drugs were randomised to one of 
three groups: discontinued drug therapy and a nutritional programme to reduce 
overweight, excess salt and alcohol consumption (group 1); discontinued drug 
therapy, with no nutritional programme (group 2), and continued drug therapy (group 
3). 24-hour sodium excretion fell 36% (60 mmol) in  group 1, and at four years, 39% 
remained normotensive without drug therapy compared with 5% in group 2 
(controls). The study was designed to test a combination of non-pharmacological 
approaches and therefore did not give an estimate o f  the independent effect of sodium 
restriction on BP: participants in group 1 also experienced an average weight loss of 
1.8 kg, and a modest reduction in alcohol intake.
These studies suggest that in hypertensive patients, sodium reduction (either alone or 
together with weight loss and moderation of alcohol intake) can reduce the amount of 
medication required to control BP; in some cases, particularly in "mild" hypertension, 
BP may be controlled by dietary measures alone.
1 .23  Sodium Reduction in Populations
The results of two controlled studies of sodium reduction in general population 
samples have recently been published (Staessen e t al., 1988; Forte et al., 1989). 
Staessen et al. (1988) report on a study in two Belgian towns, one randomly selected 
to intervention, one acting as a control town. Intervention consisted of a media 
campaign via posters, leaflets, local radio and newspapers, which promoted the 
avoidance of added salt in cooking and at the table, and  the purchase o f foods without 
added salt. In addition, local general practitioners advised individual patients to 
reduce their sodium intakes. Random samples of households in both intervention and 
control towns were contacted at baseline in 1979/80, and further samples were 
recruited five years later, to obtain measurements of BP and self-reported 
(unsupervised) 24-hour collections of urine (the method of urine collection changing 
between baseline and follow-up periods). At follow-up, average daily sodium 
excretion in men had decreased by approximately 12 mmol in both towns, but for 
women there was a decrease in the intervention town o f 17 mmol and an increase in 
the control town of 8 mmol, the difference being significant at p<0.01. Persons aged 
50 or more showed larger differences (-24.5 mmol intervention, +17.0 mmol control, 
p<0.01). Although these differences were unrelated to  BP, confidence intervals were 
wide (reflecting both the limited sample size, particularly for the baseline surveys, 
and the study design which increased variance estimates by using different samples at 
baseline and follow-up).
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Forte et al. (1989) have reported the results of the Portuguese salt intervention trial, 
which was carried out in two rural communities, one of which acted as control. At 
the outset, daily average adult salt intake was 21 g (357 mmol), and 30% of people 
had a diastolic BP of 95 mm Hg or above. Intervention consisted of advice to eat less 
salt accompanied by a request to the local bakers to reduce sodium in bread. There 
was a high degree of community involvement, and intervention was strongly 
supported by village leaders and local medical and nursing staff. Intervention was 
reinforced by frequent meetings, discussions and small training groups to instruct 
housewives on cooking with less salt In the intervention community, average 
sodium intake fell by 162 mmol and average BPs by 3.6 mm Hg systolic and 5.0 mm 
Hg diastolic at 1 year, and 5.0 mm Hg and 5.1 mm Hg respectively at 2 years. In the 
control community, average sodium intake increased by 19 mmol; there was little 
change in diastolic pressure, but systolic pressure rose during the study, thus 
increasing the difference between the two groups. This difference in BP trends 
between the two communities was highly significant (p<0.001). In addition, changes 
in BP in individuals in the intervention community correlated positively and 
significantly with changes in urinary sodium/creatinine ratio.
A further study of sodium reduction in a school setting has also recently been 
published (the Exeter-Andover project). In a non-randomised study, Ellison et al. 
(1989) reduced the sodium content of the food served in one of two boarding schools, 
with the other school acting as control. After one year, the intervention and control 
schools were reversed. BP was monitored among 341 subjects during the control 
years and 309 during the intervention years. The average age of participants was 
about 15 years. Approximately 28% of sodium intake, as determined from 24-hour 
food histories, was obtained outside the schools. Students recorded their own BPs 
using an automatic device. Overall, a 15% to 20% reduction in sodium intake over 
an intervention period lasting about 24 weeks (i.e., allowing for a run-in period and 
school holidays) was associated with BPs lower by 1.7 (SE 0.59) mm Hg systolic and 
1.5 (SE 0.48) mm Hg diastolic.
The Portuguese salt trial showed that intervention could successfully lower both 
sodium intake and BP, albeit in a community consuming large amounts of salt. A 
beneficial effect of intervention was also found in school children in the Exeter- 
Andover project, where modest changes in sodium intake were associated with 
changes in BP of between one and two mm Hg. By contrast, the Belgian trial was 
largely unsuccessful in its intervention, and only relatively small differences in 
sodium excretion and BP were observed.
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1.2.4 Sodium Loading Experiments
Experiments in man have shown that BP may rise following a large salt load, 
possibly related to a volume effect. McQuarrie, Thompson & Anderson (1936) 
described observations on four diabetic children in whom excess sodium intake o f 
more than 700 mmol of sodium chloride daily resulted in higher BP. Blood pressure 
fell when potassium chloride was added to the diet in two patients. Body weight also 
fell during this period, suggesting that an acute sodium diuresis may have occurred 
during the potassium supplementation period.
More recently, a series of sodium-loading experiments in both black and white 
normotensive subjects have been reported (Grim et al., 1977, 1979; Luft, Weinberger 
& Grim, 1982; Luft et al., 1977, 1979, 1979a). When two-litres of normal saline 
were given intravenously over four hours to 34 white and 34 black men and women, 
BP went up, significantly so in black women (Luft et al., 1977). In a subsequent 
study o f similar loading with Normal saline in 270 white and 77 black subjects, BP of 
the black group was significantly higher than the white group after the sodium load 
(BP in the white subjects actually fell during hospitalisation) and it remained elevated 
until after administration of frusemide (Luft et al., 1979); and, in a small study of 14 
volunteers, sodium intakes o f 600 to 1,500 mmol per day resulted in a rise in BP, 
especially in black subjects (Luft, et al., 1979a; Luft, Weinberger & Grim, 1982).
In another small study, no significant changes in BP were noted when 8 normotensive 
white men were fed high sodium diets of either 210 or 410 m m ol per day (Kirkendall 
et al., 1976); and in a study of sodium supplementation o f  180 mmol per day 
following one week's diuretic therapy, BP rose significantly in 33 subjects with 
borderline hypertension, but not in 12 normotensive subjects (Fujita, Noda & Ando, 
1984). However, BP rose when the diets of 10 men from the highlands of Papua New 
Guinea were supplemented with 128 and 256 mmol of sodium above their usual 
intake of about 30 mmol per day (Rikimaru et al., 1988).
The effects described here are acute and short-term, and are the result of loading with 
large amounts of sodium. Only small numbers of people have been studied in this 
way, and the relevance to the aetiology and pathogenesis o f  high BP is unclear. 
Nonetheless, the results are consistent with other evidence in so far as 
supplementation with (very) large amounts of sodium is associated with higher BP.
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1.3 Epidemiological Evidence
Epidemiological evidence relating sodium and BP comes from a variety of studies 
across and within populations, conducted with differing methodologies and 
unstandardised measurements of both sodium intake and BP (Elliott & Marmot, 
1984; Simpson, 1979). In reviewing the evidence here, the aim is firstly to discuss 
some of the methodological issues involved so that the results can be put in context, 
and secondly to summarise the contribution of this large body of work to our 
understanding of the epidemiology of sodium and BP. Studies in migrants are also 
reviewed.
1.3.1 Across-Population Studies
A positive across-population association between salt and BP was first described by 
Dahl (1960) who found, across five population groups, a remarkable straight line 
relationship between average sodium intake of a population and the prevalence of 
hypertension. Dahl (1960) noted also that hypertension was uncommon in 
populations consuming less than 4 or 5 gram of salt per day (i.e., about 70 to 80 
mmol), and hypothesised that salt increased the probability of raised BP in a group, 
though not necessarily in an individual.
Publication of Dahl's straight line graph stimulated others to review the literature for 
data on mean sodium intake and mean BP of populations (Froment, Milon & Gravier, 
1979; Gleibermann, 1973; Macgregor, 1985; McCarron, Henry & Morris, 1982; 
Simpson, 1984). These studies generally confirmed the Dahl relationship, but, to a 
greater or lesser extent, suffered from a number of uncertainties and bias. A major 
concern is that the data were not derived from one standardised source, but from a 
variety of studies in the published literature in which unstandardised and often 
unspecified methods were used. Often data on sodium intake and BP for a particular 
population were derived from different sources, and, in the well-known paper by 
Gleibermann (1973), the author's own estimates of sodium intake (6 g salt per day) 
were used for six of the 27 populations studied, whilst in a further ten "a quantitative 
value for mean salt consumption was reported with or without indications as to how it 
was calculated" (Gleibermann, 1973). A further problem is that systematic error of 
measurement in a population (e.g., of BP) may have introduced bias into the across- 
population comparisons.
Few data on confounding variables were available for consideration in these cross- 
cultural (ecological) studies. Because of multiple social, geographical and
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environmental differences between populations around the world (which may also 
relate to differences in BP) relationships in ecological studies are particularly 
susceptible to major and unmeasured confounding (Piantadosi, Byar & Green, 1988). 
Under these circumstances, there is a danger of making inappropriate inferences 
concerning relationships in individuals from data on groups. This problem has been 
termed the "ecological fallacy" and is discussed in more detail in Chapter 3.
One of the most comprehensive ecological studies of sodium and BP was published 
by Froment, Milon and Gravier (1979), using data in the literature from 28 
populations around the world. Results were presented separately by sex, and at 
approximate ages 20 and 50 years. Data on sodium intake were based on urinary 
excretion of sodium from 24-hour urine collections (although not necessarily from 
the same studies as the BP data) except in the Solomon Islands where "spot" (casual) 
urine collections and questionnaire data were used (Page, Damon & Moellering, 
1974), and in St. Kitts, West Indies, where estimates of sodium intake again relied on 
spot urine collections (Schneckloth et al., 1962). The same value for sodium was 
included in the regression equations for both men and women, although most surveys 
have shown lower sodium excretion in women (see, for example, Doyle, Chua & 
Duffy, 1976; Elliott et al., 1988; Simpson et al., 1978) which may be related in part to 
differences in body weight (Watson et al., 1980).
Some results using the data published by Froment et al. (1979) are summarised in 
Table 4. The first two columns give the regression coefficients relating mean BP and 
mean sodium intake in 50 year old men and women, across all 28 populations 
described by Froment, Milon and Gravier (1979). The coefficients relating systolic 
BP and sodium are approximately 10 mm Hg per 100 m mol sodium, and those 
relating diastolic BP and sodium are between 5 and 6 m m  Hg per 100 mmol. 
However, as shown by Elliott & Marmot (1984) these regression analyses are 
strongly influenced by the nine populations with low average sodium intakes (less 
than 2 gram salt per day). Strictly speaking, these nine "low salt" populations are not 
"independent" of one another, four being included from Papua New Guinea 
(Maddocks, 1967; Maddocks & Rovin, 1965; Sinnett & W hyte, 1973; Whyte, 1958) 
and three from the Solomon Islands (Page, Damon & Moellering, 1974). The 
remaining two populations were the !Kung bushmen of Northern Botswana (Truswell 
et al., 1972) and the Yanomamo Indians of Brazil (Oliver, Cohen & Neel, 1975). 
These nine isolated populations were likely to have had the least adequate data for 
both sodium intake and BP, and to have differed from the remainder in many ways 
other than sodium intake. When the nine populations are excluded from the analysis.
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as shown in the last two columns of Table 4, the regression slopes relating sodium 
and BP are reduced and, although positive, are no longer significant*.
The paper by Froment, Milon and Gravier (1979) also allowed an estimate of the 
relation between sodium and BP slope with age (estimated from data at approximate 
ages 20 and SO). In the 28 population analysis, the regression coefficients indicated 
that 100 mmol lower sodium intake was associated in men with a 7.7 mm Hg lower 
rise in BP over a 30 year period, and an 8.3 mm Hg lower rise in women (pc.OOl for 
both analyses). Seven of the 9 "low salt" populations (and 2 others) recorded lower 
mean BPs with increasing age. Again, the size of association relating sodium and 
slope of BP with age was reduced when the nine low-sodium populations were 
excluded.
Positive ecological relations between average sodium intake and average BP have 
also been found across different communities within individual countries. In Japan, 
extremely high levels of sodium intake have been recorded, particularly in the 
Northern prefecture of Akita (Sasaki, 1964) and BPs have also tended to be high in 
North Japan compared with the South (Hatano, 1975). Komachi and Shimamoto 
(1980) showed a positive correlation (r=0.69) between the prevalence of hypertension 
at ages 50 to 59 and average daily sodium intake across eight Japanese communities. 
In China, significant positive correlations (r=0.62 in men, r=0.81 in women) were 
found relating average systolic BP and average nine-hour sodium excretion across 12 
and ten population samples in men and women respectively (Liu & Lai, 1986); and 
across the five Chinese centres participating in the CARDIAC Study, there was a 
positive correlation between urinary excretion of sodium (estimated from 24-hour 
collections) and both systolic (r=0.79) and diastolic BP (r=0.65) (Yamori, 1989). 9
9 To some extent, this result may reflect the smaller number of populations and the more limited 
range o f sodium intakes in the analysis which excludes the low-sodium populations. A similar 
point has been made concerning the truncation of the distribution of centres in INTERSALT, 
where four low-sodium centres were excluded from some across-populalion analyses (National 
Research Council, 1989).
I
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Table 4
Regression coefficients (SE) relating mean blood pressure at age 50 and mean 
sodium intake across 28 populations, and across 19 populations excreting more
than 2 g of salt per day f
Regression Coefficients (mm Hg/100 mmol sodium)
28 Populations 19 Populations
Systolic Diastolic Systolic Diastolic
Men 10.0** 6.1** 5.3 2.6
(2.0) (1.3) (3.0) (1.9)
Women 9.8* 5.5* 3.0 1.1
(2.9) (1.6) (4.2) (2.4)
t Adapted from Froment, Milon and Gravier (1979)
* p<0.01 ** p<0.001
i
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In six Solomon Island societies, the community with the highest sodium excretion 
had the highest BPs (Page, Damon & Moellering, 1974) and in Newfoundland, higher 
mean sodium intake and higher BPs were found in an island fishing community 
compared to an inland mining and logging community (Fodor, Abbott & Rusted, 
1973). In the United States, higher BPs in Blacks compared to Whites were found 
both in children (Berenson, Voors & Dalferes, 1979) and in adults (Grim et al., 1980) 
and were associated in Blacks with lower urinary excretion of potassium, and a 
higher sodium/potassium ratio (Grim et al., 1980); and in South Africa, where Blacks 
are known to have a high incidence of hypertension, urinary sodium excretion was 
higher and potassium lower in a group of black compared to white normotensive 
adults (Barlow et al., 1982).
Stroke and stomach cancer
Further indirect evidence for an ecological relationship between salt and BP is the 
observation that mortality from stroke and stomach cancer are highly correlated both 
across countries and within countries over time (Joossens, 1968, 1980; Joossens et al. 
1971). Salt is postulated to be an aetiological factor common to both diseases 
(Joossens, 1968, 1980). For example, in Belgium, where the mortality from both 
diseases is declining, Joossens (1979) reports a decline also in 24-hour sodium 
excretion, from 15.2 g per day (per 1.77 g of creatinine) in 1966 to 8.4 g per day in 
1978-79. This contrasts with an estimated sodium intake in 1920 in Belgium of 17 g 
per day.
Although Joossens' hypothesis is of interest, there are inconsistencies, and a decline 
in sodium intake has not been observed in all countries studied. For example, in the 
United States where mortality from stroke has been declining since at least 1920 
(Moriyama, Krueger & Stamler, 1971), the amount of salt in the food supply is 
estimated to have increased by 14% since about 1910 (Friend, Page & Marston, 
1979). Whelton and Goldblatt (1982) re-examined the relationship between stomach 
cancer and stroke mortality and found no significant relationship when percentage 
changes in mortality from 1958-1970 were compared between different countries. 
They also found no association between a diagnosis of stroke and stomach cancer of 
individuals, by analysing multiple cause death certification in England and Wales for 
1975 and 1976.
In summary, across-population (ecological) studies of sodium and BP generally 
support Dahl's finding that the mean sodium intake of a population is positively 
correlated with mean BP, but they rely on a variety of unstandardised field methods
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and are subject to varying degrees of bias and confounding. Regression analyses 
across populations appear to be particularly influenced by a number of remote and 
isolated populations with low sodium intakes and low BPs.
1.3.2 W ithin-Population Studies
A different set of problems befall studies of salt and B P within populations. As 
pointed out by Watt and Foy (1982), as many as 5700 participants, each collecting a 
single 24-hour urine specimen, may be required to demonstrate a true regression 
slope between systolic BP and sodium of 10 mm Hg per 100 mmol sodium, the value 
of the across-population slope observed by both Gleibermann (1973) and Froment, 
Milon and Gravier (1979), resulting in a lack of statistical power of all but the largest 
studies. This is because (at least in most Western populations) true differences in 
urinary sodium excretion between persons are swamped by the large day-to-day 
variation within persons, so that individuals are grossly misclassified with respect to 
their true ("habitual") sodium excretion (Liu et al., 1979). The result is a major bias 
towards a zero regression relationship between BP and sodium; such bias has been 
termed "regTession-dilution" by MacMahon et al. (1990).
This problem of measurement should be contrasted with the situation for other 
variables like body weight, where within-person variability is small in comparison to 
between-person variability, and individuals can be classified appropriately into 
groups (e.g., based on "high" and "low" values) using a single (casual) measure (Liu 
et al., 1982). Associations with an outcome variable (e.g., between overweight and 
high BP) are thus much more readily demonstrated than is the case for sodium and 
BP.
In addition to regression dilution, another major potential source of bias in within- 
population studies of sodium and BP is the difficulty in obtaining complete 24-hour 
urine specimens in general population samples (Pietinen et al., 1976). The effect of 
undercollection of urine specimens and the importance o f  regression dilution are 
illustrated by results of a small methodological study conducted in a random sample 
from a general practice in North London (Elliott et al., 1988). In this middle aged 
and elderly population with a large spread of daily sodium excretion, the day-to-day 
variation in electrolyte excretion of the individual was small in comparison with other 
studies. Analysis of repeated urine collections in a sub-sample indicated that day-to- 
day within-individual variation in sodium excretion biased regression slopes by only 
14% (based on a single 24-hour urine collection) compared with a downward bias of 
over 75% in some other studies (Liu et al., 1979). Under these circumstances.
40
whereby individual sodium excretion was apparently well characterised by a single 
24-hour urine collection, the within-population regression estimates relating sodium 
and systolic BP were similar to those predicted by Gleibermann (1973) and Froment, 
Milon & Gravier (1979) from the across-population studies; and the results were 
statistically significant even though the sample size was relatively small.
Results are summarised in Table 5. The regression slope relating systolic BP and 
sodium was 9.1 mm Hg/100 mmol sodium, after adjustment for age, sex and body 
mass index. With correction for reliability, which statistically adjusts for the 
regression-dilution bias introduced by physiological within-person variability in 
sodium excretion, the systolic BP-sodium regression slope was 10.6 mm Hg/100 
mmol sodium. However, because of incompleteness of urine collections, it is 
probable that this reliability-corrected estimate was still too low. Although all 58 
participants reported complete collections, only 28 of the collections were found to be 
complete by excretion of para-amino-benzoic-acid (PABA), a biological marker 
given orally (as capsules) during the day of the urine collection. Among the 28 
people with complete collections, the regression estimate of the systolic BP-sodium 
relation, after adjustment for confounding variables, was 14.5 mm Hg/100 mmol 
sodium. A similar progression in the size of regression slopes was found for sodium 
and diastolic BP (Table 5).
Further methodological problems of within-population studies include statistical 
"over-adjustment” of the BP-sodium relationship for covariates (such as body weight) 
which are much more precisely measured than sodium, giving estimates of the 
sodium effect which are biased down towards zero in multiple regression analyses 
(Liu, 1988); and other biases caused by the effects of anti-hypertensive drug 
treatment on BP, and by hypertensive individuals selectively changing their diets as a 
consequence of the diagnosis of high BP (Elliott et ah, 1987; Hashimoto et al„ 1989).
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Table 5
Age, sex and body mass index adjusted regression coefficients relating blood 
pressure and sodium excretion in a North London population* with 
consideration of the effects of within-person variability of sodium 
excretion, and incompleteness of urine collections
Regression coefficients (SE) 
(mm Hg/100 mmol sodium)
Systolic BP Diastolic BP
All persons (n=58) 9.1* (3.7) 2.5 (2.0)
All persons, 
corrected for reliability 
(point estimate )+ 10.6 2.9
"Complete collectors” 
by PABAt excretion (n=28)
14.5* (5.9) 5.9 (3.0)
5 From Elliott et al., 1988
t  Correction for reliability based on repeat measures
t  Para-amino-benzoic-acid
*p<0.05
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Within-population studies of salt and BP have used a variety of dietary methods to 
estimate sodium intake, from a salt frequency questionnaire to multiple 24-hour urine 
collections. Early reports by Dahl and Love (1954) that the frequency of adding salt 
to food at table was related to prevalence of high BP were supported by the findings 
of one study (Finn et al., 1981) but could not be confirmed in other studies (Dawber 
et al., 1967; Miall, 1959). Recent data from the United Kingdom suggest that the 
proportion of non-discretionary sodium in the diet of Western industrialised 
populations is as high as 85% of intake, mostly added in the manufacturing process 
(Sanchez-Castillo et al., 1987; Shepherd & Farleigh, 1987). Given the variability in 
sodium content of many processed foods (Bender, 1977) methods using diet history 
are unlikely to give reliable estimates of the sodium intake of individuals. 
Nonetheless, significantly positive relations of dietary sodium with BP have been 
described in studies from Belgium (Kesteloot & Joossens, 1988) Northern Kashmir 
(Mir & Newcombe, 1988; Mir et al., 1986) and Southern California (Khaw & Barrett- 
Connor, 1988), and significantly negative relations in one study from the Netherlands 
(Kok et al., 1986). In a study from South Africa (Steyn et al., 1986) and another 
American study (Swaye, Gifford & Berrettoni, 1972), no significant differences were 
found in the dietary intakes of sodium in normotensive and hypertensive individuals; 
and analyses of dietary data from the first US National Health and Nutrition 
Examination Survey (NHANES) gave conflicting results. In analyses of the same 
NHANES data set but using different statistical methods, relations of sodium with BP 
were variously described as positive (Gruchow, Sobocinski & Barboriak, 1985) 
inverse (McCarron et al.,1984) and also as displaying no relationship (Harlan et al., 
1984).
Most studies have measured the urinary excretion of sodium as a proxy for intake. 
With the marked diurnal cycle in creatinine, electrolyte and water excretion (Ram & 
Reddy, 1970; Wesson, 1964) and the large variations in sodium excretion which are 
apparent even hour-to-hour (Stanbury & Thomson, 1951), a minimum collection 
period of 24 hours is considered necessary to adequately represent sodium intake 
(Pietinen & Tuomilehto, 1980). However, several studies have reported on the use of 
a casual or "spot" urine collection which is a far simpler method for epidemiological 
surveys, although its validity has been questioned (Cummins, Shaper & Walker, 
1981). Of the nine population studies using the spot urine method which were 
identified in the literature, seven reported significantly positive sodium-BP 
relationships (Costa, 1981; Khaw, 1983; Khaw & Rose, 1982; Kihara et al., 1984; 
Poulter et al., 1984; Simmons, 1983; Takemori et al., 1989) whereas only two
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reported no significant association (Walker et ah, 1979; Prior et al., 1968), and none a 
significantly negative relationship.
Similarly, overnight urine collections are more readily obtained than 24-hour 
collections, and compliance is likely to be higher in  epidemiological surveys 
(Pietinen et al., 1976). Although correlated with 24-hour urinary excretion of sodium 
(Liu et al., 1979a; Luft, Fineberg & Sloan, 1982) sodium estimated from overnight 
collections is also subject to methodological difficulties; for example, there is some 
evidence that hypertensive individuals excrete a relatively greater proportion of 
sodium at night than normotensive subjects (Dyer et al., 1987). Six population 
studies using the overnight urine method have reported significantly positive 
associations with BP (Faust, 1982; Hsiao et al., 1986; Liu, Tao & Lai, 1984; Liu, Xie 
& Fang, 1988; Page et al., 1981; Pan et al., 1990) including four studies of Chinese 
populations (Hsiao et al., 1986; Liu, Tao & Lai, 1984; Liu, Xie & Fang, 1988; Pan et 
al., 1990). Only one study using overnight sodium excretion has reported a non­
significant relationship with BP (Dai, Kuller & Miller, 1984), and, as with spot 
urines, no significantly negative studies were identified in  which an overnight urine 
collection was used to estimate sodium intake. Given the practical and 
methodological difficulties in conducting these studies, the above results are 
remarkable, but perhaps indicate a degree of publication bias towards positive results.
Studies o f 24-hour urinary sodium excretion and blood pressure: overview analysis
Most within-population studies have used 24-hour urine collections to estimate 
sodium intake. Both positive and negative correlations w ith BP have been described, 
although many studies lack statistical power and are too small to show significant 
associations. The literature was searched to identify those studies of 24-hour urinary 
sodium and BP which could be incorporated into an overview analysis. The aim was 
to include all studies that published a quantitative regression or correlation estimate, 
either positive or negative, of the relation of sodium to both systolic and diastolic BP 
in populations. Thus studies which compared sodium excretion in hypertensive and 
normotensive individuals (i.e., case-control studies) were not eligible, as they do not 
provide a quantitative estimate of effect; in addition, such studies are difficult to 
interpret (Watt & Foy, 1982) and are susceptible to bias, both in the selection of 
individuals (some studies being based in hospital hypertension clinics) and also 
because hypertensive patients may alter their dietary habits as a consequence of their 
diagnosis (Elliott et al., 1987; Hashimoto et al., 1989). Excluded from the overview 
for this reason are two Australian studies (Doyle, Chua & Duffy, 1976; Morgan, 
Carney & Wilson, 1975), one American (Dahl, 1957) and one Japanese study
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(Shibata & Hatano, 1979) which showed a significantly positive association between 
being hypertensive and sodium excretion; a study from Scotland which showed a 
significantly negative association (Beevers, Hawthorne & Padfield, 1980), and other 
studies showing no significant association (Dawber et al., 1967; Bing, Thurston & 
Swales, 1979; Fodor & Rusted, 1980; Miall, 1959; Phear, 1958; Thulin, Karlberg & 
Scherstdn, 1978; Tuomilehto et al., 1980). Two studies which found no significant 
difference in sodium excretion on comparing hypertensive and normotensive 
subjects, also provided regression-correlation estimates at the individual level 
(Berglund et al., 1976; Ljungman et al., 1981) and are discussed below.
Another group of studies was ineligible for the overview because they reported non­
significant BP-sodium associations without giving a quantitative estimate, e.g., 
results were reported as "not-significant" or showing "no correlation"; this includes 
studies in the United States (Langford & Watson, 1973), New Zealand (Simpson et 
al., 1978), Germany (Schlierf et al., 1980), Australia (Armstrong et al., 1979), Malawi 
(Simmons et al., 1986), South Africa (Sever et al., 1980) and Japan (Komachi and 
Shimamoto, 1980).
Other studies gave some quantitative estimates, but only when the results were 
statistically significant. Because nearly all of these significant findings were of a 
positive association, inclusion of these studies could have introduced a bias towards a 
positive relation if significantly negative findings were being underreported. 
Additionally, selective inclusion of significant results (either positive or negative) 
would tend to enter more extreme values into the overview analysis. Studies 
excluded from the overview for this reason include those reporting significantly 
positive BP-sodium associations in China (Kesteloot et al., 1987), Korea (Kesteloot et 
al., 1980), Belgium (Joossens et al., 1980) and Norway (Omvik, Lund-Johansen & 
Eide, 1983). Two Swedish studies were also excluded which reported correlations 
with sodium (for diastoic BP only) separately for hypertensive and normotensive 
individuals (Berglund et al., 1976; Waem & Aberg, 1979). (The correlations were 
significantly negative in the hypertensive group and significantly positive in the 
normotensive group.) Another Swedish study found a significantly positive 
association between sodium excretion and mean arterial pressure amongst 
normotensive individuals (but not in the group as a whole) but gave no data on 
correlations of sodium with systolic and diastolic BP (Ljungman et al., 1981); and a 
study in the United States found significant correlations between various estimates of 
24-hour sodium excretion and mean arterial pressure in simple (but not multiple) 
regression, but again gave no data for systolic and diastolic BP, although it was
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implied that they were significantly correlated with sodium excretion (Grim et al., 
1978).
Fourteen studies (of sixteen populations) remained which fulfilled the entry criteria 
(Bulpitt et al., 1986; Connor et al., 1984; Elliott et al., 1988; Joossens et al., 1971; 
Karvonen & Punsar, 1977; M'Buyamba-Kabangu et al., 1986; Pietinen, Wong & 
Altschul, 1979; Prior & Stanhope, 1980; Sinnett & Whyte, 1973; Smith et al., 1988; 
Staessen et al., 1981, 1983; Strazzullo et al., 1983; Watson e t al., 1980). These 
studies are listed in Table 6, together with their sample sizes, regression coefficients 
and standard errors. From each population, the regression estimates were either 
directly obtained (Elliott et al., 1988; Joossens et aL, 1971) or algebraically derived 
from the Pearson-r correlation coefficient and the standard deviations of both sodium 
and BP (Armitage & Berry, 1987, p.152). One otherwise eligible study of 33 
individuals was excluded from the overview, since data on standard deviations were 
absent (Farleigh, Shepherd & Land, 1985). Data were available only for simple 
(unadjusted) regression; where data (e.g., standard deviations) were given stratified 
by some other variable, e.g., age (Prior & Stanhope, 1980) the appropriate unbiased 
(whole sample) estimate was obtained by analysis of variance (Armitage & Berry, 
1987, pp. 186-192). Where possible, regression coefficients were separately obtained 
for men and for women in each population and then averaged to give an overall 
estimate of association. Two studies reported data only fo r men and women 
combined (Elliott et al., 1988; Pietinen, Wong & Altschul, 1979). Regression slopes 
were pooled by weighting with the inverse of the variance (Demets, 1987); total 
sample sizes for the three analyses were 7,099 men, 6,136 women, and 12,503 men 
and women combined.
The results are shown in Table 7, after correction for reliability using the 
INTERSALT estimate of 0.46 (INTERSALT Cooperative Research Group, 1988). 
Statistically highly significant positive relationships were seen in  all analyses. As in 
INTERSALT, regression coefficients were somewhat larger in women than in men 
(see Chapter 4). Overall, for men and women combined, the regression coefficient 
corrected for reliability indicated systolic pressure lower by 3.7 and diastolic pressure 
lower by 2.0 mm Hg for sodium lower by 100 mmol.
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Table 6
Overview of studies of 24-hour urinary sodium excretion and blood pressure: 
Summary of data abstracted
Regression Coefficients 
(m m  H g/100 mm ol sodium ) 
Systolic D iastolic
Study Sex n M ean Age b(SE) * S E )
i . Joossens.et al., 1971 M 1314 44.7 335***(0 .91) Z 2 9 * * * (0 3 5 )
W 713 46.6 4.88** (1.82) 1.53 (0.88)
2. Sinnett,et al., 1973 M 138 30-39» -1 0 3 4 (10.29) -11.63 (7 3 5 )
W 135 30-39» -3.45 (7.47) 4.93 (4.84)
3. Karvonen.et al.,1977 
W est Finns M 98 63.7 -4.67 (2.94) -2.20 (1 4 8 )
East Finns M 94 62.9 -0.67 (2.32) 1.11 (1-15)
4 . W atson.et al., 1980 
Blacks W 356 t 1.78 (1 2 9 ) 0.10 (1-29)
W hites W 104 t 2.47 (3.08) -1.76 (4.47)
5 . Prior, et al., 1980 M 234 35-445 3.06 (3.85) 0.45 (2.11)
W 261 35-445 2.25 (6.07) 2.18 (3.30)
6. Staessen, e t al., 1981 M 233 41.0 -0.95 (1.25) 0.82 (0.90)
W 202 40.4 2.01 (2 0 3 ) -0.38 (1 3 4 )
7. Staessen, e t al., 1983 M 273 41.6 -0 3 9 (1 1 9 ) 1.02 (0.88)
W 255 39.3 2.07 (1.85) -0.19 (1.19)
8. Strazzullo, et al., 1983 M 188 40.6 3.99 (2.07) 5.56** * (1 4 5 )
9 . Connor, et al., 1984 M 170 36 1.79 (1 1 4 ) 0.84 (0.92)
W 182 36 3.77 (1.99) 2.46* (1 1 3 )
10. M 'Buyamba-Kabangu e t al.,1986 M 144 32 1.85 (3.88) 0.99 (2.77)
W 169 32 5.27 (3.11) 1.85 (2.04)
11. Bulpitt,et al., 1986 M 459 45 0.29 (1 3 7 ) -0.86 (1 0 1 )
W 159 46 2.77 (2.76) 2.08 (1.83)
12. Smith, et al. 1989 M 3754 40-59* 0.61 (0.40) 0.39 (0.25)
W 3600 40-59* 1.94** (0.59) 1 .04***(033)
13. Pietinen, et al. 1979 M & W 50 26.4 7.01** (2.06) 3.75* (1.86)
14. Elliott, et al. 1988 M & W 58 57.9 9 3 * (3.6) 4.3* (2.1)
M -M en  W =W om en § Age g ro u p  including m edian age t  Young persons (originally screened at h igh  school) 
♦  Range
*p<0.05 ••peO.Ol ***p<0.001
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Table 7
Overview of population-based studies of 24-hour urinary sodium excretion and 
blood pressure: Pooled regression coefficients b (SE)$ (mm Hg/100 mmol 
sodium) by sex, and for men and women combined.
Systolic BP Diastolic BP
n t b(SE)t b(SE)t
Men 7,099 1.78* 1.55**
(0.66) (0.42)
Women 6,136 4.80** 2.02**
(0.98) (0.59)
Men & Women
Combined 12,503 3.65** 1.98**
(0.62) (0.37)
$ Corrected for reliability using INTERSALT estimate of 0.46 (INTERSALT 
Cooperative Research Group, 1988)
t  Pooled sample size. Two studies gave data for men only (Karvonen & Punsar, 
1977; Strazzullo et al., 1983), one for women only (Watson et al., 1980) and 
two studies gave data for men and women combined only (Elliott et al., 1988; 
Pietinen, Wong & Altschul, 1979).
*p<0.01 **p<0.001
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1.3 .3  Longitudinal Studies
The epidemiological studies discussed above, relating sodium excretion and BP in 
individuals and populations, are cross-sectional with measurements of both variables 
taken close together in time. The resulting regression-correlation estimates will be 
too small if the relevant exposure is sodium intake accumulated perhaps over many 
years, or if sodium intakes are changed as a consequence of high BP. An alternative 
approach is to follow people up over time to see how well their sodium excretion at 
baseline predicts future BP levels. Geleijnse, Grobbee & Hofman (1990) report the 
results of the only one such observational study that has been published (other than a 
study of migrants discussed below).
A cohort of 596 children aged 5 to 19 years was randomly selected for study between 
1975 and 1978, from the population of two districts in the western part of the 
Netherlands. Geleijnse, Grobbee & Hofman (1990) report on 233 of these children, 
who were aged up to 17 at entry, and who had at least six yearly examinations. BP 
was measured using a random zero sphygmomanometer; urine was collected as six 
timed overnight samples. The estimated change in systolic BP per year was 0.003 
mm Hg/mmol sodium which, although not significantly different from zero, was 
identical to the INTERSALT estimate based on cross-sectional data on differences in 
BP with age (see Chapter 4, and INTERSALT Cooperative Research Group, 1988). 
A significantly negative slope of BP with age was found for potassium excretion (- 
0.045 mm Hg/year/mmol potassium) and a significandy positive slope for the urinary 
sodium/potassium ratio (0.356 mm Hg/year/unit ratio).
1.3.4 Migrant Studies
Another method of examining the effects of dietary and environmental influences on 
BP is to study migrants. Most of these studies have compared different cross-sections 
of people before and after migration. For example, Shaper, Williams & Spencer 
(1961) investigated the nomadic Samburu tribe of northern Kenya. The staple fare of 
the men was milk and meat; the diet was high in fat and protein and low in 
carbohydrate. The men were lean, BPs were low and neither weight nor BP appeared 
to increase with age. Subsequently, Samburu warriors serving with the army in 
Kenya were studied and compared to young warriors in their home districts (Shaper 
et al., 1969). By the second or third years of army service, systolic BP was 
significantly higher in recruits than in controls, and the difference became more 
marked after longer army service. Shaper et al. (1969) estimated that salt intake 
increased on entering the army from about 3.5 g per day (60 mmol) on the traditional
Samburu diet to as much as 16 g per day (270 mmol) on army rations, and suggested 
that the higher BPs seen in the recruits could have been related to their high salt diets. 
However, other marked changes in the diet were observed (Shaper, 1972; Shaper et 
al., 1969) so that which of the various dietary, weight or social changes was causally 
related to the BP rise, and how much of the BP difference was related to selection 
effects, remains an open question (Shaper, 1967, 1972). Higher BPs and prevalence 
of hypertension in migrants from low BP communities have also been observed in 
other societies (Cruz-Coke, Etcheverry & Nagel, 1964; Prior & Stanhope, 1980; 
Scotch & Geiger, 1963; Sever et al., 1980).
The effect of migration has recently been reported from a study o f the Luo, in which 
the BP of recent migrants to Nairobi was compared to that of a control population 
living in the home villages in rural western Kenya (Poulter et al., 1990). Blood 
pressure was measured with a random zero sphygmomanometer and three 12-hour 
overnight urine samples were collected on up to five occasions from within 60 days, 
until up to two years after arrival in Nairobi. Blood pressures of the migrants were 
higher than those in the rural villages, even at the first examination, approximately 
one month after migration; mean body weight, pulse rate, urinary sodium excretion 
and sodium/potassium ratio were all higher in the migrant group, and urinary 
potassium was lower. Ninety of 163 new male migrants had been examined prior to 
migration when their BP was similar to that of rural controls, suggesting that the 
higher BPs in the migrants was not due to selective migration (Poulter, Khaw & 
Sever, 1988). The authors conclude that environmental factors including an increase 
in sodium intake, reduction in potassium intake and an increase in the 
sodium/potassium ratio are important factors in the shift in the BP distribution 
towards higher values when a low BP community becomes urbanised (Poulter et al., 
1990).
1.4 Summary
The evidence relating sodium and BP is largely concordant from animal studies, 
clinical observations, human experimental studies, and epidemiological studies within 
and across populations; the balance of evidence favours a causal association. Some 
of the additional evidence from INTERSALT, again largely consistent, is presented 
and discussed in Chapters 4 and 5.
The animal studies show importantly the existence of a model for salt-induced 
hypertension. In humans, the observational data arc consistent in showing that higher 
sodium is associated with higher BP, although as discussed, these studies are subject
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to important methodological difficulties and biases which confuse their interpretation. 
Across-population epidemiological studies arc positive, but rely on data drawn from 
the international literature based on a variety of unstandardised field methods, and are 
prone to unmeasured (ecological) confounding. Within-population studies, on the 
other hand, generally lack statistical power, and are subject to major regression- 
dilution bias (due to large day-to-day variation in sodium excretion) which could 
conceal true relationships of sodium to BP. Nonetheless, an overview of studies of 
24-hour urinary sodium excretion and BP showed positive and highly significant 
sodium-BP relationships both for men and for women, and for systolic and diastolic 
BP. An overview of the randomised controlled trials of sodium reduction and BP in 
individuals showed that lower sodium intake can lower BP; the effect may be more 
marked at higher BPs and with greater sodium reduction. The estimates of effect 
from overviews of the within-population epidemiological studies and the randomised 
controlled trials are quantitatively similar: for daily sodium excretion lower by 100 
mmol, systolic BP is lower by 3.7 mm Hg, and diastolic BP lower by 2.0 mm Hg 
(within-population studies) compared to 2.9 systolic and 1.6 mm Hg diastolic 
(randomised controlled trials). Estimates obtained from studies across-populations 
are somewhat larger, and may to some extent reflect ecological confounding (see 
Chapter 3).
The findings presented here have implications both for individuals, and populations 
(i.e., for public health). In treated hypertensive patients, clinical observation and trial 
data suggest that sodium reduction (either alone or in combination with weight loss 
and moderation of alcohol intake) can reduce the amount of medication required to 
control BP, and in some cases BP may be controlled by dietary measures alone, 
particularly in those whose hypertension is "mild" (i.e., uncomplicated and with less 
marked elevations of pressure). At the population level, the Portuguese Salt Trial 
showed that intervention can be successful in lowering both sodium intake and BP, 
although this was not achieved in a community trial in Belgium.
The implications of a policy of sodium reduction, including the issue of possible 
"sodium sensitivity", are discussed further in Chapter 5.
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The INTERSALT Study: Aims, Design and Field Methods
Chapter 2
In this Chapter, the INTERSALT aims, study design and field methods are briefly 
described; detailed field methods based on the INTERS ALT protocol and field 
Manual of Operations are given in Appendix 1. Procedures of the London 
Coordinating Centre (at the London School of Hygiene and Tropical Medicine) and 
Central Laboratory (at St. Raphael University Hospital, Leuven, Belgium) are also 
described in Appendix 1 in an edited version of the Manual of Operations for these 
centres. A brief description of the rationale for the study, its aims, design and field 
methods has been published and is included in Appendix 4 (INTERSALT 
Cooperative Research Group, 1986).
2.1 Origin and Aims of INTERSALT
INTERSALT arose out of a project given to fellows at the First Advanced 10-day 
Teaching Seminar of the Council on Epidemiology of the International Society and 
Federation of Cardiology (ISFC), held in Tuohilampi, Finland, in 1982. The fellows 
were asked to re-evaluate the across-population evidence on salt and BP and design a 
study to test Dahl's salt hypothesis (Dahl, 1960). The study soon grew to become a 
major international cooperative study, conducted in 52 centres and 32 countries 
worldwide. It was recognised early on that the key to its success was the collection 
of highly standardised data, with great emphasis put on detailed specification of 
methods, centralised training and a high degree of quality control.
The main aims of INTERSALT were firstly, to investigate relationships across 
populations between BP (and high BP) and the urinary excretion of sodium, 
potassium and the sodium/potassium ratio, and secondly, to investigate these same 
relationships in individuals. Major confounding variables were age, sex, body weight 
and alcohol intake. Various subsidiary hypotheses were also identified (for example, 
the relation of calcium and magnesium excretion to BP).
2.2 Design, Sample Size and Power
INTERSALT was a multicentre cross-sectional epidemiological study. Selection of 
centres was done according to presumed sodium intake, to achieve as large a 
variation as possible across-centres in the main independent (x) variable under study. 
Thus centres were chosen in presumed low-sodium populations such as the 
Yanomamo and Xingu Indians of Brazil, and presumed high-sodium centres in Japan,
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Portugal and China. In the event, although four low-sodium centres were included, 
there was none with a truly high intake (INTERSALT Cooperative Research Group,
1988).
The sample size was calculated so as to achieve high statistical power (>90%) to 
detect across-population regression slopes of BP-sodium, significant at the 5% level, 
equal to regression slopes predicted by Froment, Milon & Gravier (1979) at young 
(around 20 years) and older ages (around 50 years). The across-centre standard 
deviation in sodium used in the power calculations was taken to be 5.83 g salt/day 
based on the recruitment of 45 centres into the study and a presumed distribution of 
sodium excretion as follows: 6 with 2.0 g salt/day; 11 with 7.0; 11 with 10.0; 11 with 
14.0, and 6 with 22.0 g salt/day. Estimates of variance of BP across populations were 
taken from the regression analyses given by Froment, Milon and Gravier (1979) and 
an estimate of within-population variance of BP was obtained from the Whitehall 
Study.
With more than 45 centres, each with 50 people in each age-sex group 
(males/females; young/old), the statistical power was more than 95% for the across- 
centre analyses. Increasing the number of participants per centre had little effect on 
the across-centre power calculations. For the within-centre (individual) relationships, 
the statistical power of the study was dependent on the total sample size recruited into 
the study, and was little influenced by the number of centres; in analyses of 10,000 
people, the study had power to detect correlations between variables of the order of 
r=0.02, significant at the 5% level.
It was recognised in advance that the statistical power for the across-centre analysis 
would be much reduced if the spread of sodium excretion across centres was limited 
either by failure to recruit low- or high-sodium centres, or by excluding them in the
analysis.
2.3 Field Methods
In this section the INTERSALT field methods are briefly summarised. Methods are 
specified in detail in an edited version of the INTERSALT Field Manual of 
Operations which is given in Appendix 1. The Manual was used as the basis for 
training of investigators from the 52 centres of the study, and was used by the centres 
during field collection. The data forms which were used in the study and which 
accompany the Manual can be found in Appendix 2. A more complete account of the
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INTERSALT methods is published, including those for the London Coordinating 
Centre and the Central Laboratory (Elliott and Stamler, 1988).
Briefly, each centre was asked to recruit 200 men and women aged 20-59 years, 
stratified by age and sex into eight 10-year groups (Le., men 20-29, men 30-39, etc.). 
Whenever possible the samples were selected at random from population lists (e.g., 
electoral or general practice registers, lists of factory employees) or by chunk 
sampling of defined populations (e.g., whole island or village communities). A brief 
description of the 52 centres (in 32 countries) included in the study is given in 
Appendix 3.
Whenever an unacceptable report - for example, incomplete urine collection - was 
identified during data collection, the centre was asked to recruit an extra 
(supplementary) participant from the same age and sex group in strict order of 
random allocation. This was to facilitate the goal of 200 analysable reports per 
centre; occasionally, fewer than 200 were available. Thus data were received on 
10,648 eligible participants, of whom 569 (5.3%) were excluded, 568 because of 
problems with the urine collection and one because of an incomplete BP 
measurement. Data on the remaining 10,079 people - 5,045 men and 5,039 women - 
were the basis of the INTERSALT reports.
Blood pressure (sitting) was measured twice on a single occasion by a trained 
observer using a random zero sphygmomanometer (0-20 mm variation in the random 
zero) and the bell of a Littmann stethoscope, after participants had emptied their 
bladders and sat quietly for 5 minutes. A range of cuff sizes was used to allow for 
differing arm circumferences. Diastolic pressure was recorded when sounds 
disappeared (phase 5).
Each participant provided both a casual ("spot”) urine specimen and a 24-hour urine 
collection, the start and end of which were supervised by clinic staff. Urine 
collections were rejected if found to be incomplete on interview, or if urinary volume 
was less than 250 ml in 24 hours. The height of urine in each jar was measured on a 
standard platform and scale devised at the London School of Hygiene and Tropical 
Medicine (Figure 9) and later converted into volume by computer in London. A 
random 8% of participants completed a second urine collection for the estimation of 
within-individual variability in electrolyte excretion, enabling a correction to be made 
for reliability. Urine aliquots were kept at -20° C and sent frozen to  the Central 
Laboratory in Leuven, Belgium, for the measurement of electrolyte concentration.
54
Height and weight were measured in standard fashion, using a stadiometer and beam 
balance where possible. Seven day alcohol intake was assessed by questionnaire, 
using local data to convert consumption into ml absolute alcohol per week. The 
questionnaire also included history of hypertension, current medicines (including 
anti-hypertensive agents), education, social state and changes in diet (including salt 
intake). When necessary data forms and the questionnaire were translated into the 
local language and checked by back-translation into English. Indoor and outdoor 
ambient temperatures were recorded.
Data forms were sent to London for review, edit, coding, data entry and analysis. 
They were checked on receipt for completeness and consistency, and queries were 
referred back to the local centres for clarification. The London Centre also reviewed 
each centre's recruiting documents and urine collection registers as a further check on 
sampling procedures and data completeness and accuracy. All data were entered 
twice into the computer; a random 5% of forms were double-coded.
Sodium and potassium were analysed by emission flame photometry (American 
Association of Clinical Chemists, 1961). Reference samples were created at the start 
of the study and included in each day's analysis to monitor laboratory variation. 
Quality control was monitored in London by comparing results on anonymous 
duplicate (split) samples sent blind to the Central Laboratory for the estimation of 
technical error. Percent technical error was 1.4% (sodium) and 1.9% (potassium).
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Chapter 3
Design Issues in Multicentre Epidemiological Studies: An 
Example from INTERSALT
3.1 Introduction
In this Chapter, some of the theoretical and practical issues that arise in the design 
and analysis of multicentre epidemiological studies are discussed. An approach to 
the analysis is illustrated using INTERSALT data relating systolic BP to  body weight 
both across-and within-centres, and possible heterogeneity of the within-centre 
relationships is explored. Implications for the design of future studies are addressed.
Many studies "..are not large enough to answer the questions we want to answer as 
reliably as we would want to answer them" (Peto, 1987). Although Peto was 
referring above to the sometimes huge sample sizes demanded of modem clinical 
trials, equally his remarks could apply to many epidemiological studies. Often 
achieving the sample size desired of a study is beyond the resources of a single 
institution or centre. One possibility for enhancing sample size is to extend the 
investigation to several centres, in a so-called multicentre study. When such data are 
collected, i.e., at the group (population) level as well as in individuals, they are said to 
have a hierarchical structure (Goldstein, 1987).
The hierarchical or multi-level structure of many data sets and its importance in 
statistical modelling has been recognised in both the sociological literature 
(Firebaugh, 1978; Goodman, 1953, 1959; Robinson, 1950; Valkonen, 1969) and in 
studies of educational effectiveness (Aitken & Longford, 1986; Goldstein, 1987). In 
educational research, the inherent hierarchical structure of the data is readily 
apparent, with effects on individual pupil performance depending on peer grouping 
within classes, classes within schools and higher level aggregates, for example 
schools within local education authorities (Aitken & Longford, 1986). However in 
the epidemiological literature, relatively little attention has been paid to the 
implications of this data structure, either in the design of studies or in the statistical 
analysis.
In one of the few epidemiological papers to address this issue, Feinleib and Leaverton 
(1984) took as an example the first U.S. National Health and Nutrition Survey 
(NHANES I), in which data were collected across the United States in 100 
examination centres from a national probability sample of U.S. residents (National 
Center for Health Statistics, 1977). The data were originally presented without regard
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to the centre structure (see for example. National Center for Health Statistics, 1983) 
effectively treating them as if from one large population sample. To examine 
relationships both within and across the centres, Feinleib and Leaverton (1984) 
reanalysed some of these data, but with retention of the hierarchical structure. Some 
striking differences emerged between the within- and across-centre findings, for 
example in the relations o f body weight to serum cholesterol. Piantadosi, Byar and 
Green (1988) carried out a similar analysis using data from the Second Health and 
Nutrition Survey, and again found important differences in the within- and across- 
centre results. As discussed further below, the across-centre findings in these 
analyses were relatively unstable, since nearly all of the variation in the explanatory 
variables was within centres and there was relatively little variation OfJtos* centres 
(Piantadosi, Byar & Green, 1988).
Feinleib and Leaverton (1984) further analysed the NHANES I data to see whether 
any of the within-centre associations differed when examined across the centres; they 
found for example, significant heterogeneity of the within-centre correlations relating 
individual body weight and systolic BP. They discuss the difficulties of generalising 
findings even from within the same "level" of analysis, e.g., between geographical 
areas within a country, or from one time-frame to another, and conclude that pooling 
of data without regard to the inherent structure may lead to a biased estimate of 
effect.
The danger of extrapolating from findings across centres to relations at the level of 
individuals is well-known, and has been called the "ecological fallacy" (Piantadosi, 
Byer & Green, 1988; Robinson, 1950). Nevertheless, Blackburn and Jacobs (1984) 
argue that in epidemiological studies both across- and within-population relationships 
are important and judgments as to causality should depend on both sets of data. They 
cite as an example the relationship between saturated fat intake and serum cholesterol 
which is strongly positive across populations (consistent with the experimental 
evidence) and weak or absent within populations.
3.2 The Multicenlre Design: Theoretical Considerations
Let us consider a hypothetical case where data are collected on individuals in a 
number of population centres. Figure 1 illustrates a hypothetical "true" relationship 
between an outcome variable y and an "explanatory" variable x measured in the 
different centres. The dots give average x and y of the centres and the ellipses 
represent the cloud of observations on individuals in each centre.
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F ig u re  1
Representation of "true" relationship between response variable y and 
independent variable x in different centres, with fitted regression lines
Key: BA = across-population slope; Bw = within-population slope; 
frj- = regression slope in individuals, ignoring centre
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Potentially, three different regressions can be specified: an ecological (.across-centre) 
regression of mean y on mean x, with true rcgresson slope BA; a within-centre 
regression of individual values of y on individual values of x, with true regression 
slope &w; and a regression of individual y on individual x ignoring centre, with true 
regression slope By. For the purposes of the arguments set out here, we shall assume 
that all three regression slopes coincide, i.e., the "tme” regression slope of y on x, 
shown in the figure by the solid regression line, is &-BA-Bw-&r-
Now consider what might happen when the "true” data illustrated in Figure 1 are 
observed (measured) in practice, as shown in Figure 2. Here the filled dots represent 
the "true" across-centre relationship between y and x (as Figure 1) and the open dots 
the observed relationship (the difference being due to across-centre confounding by 
variables other than y and x). The observed within-centre relationship of y on x is 
shown as circles around the open dots, again representing the cloud of individual 
observations within the centre, but now in this example the relationship is weak 
because it has been diluted by within-centre confounding, and also by "measurement 
errors", i.e., so-called "regression dilution" (see Chapter 1 and Section 3.4, 
Discussion, below). The observed across-centre regression of mean y on mean x is 
bA, and the average observed within-centre regression slope is bw. Whereas BA, Bw 
and By coincide (Figure 1) the observed regression slopes bA and bw are very 
different, the regression being strongly positive across centres and essentially zero 
within centres. This situation is commonly observed in epidemiology, as discussed 
by Blackburn & Jacobs (1984) in reference to the relation of dietary fat to serum 
cholesterol (noted above) or as seen in Chapter 1 with reference to salt and BP.
The observed regression slope bT (obtained by disregarding the hierarchical structure 
o f the data) lies between bw and bA; in general (in simple regression) it is the 
weighted average of bw and bA, where b is given weight -  Rxx and bw weight (1- 
RXx). and where Rxx is the proportion of the total sum of squares of x that is across- 
centres (Aitken & Longford, 1986; Piantadosi, Byar & Green, 1988);
i.e., by = Rxx bA + (1 - Rxx) bw.
Being a combination of bA and bw, bx is not in itself of interest, yet in most 
multicentre studies, the data are combined and reported in this way without regard to 
the inherent hierarchical structure; this has been called "lumping" or "collapsing" of 
the data (Demets, 1987).
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F ig u re  2
X
Representation of "observed" relationship between response variable y 
and independent variable x in different centres.
The data in Figure 1 have been subjected to positive ecological 
confounding across centres, and "regression-dilution" bias w ith in  centres.
Key: B = "true" regression slope (as Figure 1); bA = observed across-population 
slope; bw = observed within-population slope; b j = observed slope in 
individuals, ignoring centre
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3.2.1 The Hierarchical Model
In this section, the hierarchical model is briefly discussed; further details can be 
found elsewhere (Aitken & Longford, 1988; Goldstein, 1987). Let us again consider 
the simple regression model shown in Figures 1 and 2 relating a y-variable to a single 
x-variable, where the data have been collected in a number of centres giving a simple 
hierarchical structure. (The method can readily be extended to encompass more 
complex models with a number of explanatory variables). An estimate of the 
regression coefficient relating average change in y to unit change in x is required; 
potentially two regression estimates are of interest: bA (from the across-centre or 
ecological regression of average y on average x) and bw (from the regressions 
relating individual y to individual x within-centres). As can be seen below, these two 
estimates are statistically independent (Aitken & Longford, 1988; Blackburn & 
Jacobs, 1984; Goldstein, 1987).
For convenience, in the following discussion, the regression equations are centred 
around the mean and not around the origin. Suppose that we observe centre 
differences in y are observed that can not be explained by the regression of y on x 
within centres, then:
(i) yy = otj + BjiXjj - Xj) + e;j (Within-centre model)
where y,j and xy are the y- and x-values of the jth individual in the ith centre; (= yj) 
is the mean "centre effect" for the ith centre; Bj is the within-centre regression 
coefficient for the ith centre; Xj is mean x in the ith centre and ey is a Normally 
distributed within-centre error term with mean zero. This is known as a "fixed 
effects" model, since no attempt has been made to model the variation in either the a ( 
or Bj , rather a separate regression model with slope Bj has been fitted in each centre.
Let us now assume that the centres are randomly selected (i.e., without reference to 
the y values) from a population of centres. True random sampling of centres is 
unlikely in practice but this should not be critical providing that selection is 
haphazard (i.e. non-systematic) with respect to the y-values. We can now relate the 
variation in the mean centre effects cij (= yj) to Xj as follows:
(ii) otj = a  + BA(Xj - x) + fj (Across-centre model)
where a  is the regression constant; x is the mean x across centres; BA is the across- 
centre regression slope, and fj is a cross-centre error term, again Normally distributed 
with mean zero.
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Suppose also that there is a with in-centre regression coefficient Bw common to all 
centres, then substituting Bw and equation (ii) into (i), we have:
(iii) y„ = a  + Ba(x; - x) + Bw(Xy - Xi) + fj + e  ^
and if BA = Bw (= common slope B):
(iv) yij = a  + B(Xy - x) + f; + Cy (Hierarchical model)
This is called a "hierarchical" model since the error term contains both across- and 
within-centre components, which are statistically independent, i.e., cov(ey , fj) is zero. 
However, observations on two individuals and in the same centre are not 
independent having covariance equal to var(fi); the intraclass correlation, 
var(fi)/[var(fi) + varfey)], is a measure of the homogeneity of individuals in the same 
centre relative to other centres.
3.2.2 An Approach to the Statistical Analysis
Because observations on individuals within centres are not independent of one 
another, standard regression techniques are no longer appropriate since they will 
under-estimate residual variance and give spuriously low standard errors for the
regression coefficients.
Although computer algorithms are being developed to analyse hierarchical data and 
to produce a single regression coefficient based on both within-centre (individual) 
and across-centre (group) components, an empirical approach is adopted here 
whereby estimates of BA and Bw are obtained direcdy, allowing them to be compared. 
Interpretation then depends on epidemiological as well as statistical considerations.
1. Regress yj on Xj to obtain bA
2. Using the separate within-centre regression coefficients bj ,pool over all 
centres using var(bj)'1 as weights to obtain bw.
The procedure in 2. above minimises the variance of the pooled estimate bw and 
gives the most powerful test of the null hypothesis that Bw (and all B4) = 0. This is 
equivalent to a pooling (overview) analysis of clinical trials (Demets, 1987), except 
that in the case of a well conducted multicentre epidemiological study all data are 
obtained in a single study using common protocol, standardised field methods, etc., 
and there is no publication bias or missing data.
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If the null hypothesis is rejected, we have good evidence for a qualitative relationship 
between y and x in individuals within-centres. But what is the best quantitative 
estimate o f that relationship? Are all the separate within-centre regression 
coefficients bj measuring the same quantity, or is there evidence for heterogeneity of 
the b ,, and if so what is the underlying distribution of the bj?
Consider now a more complex ("random effects") model in which the Bj, the "true" 
within-centre regression coefficients, are considered to be randomly distributed about 
some overall mean B , so that:
(v) B, = B + g, (Random effects model for
within-centre coefficients)
where gj is a Normally distributed across-centre "error" term for the B, with mean 
zero and variance ct2ba .
Substitution into (i) gives:
(vi) y,j = a , + (B + gjXxy - x;) + e,j 
But b j, the estimate of Bj, has the form:
(vii) bj = Bj + hj = (B + gj) + hj
where hj is a Normally distributed within-centre error term with mean zero and 
variance CT2Bi.
A simple test of heterogeneity o f the separate within-centre estimated regression 
coefficients bj is available (DerSimonian & Laird, 1986).
Since gj and hj are independent (being respectively an across-centre and a within- 
centre error term), var(bj) = a zBA + a 2Bi. Pooling bj with weights var(bj)"1 to get an 
estimate o f  bw therefore implies equal weights if ct2ba » o 2^  and weighting by 
precision if  a 2BA « (Berlin et al., 1989).
Thus if there is no evidence of heterogeneity, the most appropriate estimate of the 
within-centre relationship is given by the weighted average of bj together with its 
standard error, using varfb,)'1 as weights. But if significant heterogeneity exists, it 
has been argued (Berlin et al., 1989; DerSimonian & Laird, 1986) that the best 
summary o f  the within-centre coefficients bj is one that allows for an estimate of the 
across-centre variance a 2BA; this will give a more conservative test o f significance 
than weighting by precision. Not all authors would agree, however, preferring
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instead to use inverse variance weights in all situations, i.e., the fixed effects 
approach (Peto, 1987).
When there is evidence of heterogeneity of the b; , the model is further complicated if 
centre-level variables can be found which help "explain" the heterogeneity in b; (e.g., 
bj increases with increasing X;). In this case the underlying model is of the form:
(viii) Bj = Bo + B^Xj - x) + lq (Systematic heterogeneity
in the Bi)
where B0 and B, are respectively the regression constant and across-centre regression 
coefficient relating the within-centre coefficient B; and Xj, and k; is the (residual) 
Normally distributed error term for the B; , with mean zero.
The multicentre design affords the opportunity to explore this across-centre 
heterogeneity in the within-centre regression slopes; this could give useful insights as 
to aetiology, and provide direction for further investigation.
3.3 A Worked Example: The INTERSALT Study
In this section, the methods outlined above are illustrated with reference to the 
relations of body weight to systolic BP in the 5,045 men of the INTERSALT Study. 
Body weight was chosen as an index of body size and fatness in preference to body 
mass index, since it has been shown previously that the size of BP-body mass index 
regression coefficients is sensitive to differences in height (Dyer, Elliott & Shipley, 
1990).
The INTERSALT study design and methods are described in Chapter 2, and detailed 
statistical methods are given in Chapter 4. Briefly, the stratified nature of the 
sampling ensured approximately 100 men in each of the 52 centres. The centres were 
selected to give a large spread of mean sodium (x) values. Mean systolic BP and 
mean weight were calculated for each centre, unadjusted for age and age-stratified 
(adjusted). The unadjusted total sums o f  squares of weight were calculated and 
partitioned into across- and within-centres sums of squares. Systolic BP-weight 
regression coefficients were estimated across the centres (b*) and within-centres (b^ 
unadjusted, adjusted for age, age and height, and "fully adjusted", i.e., adjusted for 
age, height, sodium and potassium excretion, and alcohol intake. In the across-centre 
analysis, the means of the above variables were entered into the regression models 
except for alcohol which was entered as two variables: percent drinkers and median 
alcohol intake of drinkers. In the within-centre analyses, the individual values of the
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explanatory variables were entered into the analysis, except for alcohol which was 
entered as two (0,1) variables, i.e., no alcohol vs. 1-299 ml/week and no alcohol vs. 
300+ ml/week. Three different summary estimates of the within-centre regression 
coefficient (bw) and its standard error were calculated: the unweighted mean, bW(U) ; 
the "fixed effects” mean, weighted by the inverse of the variance of the individual 
centre coefficients, bW(F) and the "random effects” mean bW(R) weighted by adding an 
across-centre component of variance to the within-centre variance, according to the 
method of DerSimonian and Laird (1986). The regression coefficient ignoring centre 
(bj) was also estimated.
3.3.1 Results
When the variation in the x-values (body weight) was partitioned into across- and 
within-centre sums of squares, 38% of the variation was found to be across-centres 
and 62% within-centres (i.e., Rxx = 0.38).
The age-standardised across-centre plot relating mean systolic BP and mean weight is 
shown in Figure 3, together with the fitted regression line (bA). The relationship is 
strongly positive (p<.00001), with systolic BP higher by an estimated 4.6 mm Hg (SE 
0.76) per 10 kg average body weight.
In the first of the within-centre analyses, the number of positive within-centre 
regression coefficients, the number negative, and the number nominally significant at 
p<.05 were calculated for each of the regresión models as shown in Table 8. 
Depending on which regression model is chosen, between 48 and 51 of the 
coefficients are positive, and up to 30 of these are statistically significant at p<.05. 
The weak non-parametric sign test rejects the null hypothesis that the regression 
slopes are equal to zero, i.e., half of them positive and half negative, pc.00001 (Table 
8).
The size of the regression coefficients (adjusted for age) and their 95% confidence 
limits are shown ranked from negative to positive in Figure 4, with the overall "fixed 
effects" estimate (bW(F)) and its 95% confidence interval shown in heavy ink at the 
bottom o f  the figure. In accordance with Table 8, there are only 3 negative 
coefficients, and the 95% confidence limits of 30 of the positive coefficients exclude 
zero.
The frequency distribution of these coefficients is shown in Figure 5, ranked in class 
sizes each 0.1 mm Hg/kg wide. As can be seen, the modal value is 0.25 mm Hg/kg, 
and there is slight skewing to the right indicating possible overdispersion.
I
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F igure  3
SBP
Scatter plot of age-standardised mean systolic blood pressure (mm Hg) against 
mean body weight (kg), and fitted regression line, men, 52 centres
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T able  8
Summary of within-centre regressions relating systolic BP and weight in the 
5,045 men in INTERSALT, unadjusted, adjusted for age, age and height, and 
fully adjustedt: number of coefficients positive, number negative and sign test
Unadj. Adj. age Adj. age,ht Fully adj
No. of positive coeffecients 48 49 51 51
No. significant (p<0.05) 30 30 28 25
No. of negative coefficients 4 3 1 1
No. significant (p<0.05) 0 0 0 0
Sign test z-score 6.10 6.38 6.93 6.93
All z-scores, p<0.00001
t Adjusted for age, height, sodium, potassium, alcohol
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F igure 4
Diagramatic representation of the age-adjusted regression coefficients an d  95% 
confidence intervals relating systolic blood pressure (mm Hg) and body weight 
(kg) in men, in the 52 centres of INTERSALT.
The heavy point and line at the bottom of the figure give the pooled regression 
coefficient, and its 95% confidence interval.
68
Figure 5
Frequency
SB P-W eight
Frequency distribution of the age-adjusted regression coefficients relating 
systolic blood pressure (mm lig) and body weight (kg) in men in the 52 centres
of INTERSALT
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Table 9 summarises the results of across- and within-centre regressions of systolic 
BP-weight, and also those done ignoring centre (by). As can be seen, the across- 
centre coefficient bA is heavily influenced by the addition o f across-centre 
confounding variables to the regression models, ranging from 4.6 (unadjusted and age 
adjusted) to 2.6 mm Hg/10 kg (fully adjusted). It is also much less precisely 
estimated than the regressions in individuals (bw and bT) since it is based on SI 
degrees of freedom rather than 4,500-5,000 in the individual analyses.
The within-centre coefficients bw are confounded (in opposite directions) by age and 
height, but with both these variables in the model, the addition o f  other variables 
makes litde difference to the size of the regression coefficients. The least stable is 
bW(U) which is to be expected as it is more susceptible to outliers in the tails of the 
distribution (Figure 5). The estimates and bw(R) are similar, although the latter 
has a higher standard error due to the addition of an across-centre component into the 
variance estimate. All these coefficients are highly statistically significant 
(pc.OOOOl). In the unadjusted model, and the model adjusted for age, within-centre 
regression coefficients are (significantly) smaller than the across-centre coefficient bA 
by 30% or more, whereas in the other two models, within-centre coefficients are 
some 10% to 25% larger.
As expected, in the unadjusted analysis, bT lies between bA and bw, although this is 
not necessarily the case when potentially confounding variables are added to the 
model. bT is largely unaffected by the addition of individual-level confounding 
variables to the regression models. The x2 test of heterogeneity is highly significant 
in all the regression models, although as more within-centre variables are added its 
value decreases. This suggests that some of the heterogeneity o f slopes may be 
explained by within-centre confounding, although it may partly reflect the size of the 
within-centre variance estimates, which tend to increase as more variables are added 
to the model.
In an attempt to "explain" some of this heterogeneity, the systolic BP-weight 
regression slope from each centre was correlated with mean centre values of a 
number of explanatory variables, as shown in Table 10. As can be seen, in two of the 
models, the regression coefficient is positively and significantly correlated with mean 
sodium/potassium ratio, and in all 3 models, negatively and significantly correlated 
with mean weight and height of the centres. The scatter plot illustrating this 
relationship for weight is shown in Figure 6, i.c., the higher the mean body weight of 
a centre, the smaller the regression slope relating systolic BP and weight within that 
centre.
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T able 9
Summary of across- and within-centre regression coefficients (SE) relating 
systolic BP and weight in the 5,045 men in INTERSALT, unadjusted, adjusted 
for age, age and height, and fully adjusted!
Coefficient 
(mm Hg/10 kg)
Unadj. Adj. age Adj .age, ht Fully adjf
bA 4.58 (0.76) 4.59 (0.76) 2.93(1.29) 2.62(1.08)
bW(U) 3.20 (0.32) 2.84 (0.28) 3.51 (0.32) 3.40 (0.30)
b\V(F) 2.82 (0.16) 2.59 (0.17) 3.13(0.19) 3.13(0.20)
b\V(R) 3.04 (0.27) 2.72 (0.25) 3.33 (0.28) 3.26 (0.28)
t>r 3.57 (0.15) 3.44(0.14) 3.58 (0.18) 3.38 (0.18)
X2(si) 128.9 105.2 102.9 89.7
All coefficients are significant, p<0.00001, except bA (adj. age, ht and fully adj.), 
p<0.05
Legend:
bA Across-centre coefficient
bW(U) Summary within-centre coefficient - Unweighted mean 
bW(F) Summary within-centre coefficient - Fixed effects mean 
bW(R> Summary within-centre coefficient - Random effects mean 
bT Coefficient in individuals, ignoring centre
X2(5 i) X2 test of heterogeneity of within-centre coefficients on 51 d.f.
+ Adjusted for age, height, sodium, potassium, alcohol
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Table 10
Simple pearson-r correlation coefficients relating systolic BP-weight regression 
coefficients and mean values of various centre-level variables, INTERSALT, 52
centres, men
SBP-wt coeff: Wt Ht Na K Na/K Ale 1 Ale 2
Adj age -.35* -.37** .07 -.33 .36** -.04 -.04
Adj, age, ht -.42** -.38** .17 -.35* .51*** -.12 .05
Fully adjt -.41** -.44** .01 -.26 .26 -.14 .04
*p<0.05 **p<0.01 ***p<0.001 
t  Adjusted for age, height, sodium, potassium, alcohol
Abbreviations: Wt, weight; Ht, height; Na, sodium; K, potassium; Na/K, 
sodium/potassium ratio; Ale 1, prevalence of alcohol drinking; Ale 2, alcohol intake 
of drinkers.
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Figure 6
1 - I
SBP-Weight Coefficient
o .a  -
0.6  -
0.4  -
0.2 -
Scatter plot of age-adjusted systolic blood pressure-weight regression 
coefficients (mm Hg/kg) vs mean weight (kg), 52 centres, men
73
Finally, Table 11 shows the multiple R2 of the multiple regression models relating the 
systolic BP-weight regression coefficient to the other explanatory across-centre 
variables. Between 14 and 28% of the variance of the systolic BP-weight coefficients 
could be "explained” by the across-centre variables studied. These regression models 
are statistically significant (p<.01 to p<.05), but none of the variables shown 
remained individually significant in the multiple regression models.
3.4 Discussion
The analysis outlined above illustrates some important issues:
1. Because of the INTERSALT study design in which centres were deliberately 
selected (on sodium values) to be very different, some 38% of the variation in 
x (weight) was across-centres. This compares with the analyses o f  NHANES 
data mentioned above, in which nearly all of the variation was within centres 
(Piantadosi, Byar, and Green, 1988), so that the regression estimate ignoring 
centre (bT) was virtually identical to the within-centre regression slope bw.
By contrast, in INTERSALT, bj is difficult to interpret, being a combination 
of both across- and within-centre effects.
2. The analysis across centres was much less stable than that within centres, and 
gave regression estimates ranging from some 3^% higher to some 10% lower 
than the within-centre coefficients. The across-centre findings were far more 
susceptible to confounding.
3. The analysis not only gave an efficient and precise estimate of within-centre 
effect (based on a pooling of results in more than 5,000 individuals) but also 
allowed the effect within the centres to be examined for heterogeneity across 
centres. This is a unique feature of the multicentre design.
4. When (significant) heterogeneity was found, some of that heterogeneity could 
be explored by examining the relations of the within-centre regression 
coefficients to measured across-centre variables.
In general, once estimates of the across-centre regression coefficient BA and the 
within-centre coefficient Bw have been obtained, difficulties in interpretation arise. If 
bA and bw are similar they can readily be reconciled to give an overall estimate of the 
relationship of y to x based on both across- and within-centre data. But what should 
be done if bA and bw are very different?
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Table 11
Multiple R2 for regression models of systolic BP - weight regression coefficients 
against various centre-level variables, INTERSALT, 52 centres, men
Regression Model
Wt, ht, Na,
SBP-wt coeff: Wt, ht K, Ale 1, Ale
Adj age .14* .26*
Adj age, ht .20** .28*
Fully adjt .20** .26*
* p<0.05 ** p<0.01
t  Adjusted for age, height, sodium, potassium, alcohol
Abbreviations: Wt, weight; ht, height; Na, sodium; K, potassium; Ale 1, prevalence 
of alcohol drinking; Ale 2, alcohol intake of drinkers
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The approach suggested here is to present both bA and bw separately, since both are 
liable to error: interpretation then depends on the relative weight one places on 
ecological or individual relationships. As with the INTERSALT analysis, the 
estimated across-centre regression coefficient bA is particularly liable to ecological 
confounding, much of which may be unmeasured and which may introduce serious 
bias. The across-centre slope bA is also sensitive to systematic differences between 
centres in the techniques or circumstances of measurement (e.g., systematic 
undercollection of urine in one or more centres biasing estimates of 24-hour sodium 
excretion), and it is estimated with less precision than bw unless there are large 
across-centre differences in mean x. On the other hand, bA is much less sensitive 
than bw to (random) "measurement error" in the explanatory variable x, provided 
sample sizes within centres are adequate.
Here the term "measurement error" is taken in its widest sense to mean all the 
circumstances leading to "random" variation in measurement (including biological or 
physiological variation) and hence to mis-classification of individuals on the 
measured variable. This is unlikely to have been an important source of error in the 
analysis presented here of BP and body weight, since body weight is measured with 
reliability close to one (Liu et al., 1982; Marks, Habicht & Mueller, 1989). However, 
it would be a major problem in analyses of BP and sodium excretion ( as discussed in 
Chapter 1) or dietary fat and serum cholesterol (Jacobs, Anderson & Blackburn, 
1979). As mentioned previously, the situation showing positive ecological 
confounding and within-centre measurement error is shown graphically in Figure 2, 
leading to biased estimates of effect both across-centres (postive bias) and within- 
centres (negative bias).
In summary, "measurement error” in the x variable will tend to bias the within-centre 
regression coefficient bw towards zero; but whereas for bw the bias can be estimated 
and corrected using repeat measures (Liu et al., 1979), for bA, bias due to unmeasured 
ecological confounding may be unsuspected and can not be corrected.
3.5 Implications for Future Studies
Given the choice of conducting a large epidemiological study in one place, or 
investigating the same number of people in many different centres, which would be 
the optimal design? The answer to this question is not straightforward, but a number 
of issues should be considered:
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1. By adopting the multicentre design, there is little loss of power for examining 
relationships at the level of individuals (bw). Furthermore, the opportunity to 
explore relationships across the centres (b^) is gained, provided enough 
centres are included in the study (empirically, about 30+).
2. In the multicentre study, the individual (within-centre) results can be 
examined for heterogeneity. If heterogeneity exists, it can be further 
explored; if it does not, then the study gives some evidence internally for 
generalisability. This could be a major gain.
3. On the other hand, the statistical analysis is complicated by the need to stratify 
by centre, and some analyses (for example, dose response relationships) may 
be difficult to carry out within a multicentre framework.
4. There may be gains in organisation, cost-sharing and staff recruitment in the 
multicentre study since each centre is responsible for a smaller amount of data 
collection than if the study were conducted in one place. On the other hand, 
there is loss of control from the organisational centre, and large added costs in 
terms of centralised training and coordination.
In conclusion, recent advances in techniques of meta-analysis and the understanding 
of hierarchical models make multicentre studies an attractive design under certain 
circumstances. Without loss of statistical power for individual-level relations, the 
ability to look for across-centre relations and heterogeneity of effect is gained, and 
lack of heterogeneity gives some generalisability to the results. In addition, costs can 
be shared. This has to be offset against the organisational difficulties of conducting 
studies in many centres. As with matching in case-control studies, the statistical 
analysis needs to take account of the inherent structure of the data introduced by the 
study design.
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Chapter 4
INTERSALT: Age and Sex Specific Results for 24-Hour 
Sodium and Potassium, and Findings for the Three United 
Kingdom Centres.
Overall findings for 24-hour sodium and potassium in the 10,079 men and women of 
the study are published (INTERSALT Cooperative Research Group, 1988; see 
Appendix 4). Briefly, in individuals, urinary sodium excretion and the 
sodium/potassium ratio were positively and significantly related to BP, and, after 
adjustment for confounding variables, potassium excretion was negatively and 
significantly related to BP. In addition, across the centres, average sodium excretion 
was positively and significantly related to the average change (slope) of BP with age.
In this Chapter, results of two further analyses are presented: age- and sex-specific 
results for sodium and potassium, and results for the three United Kingdom (U.K.) 
centres. The results are discussed in Chapter 5.
4.1 Methods
Field methods are summarised briefly in Chapter 2, and a detailed account o f  the 
methods is given in Appendix 1.
4.1.1 Statistical Methods
Age-sex analysis: all centres
Values of sodium and potassium excretion were the product of urinary concentration 
and volume corrected to 24 hours. Body mass index was the ratio of weight (kg) to 
(height)2 (m2). Analyses are reported for the 5,045 men and 5,034 women with 
complete data. Both within- and across-centre analyses were carried out (see Chapter
3).
In the within-centre analyses, the relations of BP to urinary sodium, potassium, and 
sodium/potassium ratio, were explored by multiple linear regression in each of the 52 
centres of the study. Centre-specific regression coefficients were then combined 
(pooled), weighting by the inverse of the variance, to give overall study estimates of 
the relation of BP to each of the independent variables. Separate analyses were run 
for men aged 20-39, men 40-59, women 20-39, women 40-59, and for men and 
women combined at ages 20-29, 30-39, 40-49 and 50-59. Because of the balanced
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nature of the sampling procedure, the sample size for each of these analyses was 
approximately one quarter of the total (i.e., about 2,500 people). Adjustments were 
made for age and sex as appropriate. Further adjustments were made for body mass 
index, alcohol intake, and (for the sodium model) potassium excretion, or (for the 
potassium model) sodium excretion. Alcohol intake was entered as two (0,1) 
variables, i.e. zero vs 1-299 ml (0,1) and zero vs 300+ ml (0,1). Analyses for all ages 
combined were also run for men, for women, and for men and women combined, 
adjusted appropriately for age, sex and the other confounders.
For each analysis, a test o f significance (two-sided) was obtained by comparing the 
combined regression coefficient to its combined (pooled) standard error, giving a z- 
score. The significance o f association between BP and the independent variable is 
given by the size of the z-score, enabling regression models to be compared at 
different ages, or between the sexes.
Regression estimates obtained from these models in individuals arc seriously biased 
towards zero because of within-individual variability of electrolyte excretion (see 
Chapter 1). Study-wide estimates (ignoring age and sex) of the degree of "regression- 
dilution" were obtained by correlating (within each centre) the first and second 
measure of electrolyte excretion in the 8% of particpants with repeated 
measurements. These centre-specific Pearson-r correlation coefficients were then 
combined (pooled) over all centres by using the z-transform and weighting by the 
inverse of the variance. The weighted z was re-transformed to r, giving an estimate 
of reliability for each variable. Finally, regression coefficients were "corrected" for 
reliability of measurement, by dividing the combined regression coefficient by the 
combined coefficient of reliability (INTERSALT Cooperative Research Group, 
1988).
In the analysis across centres, median sodium excretion, potassium excretion and 
sodium/potassium ratio were related to a number of BP variables. These were slope 
of BP with age (estimated separately for each sex by linear regression o f BP on age 
within each centre), median BP and prevalence of high BP (defined as systolic 
pressure of 140+ mm Hg, or diastolic pressure of 90+ mm Hg, or on anti- 
hypertensive medicaton). For median BP and prevalence of high BP, analyses were 
done for men and for women standardised for age (20-39 years and 40-59 years) and 
for men aged 20-39, men 40-59, women 20-39, and women 40-59. Aross-centre 
analyses were also carried out after adjustment for median body mass index and 
alcohol intake (entered into these analyses as two variables: prevalence of drinkers 
and median alcohol intake in drinkers).
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Four centres with low sodium excretion (less than 50 mmol per day), low BP and 
little or no rise of BP with age were found to strongly influence across-centre 
associations. The across-centre analyses were therefore carried out with and without 
these four centres (INTERSALT Cooperative Research Group, 1988).
United Kingdom centres
Three U.K. centres were included in INTERSALT, and age-sex stratified random 
samples were drawn in each centre, from the general practice master patient index 
(Belfast), from the roll of employees at an electrical components factory 
(Birmingham) and from a general practice age-sex register (South Wales) (Appendix 
3). To facilitate the goal of 200 age-sex eligible participants per centre, the 
populations were over-sampled, and replacements were found - in strict order of 
random allocation - whenever an unacceptable record was obtained (i.e., incomplete 
urine collection as determined by interview, or pregnancy). Data collection took 
place between June 1985 and April 1986 (Belfast), April and November 1985 
(Birmingham) and March and April 1985 (South Wales). Investigators from each 
centre attended a central training meeting in London in December 1984.
For the U.K. centres, means (and standard deviations) were calculated separately by 
centre in men and women aged 20-39 and 40-59 years, and then averaged over those 
centre and age-sex specific groups. Comparison between groups was by unpaired t- 
tests or x2 as appropriate; multiple comparison across groups was done by the 
Student-Newman-Keuls method after first testing for heterogeneity by analysis of 
variance.
Multiple regressions of BP-sodium are presented separately for the U.K. centres, 
according to the methods outlined above in the age-sex analysis. Although regression 
coefficients in the U.K. centres can usefully be compared with the rest, it should be 
recognised that any differences from the overall results may reflect chance variation 
among centres rather than real differences.
Each individual in the three U.K. centres was assigned a "risk score" (for high BP) 
depending on level of urinary sodium and potassium excretion and body mass index 
relative to the appropriate age and sex adjusted medians in that individual's centre, 
and whether or not the individual drank at least 300 ml alcohol per week. For each of 
the above variables, 0 was defined as "lower risk" (for high BP) and 1 as "higher risk” 
(i.e., for sodium excretion and body mass index, 0 = below adjusted median, 1 = 
above adjusted median; for potassium excretion, 0 = above adjusted median, 1 =
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below adjusted median, and for alcohol consumption, 0 = <300 ml/week, 1 = ¿300 
ml/week). The sum of these (0,1) values gave the "risk score" for each individual. 
Sex-specific mean BPs (age-adjusted) were then calculated for "lower risk" 
individuals (i.e., "risk score” zero) and for "higher risk" individuals (i.e., those with 
"risk scores" of one, two, or three or more, and also those with scores of one or 
more).
4.2 Results
4.2.1 Age and Sex Specific Results: All Centres
Median values (men and women combined) for urinary sodium ranged from 0.2 
mmol/24 hour (Yanomamo Indians o f Brazil) to 242.1 mmol/24 hour (Tianjin, North 
China); for urinary potassium from 23.4 to 81.1 mmol/24 hour, and for 
sodium/potassium ratio from <0.01 to 7.27. Median systolic pressure ranged from 
95.4 to 132.4 mm Hg, and diastolic pressure from 61.4 to 82.1 mm Hg. Amongst the 
48 centres (excluding the four low sodium centres) median values of sodium and 
potassium excretion were on average higher for men than for women (174.7 vs 142.6 
mmol/24 hour, p<0.001, and 57.3 vs 47.4 mmol/24 hour, p<0.01, respectively), as 
were median systolic BP (120.9 vs 115.5 mm Hg, p<0.001) and diastolic pressure 
(75.6 vs 71.4 mm Hg, p<0.001). In addition, men had on average higher creatinine 
excretion (13.2 vs 8.8 mmol/24 hour, p<0.001) and greater urinary volume (1.37 vs 
1.24 1/24 hour, p<0.05). Sodium/potassium ratio and body mass index were similar 
in the two sexes.
Results in individuals of the relations of urinary sodium, potassium and 
sodium/potassium ratio to BP are summarised in Tables 12-14. These give regression 
coefficients by sex and age, combined over all 52 centres, together with their 
corresponding standard errors and z-scores. The coefficients are uncorrected for 
within-person variability in electrolyte excretion (reliability) and hence underestimate 
the size of true relationships with BP; however, inspection of the z-scores allows the 
relative strengths of the relationships by age and sex to be examined.
With adjustment for age, sodium was positively and significantly associated with 
systolic and diastolic pressure of individuals, both for men and for women (Table 12). 
These positive and significant relationships were also found in seven of the eight age- 
sex specific analyses (the exception being diastolic pressure in men aged 20-39 where 
the relationship was negative but non-significantly different from zero). For all but 
one of these analyses, the z-scores suggested stronger associations in women than in
men; the size of regression coefficients in women was as much as twice that of the 
corresponding coefficients in men. Adjustment also for potassium excretion, body 
mass index and alcohol intake, reduced these associations between sodium excretion 
and BP except for diastolic pressure in men aged 20-39, which became more negative 
and significant (Table 12).
In the age-specific analyses (men and women combined) with adjustment for age and 
sex, sodium was positively related to BP, significantly so for systolic pressure at all 
ages and for diastolic pressure at ages 50-59 (bottom of Table 12). With adjustment 
also for the other confounders, only the relationship between sodium and systolic 
pressure at ages 50-59 remained significant. Regression coefficients were generally 
larger at older ages, reflecting to some extent stronger relationships between sodium 
and BP (as evidenced by the size of the z-scores) but also an increasing spread in the 
dependent variable (BP) with advancing age.
Findings after correction for reliability do not appear in the Tables, but are reported 
here. The analysis of repeat measurements indicated a reliability coefficient for 
sodium of 0.46, and hence a correction factor for sodium-BP coefficients of 
l/(reliability), or 2.17 (INTERSALT Cooperative Research Group, 1988). Recent 
work suggests that this study-wide estimate (i.e., ignoring age and sex) is likely to be 
too low (A. Dyer, personal communication). Nonetheless, the regression analysis in 
women, adjusted for age and corrected for reliability using the study-wide estimate, 
indicated systolic pressure lower by 4.7 mm Hg per 100 mmol sodium (i.e., 0.215 x 
10 x 2.17) and diastolic pressure lower by 1.8 mm Hg per 100 mmol sodium. 
Adjustment also for potassium excretion, body mass index and alcohol intake, 
reduced these estimates to 2.8 mm Hg systolic and 0.2 mm Hg diastolic. Age- 
specific estimates for men and women combined were also correspondingly larger 
when corrected for reliability; for example, at ages 50-59 after adjustment for age, 
sex, potassium excretion, body mass index and alcohol intake, the regression 
coefficient indicated systolic pressure lower by 3.6 mm Hg per 100 mmol sodium 
(i.e., 0.165 x 10x2.17).
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Table 12
Summary of combined within centre regression coefficients (b), standard errors 
(SE) and z-scores (Z) relating 24-hour urinary sodium excretion and blood 
pressure in individuals. Results by sex and age, uncorrected for reliability of
measurement.
Systolic Blood Pressure Diastolic Blood Pressure
Adjusted age Adjusted age (sex) Adjusted age Adjusted age (sex)
(A K=0+ A  ocher confounders# (A iex)+ A  o ther confounders#
b (S E )t Z b(SE)t z b(SE)t z b (S E )f z
Men
20-39 0 105(0 034) 3.14** 0.008(0.039) 0.20 -0.020(0.030) -0.67 -0.087(0.035) -253*
40-59 0.115(0.046) 2.50* 0.110(0.056) 1.99 0.102(0.031) 3.30*** 0.043(0.036) 1.19
All ages 0.120(0 029) 4.09*M 0.056(0.034) 1.67 0.057(0.022) 2.54* -0.006(0.025) -0.24
Women
20-39 0.1*6(0 040) 4.69* •* 0.083(0.046) 1.83 0.082(0.033) 248* 0.027(0.038) 0.69
40-59 0.226(0.059) 3*2* •• 0.155(0.068) 2.28* 0.075(0.036) 206* -0.012(0.042) -0.29
All ages 0.213(0.037) 5.86*»» 0.131(0.042) 3.13** 0.085(0.025) 3.40* •• 0.009(0.028) 0.34
Men A  Women
20-29 0.165(0.035) 4.74*** 0.079(0.041) 1.90 0.008(0.032) 0.25 -0.037(0.038) -0.97
30-39 0.141(0.039) 3.64*** 0.069(0.044) 1.56 0 043(0 032) 1.35 -0.023(0.036) -0.64
40-49 0.119(0.047) 2.52* 0.102(0.056) 1.81 0.063(0.033) 1.90 0.025(0.040) 0.64
50-59 0 224(0.059) 3.80*** 0.165(0.069) 2.39* 0.086(0.035) 246* 0.019(0.041) 0.47
AU ages 0.163(0.023) 6.97*** 0.100(0.026) 3.79* • • 0.068(0.017) 4.08*** 0.003(0.019) 0.16
Adjusted for *ge in men, and in women, and age and sex in m en an d  wom en combined
# Adjusted for age, (sex), body mass index, alcohol intake and p o tassium  excretion 
t  mm Hg/ 10 mmol sodium
* p<0.05 •* p<0.01 ***p<  0.001
83
Relationships between potassium excretion and the BP of individuals are summarised 
in Table 13. The relationships to pressure were similar in the two sexes, and were 
mostly negative and stronger at older ages, and in the fully adjusted analysis. Thus, 
with adjustment for age (sex) sodium excretion, body mass index and alcohol intake, 
significantly negative associations between potassium excretion and systolic pressure 
were observed for men and for women at ages 40-59, and for men and women 
combined at ages 40-49 and 50-59. For diastolic pressure, associations in the fully 
adjusted analysis were significantly negative for men (all ages) and for men and 
women combined at ages 40-49.
The study-wide reliability coefficient for potassium was 0.57, giving a correction 
factor for regression coefficients of 1.75. Thus the regression coefficient relating 
potassium excretion and systolic pressure for men and women combined at ages 50- 
59, adjusted for confounders and corrected for reliability, indicated BP lower by 0.7 
mm Hg for potassium higher by 10 mmol (i.e., -0.395 x 1.75).
The relations of sodium/potassium ratio and BP in individuals are summarised in 
Table 14. In general, results were similar to those for sodium, although more 
consistent, being stronger and more positive for women and - at least for systolic BP - 
at older ages. Thus, with adjustment for age (and sex) positive and significant 
associations between sodium/potassium ratio and BP, systolic and diastolic, were 
seen in all analyses except for men aged 20-39 and men and women combined at ages 
20-29. With adjustment also for body mass index and alcohol intake, relationships 
with systolic pressure remained significant in all analyses except men aged 20-39, 
women aged 20-39 and men and women combined at ages 20-29. For diastolic 
pressure, only the relationships for men and women combined at ages 30-39, and at 
all ages were significant.
The study-wide estimate of reliability for sodium/potassium ratio was 0.39, giving a 
correction factor of 2.59. Thus, with full adjustment and correction for reliability at 
ages 50-59 for men and women combined, the regression coefficient indicated 
systolic pressure lower by 2.6 mm Hg per unit decrease in the sodium/potassium
ratio.
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Table 13
Summary of combined within centre regression coefficients (b), standard errors 
(SE) and z-scores (Z) relating 24-hour urinary potassium excretion and blood 
pressure in individuals. Results by sex and age, uncorrected for reliability of
measurement.
Systolic Blood Pressure D iastolic Blood Pressure
Adjusted age
(A*»)*
Adjusted age (sex) Adjusted age
A  other confounders# (A  sex)'*'
Adjusted age (sex) 
A  o th er confounders#
b(SE)f Z b(SE)t Z b(S E )t Z b (S E )t Z
Men
20-39 0.181(0.101) 1.79 -0.022(0.109) -0.20 -0.092(0.091) -1.01 -0.151(0.100) -1.51
40-59 -0.110(0.128) -0.86 -0.386(0.138) -2.80** •0.025(0.0*8) -0.29 -0.177(0.094) -1.88
All ages 0.032(0.0*4) 0.38 -0.214(0.090) -2.39* •0.051(0.065) -0.79 -0.193(0.069) -2.79*
W omen
20-39 0.180(0.110) 1.64 0.016(0.121) 0.13 0.028(0.094) 0.30 -0.052(0.105) -0.50
40-59 -0.283(0.162) -1.75 -0.561(0.175) -3.20** -0.063(0.110) -0.58 -0.226(0.120) -1.89
AU ages -0.034(0.099) 
Men & W omen
-0.34 -0.266(0.106) -2.50* -0.013(0.073) -0.17 -0.150(0.079) -1.91
20-29 0.262(0.099) 2.64** -0.004(0.113) -0.04 -0.035(0.092) -0.38 -0.141(0.105) -1.34
30-39 0.142(0.116) 1.22 -0.046(0.125) -0.36 0.002(0.098) 0.02 -0.070(0.106) -0.66
40-49 -0.371(0.131) -2.84** -0.583(0.139) -4.19*** -0.169(0.096) -1.77 -0.336(0.105) -3.20*
50-59 -0.058(0.162) -0.35 -0.395(0.178) -2.22* 0.044(0.102) 0.43 -0.101(0.112) -0.90
AU ages 0.012(0.065) 0.19 -0.254(0.070) -3.63*** -0.020(0.04*) -0.41 -0.165(0.052) -3.18*
Adjusted fo r age in m en, and in women, and age and sex in men and women combined
# Adjusted for age, (sex), body mass index, alcohol intake and sodium excretion 
T mm Hg/  10 mmol potassium
* p<0.05 **p<0.01 * **p<  0.001
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Table 14
Summary of combined within centre regression coefficients (b), standard errors 
(SE) and z-scores (Z) relating 24-hour urinary sodium/potassium ratio and blood 
pressure in individuals. Results by sex and age, uncorrected for reliability of
measurement
Systolic Blood Pressure Diastolic Blood Pressure
Adjusted age Adjusted age (sex) Adjusted age Adjusted age (sex)
(A sex)* A other confounders# (A «e*)+ A other confounders#
b(SE)t z b(S E )t Z b(SE)t Z b(S E )t z
Men
20-39 0.297(0.156) 1.91 0131(0.154) 0.85 0.095(0.139) 0.68 -0.049(0.138) -0.35
40-59 0.993(0.249) 399*** 0948(0.252) 3.76*** 0.410(0.170) 242* 0.222(0.168) 1.32
AU ages 0.658(0.147) 4.48*** 0.508(0.146) 3.49*** 0.295(0.111) 2.66** 0.126(0.109) 1.15
Women
20-39 0.468(0.157) 2.98* • 0.241(0.154) 1.56 0.266(0.129) 205* 0.147(0.127) 1.16
40-59 1.326(0.245) 5.41*** 0.963(0.247) 3.90*** 0.450(0.148) 3.05** 0.285(0.150) 1.90
AU ages 0.936(0.151) 6.19*** 0.636(0.149) 4.25*** 0.354(0.101) 3J1*** 0.198(0.100) 1.98
Men & W omen
20-29 0.230(0.148) 1.56 0.152(0.151) 1.00 -0.206(0.137) -1.50 -0.246(0.140) -1.75
30-39 0.651(0.170) 3.82*** 0.482(0.167) 2.88** 0.527(0.137) 3.86*** 0.371(0.135) 274*«
40-49 1.093(0234) 4.68*** 0.877(0.231) 3.79*** 0.457(0.160) 286** 0.304(0.158) 1.92
50-59 1.183(0.261) 4.54*** 1.023(0.268) 3.82*** 0.349(0.160) 218* 0.260(0.163) 1.60
AU ages 0.810(0.106) 7.62*** 0.621(0.105) 5.94*** 0.319(0.075) 4.24*** 0.166(0.074) 226*
Adjusted for age in men, and in womeni, and age and sex in m en and women combined
# Adjusted for age, (sex), body mass index and alcohol intake 
t mm Hg/ unit
* p<0.05 ** |x 0 .0 1  ***p<  0.001
86
In the across-centre analyses, median sodium excretion was positively and 
significantly related to the slope of systolic and diastolic BP with age in men, in both 
the 52 and 48 centre analyses, and with and without adjustment for confounding 
variables. For women, relationships with slope of BP with age were positive in all 
analyses, but were significant only in the analyses across 52 centres. These results 
are summarised in Table 15; in the 52 centre analyses, regression coefficients were 
larger in women than men, although the reverse was true in the 48 centre analyses, 
such that with full adjustment across 48 centres, coefficients in men were some 50% 
or more higher than the corresponding coefficients in women.
In the fully adjusted analysis in men and women combined, and across the 48 centres 
(excluding the four low-sodium centres), the regression coefficient indicated that the 
increase in systolic BP over a 30 year period (e.g., from age 25 to age 55) would be 
less by 9 mm Hg for sodium excretion lower by 100 mmol per day (i.e., 0.03 x 30 x 
10 = 9 mm Hg). In the equivalent analysis for diastolic BP, the regression coefficient 
indicated BP less by 4.5 mm Hg per 100 mmol over 30 years.
When median sodium excretion was related across centres to median BPs and 
prevalence of hypertension, results were less consistent. Across 52 centres in the age- 
standardised analysis, sodium was positively and significantly related to median 
systolic BP and diastolic BP, in both men and women; however, after adjustment for 
body mass index and alcohol intake and exclusion of the four low-sodium centres, 
relationships were both positive (systolic BP) and negative (diastolic BP) but no 
longer significant. Relations of both potassium and sodium/potassium ratio to these 
BP variables were inconsistent, being both positive and negative (results not shown).
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Table 15
Summary o f across-centre regression coefficients (SE) relating sodium and 
systolic and diastolic blood pressure slope with age in men and women, 52 and 
48 centres, age standardised and multiple adjustedf
Regression coefficients (mm Hg/year/10 mmol sodium)
Age stand. Mult adj.f
No. of centres: 52 48 52 48
Systolic BP slope with age
Men 0.021*** 0.021* 0.028*** 0.026*
(0.006) (0.010) (0.007) (0.010)
Women 0.037*** 0.007 0.033*** 0.015
(0.008) (0.013) (0.008) (0.014)
Men and Women 0.030*** 0.019 0.034*** 0.030**
(0.006) (0.010) (0.006) (0.011)
Diastolic BP slope with age
Men 0.018*** 0.014* 0.019*** 0.015*
(0.003) (0.006) (0.004) (0.006)
Women 0.022*** 0.009 0.020*** 0.010
(0.004) (0.006) (0.004) (0.007)
Men and Women 0.021*** 0.014** 0.021*** 0.015**
(0.003) (0.005) (0.003) (0.006)
*p<0.05 **p<0.01 *** p<0.001
t Standardised for age, and adjusted for body mass index and alcohol intake
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4.2.2 United Kingdom Centres
Six hundred and forty-one eligible participants (including replacements) attended the 
three centres, of whom 43 (6.7%) were excluded, 41 for an incomplete urine 
collection and 2 who were pregnant. Data on the remaining 598 people (299 men and 
299 women) are included in this report, 199 in Belfast, 200 in Birmingham and 199 
in South Wales. Response rates (given by the ratio of clinic attenders to eligible 
persons selected for study) were 55%, 83% and 83% respectively in the three centres.
Means and ranges of selected variables by centre are given in Table 16. Mean 
systolic pressure was higher in South Wales (124.3 mm Hg) than Belfast (120.3 mm 
Hg, p<0.05) and Birmingham (119.6 mm Hg); diastolic pressure was significantly 
(p<0.05) higher in Belfast (73.8 mm Hg) than in the other two centres (71.2 mm Hg 
and 71.3 mm Hg). Mean body mass index ranged from 24.8 kg/m2 (Belfast) to 25.7 
(South Wales) and mean sodium excretion from 150.8 mmol/24-hour (Belfast) to
153.1 (Birmingham): these differences were not significant. Mean potassium 
excretion was significantly (p<0.001) lower in Belfast than in the other two centres 
(56.9 mmol/24-hour vs 63.0 and 63.1 mmol/24-hour); and the prevalence of heavy 
drinking (defined as £300 ml/week) was higher in Belfast (20.2%) than in 
Birmingham (11.5%, p<0.05) and South Wales (14.0%). A wide range of individual 
values was recorded; for example, systolic BP ranged from 89 to 210 mm Hg, 
diastolic pressure from 35 to 122 mm Hg and sodium excretion from 31.7 to 393.2 
mmol/24-hour.
Mean values in men were significantly (p<0.001) higher than in women for BP, 
weight, height, urinary volume, and urinary excretion of sodium, potassium, chloride, 
calcium, magnesium and creatinine (Table 17). The prevalence of heavy drinking as 
defined was also significantly higher in men (27.5% vs 3.0%, p<0.001).
Pulse rate was significantly (p<0.001) higher in women, but body mass index and 
urinary sodium/potassium ratio were similar in the two sexes (Table 17). Overall in 
the three centres, mean BP was 121.4/72.1 mm Hg, body mass index 25.2 kg/m2, 
sodium excretion 152.1 mmol/24-hour, potassium excretion 61.0 mmol/24-hour and 
sodium/potassium ratio 2.64 (Table 17). The relations of urinary sodium, 
sodium/potassium ratio, and potassium to BP in the three U.K. centres and in all 
INTERSALT centres, are summarised in Table 18. Overall, INTERSALT found 
significant positive relations in individuals between BP and urinary sodium excretion, 
sodium/potassium ratio, and, with adjustment for confounding variables, significant 
negative associations between potassium excretion and BP. In addition, the average
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sodium intake of centres was positively and significantly related to the slope of BP 
with age (Table 15). In the U.K. centres, relationships were mostly positive between 
systolic pressure and both sodium and sodium/potassium ratio, and were both positive 
and negative in the other analyses. Confidence intervals were wide (reflecting the 
relatively small sample size in each centre) such that the U.K. results were consistent 
with the overall INTERSALT findings.
Pooled regression coefficients of BP with body mass index and heavy alcohol intake 
(¿300 ml/week) are shown in Table 19. Overall in INTERSALT, body mass index 
and heavy alcohol intake were positively and significantly related to the BP of 
individuals. In each of the three U.K. centres, positive coefficients were found in all 
analyses relating both body mass index and heavy alcohol drinking to BP.
To illustrate the potential benefit o f  a multifactorial approach to control of BP in the 
population, a cross-stratification analysis was carried out for all 598 individuals in the 
three U.K. centres as described in the Methods above. Individuals within each centre 
were ranked according to risk score and mean BPs were calculated as shown in Table 
20. Twenty men and 27 women were identified as at "lower risk" for high BP (i.e., 
risk score zero): mean systolic pressure for men, and both systolic and diastolic 
pressure for women, were lowest in this group. By contrast, higher average BPs were 
found in those with scores of two o r more: tests for heterogeneity were significant for 
both systolic and diastolic pressure in men (p<0.001) and for systolic pressure in 
women (p<0.05) (Table 20). The difference in BP (systolic/diastolic) between those 
with lowest and highest risk scores was approximately 12/7 mm Hg for men and 7/5 
mm Hg for women.
Comparison of those with risk score zero and the remainder (risk score of one or 
more) is not shown in the Tables but is given here. For men with score zero, age- 
adjusted mean systolic pressure was 114.6 mm Hg (SE 3.4) compared with 125.5 
(0.9) (score one or more) (p<0.01) and for women, 113.2 mm Hg (SE 2.6) vs 118.5 
(0.8), (p=0.06). Corresponding figures for diastolic pressure were for men 71.2 mm 
Hg (SE 2.5) vs 74.8 (0.7), (p=0.19) and for women 65.7 mm Hg (SE 1.7) vs 70.1 
(0.5), (p<0.05).
These results and some implications for U.K. food and health policy are discussed in 
Chapter 5.
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Table 16
Three ILK. centres: Age and sex standardised means (sd) and ranges of selected
variables by centre
Belfast (N=199) Birmingham (N=200) S. W ales (N=199)
M ean (*d) M in M ax M e an (•d ) M in M ax M ean (*d) M in  M ax
SB P (mm Hg) 120.3 (13.7) 95 174 119.6 (14.8) 89 182 124.3 (16.7)* 89 210
DBP (mm Hg) 73.8 (10.8)° 35 112 71.2 (lftO ) 44 109 71.3 (10.7)* 42 122
W t (kg) 69.0 (11.2) 42.8 105.6 69.2 ( l(X 9 )tt 47.0 107.5 72.5 ( M l ) * * 39.7 139.7
Ht (m) 1.67 (0.07) 1.44 1.90 1.66 (0.06)t1 1.42 1.89 1.68 (0.06) 1.41 1.90
BM I (kg/m2) 24.8 (4.0) 17.6 42.5 25.2 (3.8) 18.2 48.8 25.7 (4.8) 17.0 54.6
Pulse (bt/min) 72.6 (12.0) 43 117 73.9 (10.1) 49 99 76.3 (11.7)** 42 120
Alcohol
(£300 ml/wk) 20.246° 11.5% 14.0%
24 -hour urinary excretion:
Na (mmol/24hr) 150.8 (56.4) 31.7 342.8 153.1 (46.4) 53.3 313.6 152.3 (54.9) 52.9 393.2
Na/K(mmol/mmol) 2.79 (1.04) 0.90 7.78 2.59 (0.97) 0.68 8.92 2.54 (0.86)* 0.97 5.96
K (mmol/24hr) 56.9 (18 .5)°° 15.9 143.0 63.0 (18.9) 23.5 167.0 63.1 (22.0)** 20.3 160.6
Cl (mmol/24hr) 151.7 (58.3) 12.8 345.3 156.1 (47.5)t 54.8 364.5 151.7 (57.7) 39.5 444.9
Ca (mmol/24hr) 4.83 (2.23) 0.56 13.13 4.93 (2 .0 6 )tt 0.34 13.43 4.43 (1 9 7 ) 0.95 12.89
Mg (mmol/24hr) 4.14 (132) 1.32 8.81 3.93 (118) 0.91 6.95 4.38 (1-43) 1.22 9.70
Creat (mmol/24hr) 10.9 (2.3) 3.6 18.8 11.0 (2.3) 4.8 22.9 11.3 (2 7 ) 3.7 25.0
Vol (1/24hr) 1.53 (0.81)° 0.51 8.09 1.74 (0.65)t 0.62 4.11 1.55 (0.70) 0.39 4.29
Multiple comparison was done by the Sludent-Newman-Keuls method.
South W ales significantly different from Belfast: * p<0.05, ** p<0.01
Birmingham significantly different from South W alesrf p<0.05, f t  p<0.01 
Belfast significantly different from Birmingham: °  p<0.05, 00 p<0.01
Abbreviations: SBP, systolic Mood pressure; DBP, diastolic blood pressure; W t, weight; Ht, height; BMI, body m ass index; Na, 
sodium; K, potassium; Na/K, sodium/poUssium ratio; Cl, chloride; Ca, calcium; Mg, magnesium; Great, creatinine; Vol, volume.
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Table 17
Three U.K. centres combined: age and centre standardised means (sd) of 
selected variables by sex, and for men and women combined
Men Women Men & Women
(N=299) (N-299) (N=598)
Systolic BP (mm Hg) 124.8 (16.0) 118.0» (14.2) 121.4 (15.1)
Diastolic BP (mm Hg) 74.5 (11.7) 69.7* (9.1) 72.1 (10.5)
Weight (kg) 75.6(11.6) 64.8* (12.6) 70.2 (12.1)
Height (m) 1.73 (0.07) 1.60* (0.06) 1.67 (0.06)
BMI (kg/m2) 25.2 (3.3) 25.2 (4.9) 25.2 (4.2)
Pulse (bcals/min) 72.4 (11.9) 76.1* (10.6) 74.3 (11.3)
Prevalence of heavy 
drinking (>300 ml/wk) 27.5% 3.0%* 15.2%
24-hour urinary excretion:
Sodium (mmol/24hr) 168.5 (59.1) 135.6*(45.5) 152.1 (52.7)
Sodium/potassium 
ratio (mmol/mmol) 2.63 (0.93) 2.66 (0.98) 2.64 (0.96)
Potassium (mmol/24hr) 68.3 (23.1) 53.7*(16.0) 61.0 (19.8)
Chloride (mmol/24hr) 172.0 (62.5) 134.4*(45.8) 153.2 (54.8)
Calcium (mmol/24hr) 5.35 (2.31) 4.11 *( 1.85) 4.73 (2.09)
Magnesium (mmol/24hr) 4.47 (1.47) 3.83*(1.14) 4.15 (1.31)
Creatinine (mmol/24hr) 13.1 (2.9) 9.0* (1.8) 11.1 (2.4)
Volume (l/24hr) 1.75 (0.85) 1.47*(0.56) 1.61 (0.72)
Key: BMI, body mass index
* Women significantly different from men, pcO.OOl
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Table 18
Regression coefficients (SE) relating blood pressure (BP) and 24-hour urinary 
sodium (Na) excretion (mm Hg/10 mmol Na) urinary sodium/potassium (Na/K) 
ratio (mm Hg/molar ratio) and urinary potassium (K) excretion (mm Hg/10 
mmol K), for the 3 U.K. centres and all INTERSALT centres. Adjusted for 
centre and for age and sex, and age, sex and other confounderst
Systolic BP Diastolic BP
Regression: Adjusted for Adjusted for Adjusted for Adjusted for
age and sex age, sex and age and sex age, sex and
other confounderst other confounderst
BP-Na 
UK Centres:
- Belfast 0.374* (0.172) 0.224 (0.201) 0.119 (0.138) -0.038 (0.156)
- Birmingham 0.020 (0.299) -0.056 (0.242) -0.058 (0.157) -0.163 (0.160)
- South W ales 0.461* (0.218) 0.494* (0.249) -0.133 (0.143) 0.021 (0.164)
All INTERSALT Centres 0.163*** (0.023) 0.100*** (0.026) 0.068*** (0.017) 0.003 (0.019)
- corrected fo r reliability* 0.354 0.217 0.148 0.006
BP-Na/K
UK Centres:
- Belfast 0.443 (0.960) 0.044 (0.975) 0.355 (0.761) -0.276 (0.749)
- Birmingham 0.105 (1.089) 0.092 (1.063) -0.462 (0.745) -0.454 (0.705)
- South W ales 1.750 (1.328) 2.177 (1.347) -0.324 (0.868) -0.279 (0.885)
AU INTERSALT Centres 0.810*** (0.106) 0.621*** (0.104) 0.319*** (0.075) 0.166* (0.074)
- corrected fo r reliability* 2.098 1.608 0.826 0.431
BP-K
UK Centres:
- Belfast 0.819 (0.532) 0.520 (0.529) 0.173 (0.424) -0.118 (0.407)
- Birmingham -0.562 (0.553) -0.056 (0.242) 0 .076 (0.379) -0.163 (0.160)
- South W ales 0.188 (0.560) -0.810 (0.630) -0.358 (0.362) -0.608 (0.411)
All INTERSALT Centres 0.012 (0.065) -0.254* *• (0 070) -0.020 (0.048) -0.165** (0.052)
- corrected for reliability* 0.021 -0.446 -0.035 -0.289
t BP-Na adjusted for age, sex, body mass index, potassium, alcohol; BP-Na/K adjusted fo r age, sex, body m ass index, alcohol; 
BP-K adjusted for age, sex, body mass index, sodium, a lco h o l.
+ Reliability coefficient estimated from data on repeat urine measurements
* p < 0.05 •*  p < 0 .0 1  p <  0.001
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Table 19
Regression coefficientst (SE) relating blood pressure (BP) to Body Mass Index 
(BMI) and heavy alcohol intake (>300ml/week) for the 3 U.K. centres, and for all 
INTERSALT centres. Adjusted for age, sex and other confounders+
Systolic BP Diastolic BP
BP-BMl
UK Centres:
Belfast 0.73* (0.25) 0.96** (0.19)
Birmingham 0.94* (0.28) 0.88** (0.18)
South Wales 1.07** (0.24) 0.70** (0.16)
All INTERSALT Centres 0.775** (0.036) 0.597** (0.026)
BP-Alcohol
UK Centres:
Belfast 2.83 (2.92) 2.28 (2.26)
Birmingham 2.69 (4.04) 1.43 (2.67)
South Wales 4.57 (3.98) 3.04 (2.61)
All INTERSALT Centres 3.34** (0.57) 1.98** (0.41)
t Coefficients estimate the difference in BP (mm Hg) per unit BMI, or, for 
alcohol, for drinkers of >300ml/week compared to non-drinkers
+ BP-BMI adjusted for age, sex, sodium, potassium, alcohol; BP-Alcohol 
adjusted for age, sex, sodium, potassium, BMI
** p<0.01 *** p<0.001
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Table 20
Three U.K. centres combined: mean (SE) blood pressure (mm Hg) by sex and by 
"risk score"f, estimated from individual values of sodium and potassium 
excretion, body mass index and alcohol intake. Adjusted for centre, and for age.
Men Women
N Systolic Diastolic N Systolic Diastolic
"Risk score"\\
0 20 114.6(3.4) 712(2.5) 27 113.2(2.6) 65.7 (1.7)
1 91 119.9(1.6) 70.2(1.2) 121 116.1 (1.2) 69.8 (0.8)
2 125 129.0(1.4) 76.5(1.0) 117 120.5(1.3) 70.3 (0.8)
3+ 63 126.7(1.9) 77.9(1.4) 34 120.1 (2.3) 70.7(1.6)
F - test for hetrogeneity (df = 3 & 290):
Males, systolic = 9.48, diastolic = 8.34 (p < 0.001)
Females, systolic = 3.46 (p < 0.05), diastolic = 2.01 (p = 0.1)
t For each invidual, the "risk score" is calculated by summing (0,1) values for that 
individual relative to the appropriate age, sex and centre adjusted values, where 0 = 
"lower-risk" and 1 = "higher risk" (i.e., for sodium and body mass index: 0 = below 
adjusted median, 1 = above adjusted median; for potassium: 0 = above adjusted median, 
1 = below adjusted median, and for alcohol consumption 0 = less than 300 ml/weck, 1 = 
at least 300 m l / w e e k ) .
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Chapter 5
Discussion, Conclusions and Recommendations
In this Chapter, the results of the age and sex specific anlyses and the findings for the 
three U.K. centres presented in Chapter 4 are briefly discussed; and the results of 
INTERSALT relating sodium and BP are put into the context of the other evidence 
presented in Chapter 1. Some of the implications of the study are also addressed and 
recommendations made with regard to sodium intake of both individuals and 
populations.
5.1 Age and Sex Specific Results
Summarising the results in Chapter 4, the study found positive and significant 
relationships in individuals between urinary sodium excretion and BP in both men 
and women. These positive and significant relationships were also found in seven of 
eight age-sex specific analyses. In most analyses, z-scores suggested closer 
associations in women than in men: the size o f regression coefficients in women was 
as much as twice that of the corresponding coefficients in men. In age-specific 
analyses for men and women combined, sodium excretion was positively related to 
BP, significantly so for systolic pressure at all ages and for diastolic pressure at ages 
50-59; these regression coefficients were generally larger at older compared to 
younger ages. Results for sodium/potassium ratio in individuals were similar to those 
for sodium, being stronger in women than in men, and (at least for systolic pressure) 
at older compared to younger ages. With adjustment for confounding variables, 
potassium excretion was negatively and significantly related to the BP of individuals; 
again these relationships were more marked at older ages. Across the centres, median 
sodium excretion was positively and significantly related to the slope of systolic and 
diastolic blood pressure with age in men, in both the 52 and 48 centre analyses, and 
with and without adjustment for confounding variables. For women, relationships 
with slope of blood pressure with age were positive in all analyses, but were 
significant only in the analyses across 52 centres. Other across-centre relationships 
were less consistent.
These results confirm the importance of sodium and potassium in relation to the BP 
of individuals, despite the well-known problems of within-individual variability 
which seriously bias these relationships (Liu et al., 1979); and they extend the 
findings of the main INTERSALT report (INTERSALT Cooperative Research 
Group, 1988) to age- and sex-specific sub-groups. The power of the sub-group
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analyses to detect significant associations between BP and electrolytes is lower than 
in the study as a whole, and the power to detect significant interactions is limited 
(e.g., different sized relationships in men and women, or at different ages) since the 
study was designed to  test out hypotheses in all 10,000+ participants. Nevertheless, 
there was some indication of stronger relationships in women than in men of sodium 
(and sodium/potassium ratio) with BP, consistent with the findings in the other 
epidemiological studies discussed in Chapter 1 (Table 7). There was also indication 
of stronger relationships at older compared to younger ages, as has been predicted 
(Simpson, 1988).
The reasons for the differences by sex and age are not clear, and may to some extent 
indicate different reliability of measurement for men and women, and at different 
ages. Alternatively, the stronger relationships in women compared to men might 
reflect a reduced ability in women to handle an equivalent sodium load given their 
smaller frame and hence kidney size (Simpson et al., 1982). The difference with age 
may also reflect reduced ability to handle a sodium load with advancing age and 
hence decreasing renal function, or possibly the effect of greater cumulative exposure 
to sodium which is apparent at older ages. The results with age are consistent with 
the findings of Grobbee and Hofman (1986) with respect to their review of the trials 
of sodium reduction discussed in Chapter 1 (i.e., an apparent greater effect at older 
ages) and warrant further investigation in laboratory as well as epidemiological 
studies.
Recent work suggests that the estimates of reliability which were published 
previously (INTERSALT Cooperative Research Group, 1988) are probably too high, 
so that correction factors (which are the inverse of reliability) are too low (A. Dyer, 
personal communication). Taken together with the larger effects at older ages, these 
results suggest that previous INTERSALT estimates of the relations between sodium, 
potassium and BP are conservative. Even with correction for reliability as indicated 
previously (INTERSALT Cooperative Research Group, 1988), the analysis at ages 
50-59 suggests that 100 mmol lower sodium excretion is associated with average BP 
lower by 4.9 mm Hg systolic and 1.9 mm Hg diastolic (after adjustment for age and 
sex), or 3.6 mm Hg systolic and 0.4 mm Hg diastolic (with adjustment also for 
potassium excretion, body mass index and alcohol intake). As previously reported 
(INTERSALT Cooperative Research Group, 1988) equivalent figures for the analysis 
of men and women combined at all ages are respectively 3.5 mm Hg systolic, 1.5 mm 
Hg diastolic, 2.2 mm Hg systolic and 0.1 mm Hg diastolic.
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Across the 52 centres, the positive, significant and independent association between 
average sodium excretion and slope of BP with age was present in men and women 
for both systolic and diastolic pressures with and without adjustment for confounding 
variables. Across 48 centres (excluding the four low-sodium centres) it remained 
significant in men, and positive but non-significant in women. For men and women 
combined, this across-centre association gave the estimate that the rise in systolic BP 
over a 30 year period (e.g., from age 25 to age 55) would be less by 9 mm Hg for a 
100 mmol lower average sodium excretion.
Average sodium excretion was also positively and significantly related to average 
BPs and prevalence of hypertension across all 52 centres. This is the analysis most 
comparable to the famous straight line graphs of Dahl (1960), Froment, Milon and 
Gravier (1979) and Gleibermann (1973), who included populations with very low and 
very high levels of sodium intake: as shown in Chapter 1 (Table 4), the size of the 
coefficients is reduced when populations at the extremes of sodium intake are 
excluded from the analyses. The same phenomenon can be seen in INTERSALT 
when the four low-sodium centres are excluded, since in these analyses, the power to 
detect significant associations is low given the limited range of average sodium 
excretion amongst the 48 centres (Chapter 2). Relationships in INTERSALT are 
further confounded by average body weight, since some populations (particularly 
those in the Far East) tend to have relatively high sodium excretion, but low body 
weight which is itself related to BP (Dyer & Elliott, 1989). Thus there is important 
ecological confounding in INTERSALT which, as discussed in Chapter 3, makes 
interpretation of the across-centre findings hazardous; taken together with the 
relatively low statistical power in these across-centre analyses compared with the 
high power within-centres, this suggests that far more weight in INTERSALT should 
be given to the within- rather than the across-centre findings.
5.2 Findings for the United Kingdom Centres
The study gives standardised data on BP levels, electrolyte excretion and other 
factors in representative samples of defined populations in three U.K. centres. In 
common with other European centres in INTERSALT, the U.K. centres had relatively 
high average BPs, body mass index, sodium excretion and sodium/potassium ratio; 
prevalence of heavy alcohol drinking (S300 ml/week) in men was also high (27.5%). 
Only the relatively high mean potassium excretion in the U.K. (61 mmol/24 hr) could 
be considered favourable, but even so, it was exceeded in 17 of the 52 centres 
(INTERSALT Cooperative Research Group, 1988).
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Mean sodium excretion was 152 mmol/24-hour (equivalent to 8.9 g salt per day). 
Few other data on sodium intake in the U.K. are available; James, Ralph & Sanchez- 
Castillo (1987) reviewed studies of salt consumption in Britain published between 
1959 and 1984, in which salt intake was assessed by the urinary excretion of sodium 
or chloride. Estimates in men ranged from 9.7 g salt/day in South Wales (Watt, Foy 
& Tudor Hart, 1983) to 15.7 g in Plymouth (Dauncey & Widdowson, 1972) 
compared with 9.8 g (169 mmol sodium) in the INTERS ALT U.K. centres; in 
women, previous estimates ranged from 6.5 g salt/day in South Wales (Watt, Foy & 
Tudor Hart, 1983) to 10.1 g in Renfrew, Scotland (Beevers, Hawthorne & Padfield, 
1980), compared with the 7.9 g (136 mmol sodium) reported here.
Estimates of salt intake were derived from 24-hour urine collections in random 
general population samples in tw o of the studies (both in Cambridgeshire) reviewed 
by James, Ralph & Sanchez-Castillo (1987), giving values of salt excretion of 10.6 
g/day (Sanchez-Castillo et al„ 1987) and 10.1 (Williams & Bingham, 1986) in men, 
and 7.4 g/day (Sanchez-Castillio et al., 1987) and 7.5 (Williams & Bingham, 1986) in 
women. Only four other studies could be identified by the present author in which 
estimates of sodium excretion were based on 24-hour urine collections from random 
population samples in Britain (Bulpitt et al., 1986; Elliott et al., 1988; Gregory et al., 
1990; Smith et al., 1988). In a small study in a North London general practice, mean 
sodium excretion was 193 mmo 1/24-hour (11.3 g salt/day) in men and 142 mmol/24- 
hour (8.3 g salt/day) in women (Elliott et al., 1988); in London civil servants, it was 
171 mmol/24-hour (10 g salt/day) in men and 136 mmol/24-hour (7.9 g salt/day) in 
women (Bulpitt, et al., 1986); in a large population survey in Scotland, mean values 
were 193 mmol/24-hour (11.3 g salt/day) in men and 143 mmol/24-hour (8.4 g 
salt/day) in women (Smith et al., 1988); and in a recently published population survey 
of the dietary habits of British men and women (Gregory at al., 1990), mean sodium 
excretion was 174 mmol/24-hour in men (10.2 g salt/day) and '41 mmol in women 
(8.3 g salt/day).
Thus the somewhat limited data available suggest a relatively high average salt 
consumption across the U.K. which has probably varied little in recent years. This 
contrasts with the experience of other countries, e.g., Belgium (Joossens & Geboers, 
1985) and Japan (Hashimoto et al., 1989) where sodium consumption appears to have 
declined. The apparent constancy of sodium intake in the U.K., however, conceals 
marked individual variability: in the present study, values of sodium excretion of up 
to 393 mmol/24-hour (23 g salt/day) were recorded.
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Significant (p<0.05) positive relations were observed between sodium and systolic 
pressure in two centres (Belfast and South Wales). These findings are consistent with 
some of the other studies in the U.K. which found positive and significant 
relationships between sodium and BP (Elliott et al., 1988; Smith et al., 1988; Khaw, 
1983). Within the context of INTERSALT, however, they may to some extent 
represent chance variation amongst the 52 centres; results were similarly positive and 
significant in 13 other centres (INTERSALT Cooperative Research Group, 1988). 
Some implications of the INTERSALT findings for U.K. food and health policy are 
discussed in section 5.4.2 below.
5,3 Findings of the INTERSALT Study in the Context o f Other 
Evidence on Salt and Blood Pressure
The evidence reviewed in this thesis from controlled trials of sodium reduction, 
epidemiological studies except INTERSALT, and the INTERSALT study itself, is 
consistent in showing that lower urinary sodium excretion is associated with lower 
BP. Furthermore, these different types of study give quantitatively similar estimates 
of effect. To some extent this finding might be fortuitous, in so far as the 
epidemiological studies are prone to bias and confounding as discussed in Chapter 1, 
while the trials may underestimate the sodium-BP relation due to carry-over effects, 
and incomplete reversibility.
Thus the overview of randomised controlled trials presented in Chapter 1 gave the 
estimate that a reduction in sodium excretion averaging 70 to 75 mmol per day 
lowered BP in hypertensive subjects by 4.9 mm Hg systolic and 2.6 mm Hg diastolic, 
and by 1.7 mm Hg and 1.0 mm Hg respectively in normotensive subjects (Table 3). 
The overview of within-population epidemiological studies, again presented in 
Chapter 1, gave a pooled (simple) regression estimate that 100 mmol lower sodium 
was associated with BP lower by 3.7 mm Hg systolic and 2.0 mm Hg diastolic in men 
and women combined, after correction for intra-individual variability in sodium 
excretion (Table 7); and the corrected pooled within-centre regression estimate from 
INTERSALT in men and women combined was that, with adjustment for age and 
sex, 100 mmol lower sodium was associated with BP lower by 3.5 mm Hg systolic 
and 1.5 mm Hg diastolic, reducing to 2.2 mm Hg and 0.1 mm Hg respectively after 
adjustment for other confounders (INTERSALT Cooperative Research Group, 1988; 
and Table 18). Across the centres in INTERSALT, average sodium excretion was 
positively and significantly related to slope of BP with age, such that 100 mmol lower 
sodium was associated with a 9 mm Hg lower rise in systolic BP from age 25 to age 
55 (Table 15).
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A number of considerations relevant to the interpretation of the INTERSALT results 
should be noted. As discussed in Chapter 3, the design allowed relationships to be 
studied both in individuals and across centres, although the across-centre analyses are 
particularly prone to bias from unmeasured (ecological) confounding. Thus the study 
is perhaps best regarded as a pooling of 52 separate epidemiological studies in 
individuals, with standardised methods, equipment and protocol in all centres, and 
with central coordination of quality control, data collection, and of the data and 
biochemical analyses.
Under these circumstances, the study gave a powerful qualitative test of the sodium- 
BP relationship. However, it is likely that a combination of factors led to an 
underestimate of the size of that relationship: firstly, the study was cross-sectional, 
relating current sodium excretion (as a proxy for current intake) to current BP. If 
sodium is implicated in higher BP, it is likely that exposure since childhood, even 
from birth, is important (Hofman, Hazebroek & Valkenburg, 1983). Secondly, as 
discussed, a single 24-hour urine collection is a relatively weak method for 
quantifying the "true" (habitual) electrolyte excretion of the individual, due to large 
within-individual variability. Even though there was an attempt to correct for this 
error using study-wide estimates of reliability, the adjustment that was made probably 
underestimated the bias, as noted above. Thirdly, although the protocol required that 
the start and end of the 24-hour collection be supervised by clinic staff, and each 
person was queried about completeness of collection, nevertheless it is likely that 
varying degrees of incompleteness of urine collection took place in some (or all) of 
the centres, which would again tend to lead to underestimates of true associations 
(Elliott et al„ 1988).
Fourthly, many populations in the study (e.g„ those in Japan and the United States) 
have been subjected to public health campaigns against a high salt intake. This could 
bias true associations downwards, or even convert positive relations to negative, if, as 
was in fact seen in the study, hypertensive individuals in the population were 
selectively reducing sodium intake (Hashimoto et al., 1989). Fifthly, a number of 
individuals in the study were on anti-hypertensive medication (indeed, the majority at 
older ages in some centres) and hence BPs as measured were artificially low. Again 
the effect would be in the direction of reducing observed relationships between 
sodium and BP; and sixthly, adjustment for body mass index and other confounders, 
which are positively correlated with sodium excretion but are more accurately 
measured, may have led to an underestimate of the independent effect of sodium in 
the multiple regression analyses (Liu, 1988).
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Despite this likely underestimation of effect, the sum of evidence relating sodium to 
BP from animal studies, clinical observations, clinical trials and epidemiological 
studies is persuasive, and consistent with a judgment as to causality. In the remainder 
of this Chapter, some of the public health implications of these findings are briefly 
considered.
5.4 Some Public Health Implications
In this section, some of the issues are reviewed concerning a possible public health 
recommendation for improved lifestyles to lower BP and in particular, a policy of 
sodium reduction to lower BP in the community. After a brief discussion of the 
nature of the BP problem in populations, the issue of salt sensitivity is discussed, as is 
whether a recommendation to lower sodium intake in the community would be 
appropriate, and likely to be safe and of benefit.
First, the risk associated with raised BPs in the community is considered. This is 
discussed in detail elsewhere, as is the potential for non-pharmacological approaches 
to BP control in the community (Elliott, in press; Marmot & Elliott, 1989; J. Stamler 
et al., 1989). The following points are relevant:
BP associated risk is not confined to the minority with established hypertension, but 
is a problem for the population as a whole. This is best illustrated using data on the 
360,000 men aged 35 to 57 years at entry, who attended the first screen of the 
Multiple Risk Factor Intervention Trial (MRFIT), and whose mortality experience 
has now been reported after 6 years of follow-up. There was a graded and continuous 
increase in coronary heart disease mortality with increasing BP above "baseline" (i.e., 
BPs higher than 76 mm Hg diastolic or 118 mm Hg systolic), so that some 80% or 
more of the cohort were at increased risk (Stamler, Neaton & Wentworth, 1989). 
Men with the highest BPs (e.g., systolic BP 160+ mm Hg) had the highest individual 
risk of death and contributed as a group about 30% of the deaths attributed to raised 
BP in the MRFIT screened cohort; however, over 60% of those attributable deaths 
occurred in the far larger group with entry systolic BPs of 130 to 160 mm Hg, i.e., 
within the so-called "normal" to "mild hypertension" range (Elliott, in press). Thus 
for a measure like sodium reduction to be effective in reducing the community 
burden of BP-related disease, intervention needs to be directed at the population as a 
whole, not just at those with the highest pressures.
Small changes in the average BP o f a population could have a large effect both on 
the prevalence of hypertension (due to the continuous nature o f the BP distribution)
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and on mortality from cardiovascular disease. For example, using multiple logistic 
regression coefficients from the Whitehall study (M. Shipley, personal 
communication) it can be predicted that average systolic BPs lower by 2, 3 or 5 mm 
Hg are associated with annual mortality from cardiovascular disease lower by 3.2%, 
4.8% and 7.8% respectively in middle-aged men. These figures can be regarded as 
the potential gain to the community from lifelong changes in environment or lifestyle 
factors, resulting in a slower rise of BP through young adulthood and middle-age 
(Marmot & Elliott, 1989).
5.4.1 Salt Sensitivity?
By analogy with experience in rats, it has been argued (Luft, Weinberger & Grim, 
1982) that only a proportion o f the population, about 20% according to Tobian 
(1979), is sensitive to the pressor effects of sodium, so that sodium restriction should 
be directed at this sub-group and not at the population as a whole (Luft et al., 1988). 
If this were true, one might expect that positive relationships in individuals between 
salt and BP would be "generated" by the minority who were "sodium sensitive" (and 
who would therefore attain the highest pressures): for the remainder of the 
population, associations between sodium and BP should be absent or much reduced. 
This hypothesis can be tested directly using INTERS ALT data. Regression analyses 
relating sodium and BP were run excluding those with hypertension (BPs at or above 
140 mm Hg systolic or 90 mm Hg diastolic, or on anti-hypertensive medication). 
Sodium remained positively and significantly related to BP in these analyses, with 
regression coefficients only marginally lower than those obtained in the study 
population as a whole (Stamler, 1991).
These results suggest that the positive association of sodium and BP in individuals is 
observed across the BP range, and is not restricted to a minority with BPs at the high 
end of the distribution; they further imply that a policy of sodium reduction would be 
better directed at the population as a whole, than at a sub-group of "sodium sensitive" 
individuals. Since "sodium sensitivity" (i.e., a positive individual BP response to 
sodium) appears to be continuously and Normally distributed in the population, and 
not a discrete entity (Weinberger et al., 1986), studies labelling individuals as 
"sodium sensitive" or "sodium insensitive" have perhaps reflected random variation 
as much as true biological variability (Grobbee, 1991).
The concept of "sodium sensitivity” has not been convincingly demonstrated in man 
(except perhaps for a greater effect of sodium on BP at older ages) and as yet there is 
no reliable marker of "sodium sensitivity” (Grobbee, 1991). This implies that an
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approach to intervention based on "sodium sensitive" individuals is not appropriate. 
By contrast, at the level of populations, it is likely that lower average sodium intake 
would result in lower average BP, despite known variability in the individual 
response to sodium.
5.4.2 What Changes in Lifestyle Factors are Required to Produce 
Worthwhile Changes in Average Blood Pressure?
Despite likely underestimation of the INTERSALT regression estimates (see above), 
they provide a useful basis for making judgements concerning the likely reductions in 
BP to be gained from appropriate lifestyle changes. Consider for example, results 
from the three U.K. centres. The relatively small sample size in any one centre and 
large within-person variability in electrolyte excretion restrain the use of the 
individual U.K. centre regression coefficients for estimation purposes; but 
implications for the U.K. can appropriately be based on pooled results of all 52 centre 
regression coefficients in INTERSALT, corrected for reliability, and applied to the 
distributions observed in the U.K.
Thus reduction in average sodium excretion by one-third, i.e., by 50 mmol per day 
(from 150 mmol to 100 mmol) accompanied by an increase in average potassium 
excretion by one-third, i.e., by 20 mmol per day (from 60 mmol to 80 mmol) would 
also change sodium/potassium ratio by about 1.25 units (from about 2.5 to 1.25). The 
above changes are within the observed distributions of these electrolytes within the 
U.K., being in each case (at least on the day of study) about one standard deviation 
about the mean, and represent realistic medium-term goals for population values of 
these variables.
By applying the regression coefficients from the fully adjusted models relating 
electrolytes and BP (Chapter 4, Tables 12-14) it can be estimated that these changes 
would be associated with differences of about 2-3 mm Hg in average population 
systolic pressure. Further, the across-centre findings indicate that a 50 mmol 
reduction in sodium intake might reduce the rise in systolic pressure over 30 years by 
4 to 5 mm Hg (Chapter 4). As discussed above, differences in average BP of this 
magnitude have been shown in follow-up studies to be associated with large 
differences in mortality (J. Stamler et al., 1989; Stamler, 1991). Additional benefits 
might be expected from favourable changes in average body mass index or (for heavy 
drinkers) in alcohol intake, both of which were positively and significantly related in 
INTERSALT to the BP of individuals, independent of the effects of sodium and 
potassium (Table 19).
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The cross-stratification analysis in the U.K. centres allowed direct comparison of BPs 
to be made at different levels of the lifestyle factors identified above, despite likely 
mis-classification of individuals due to within-individual variability and other biases 
which would tend to reduce BP differences. For the group of men and women at 
"lower risk" of high BP (i.e."risk score" zero) based on simple stratification about the 
relevant age, sex and centre-adjusted medians, and including only those who were not 
heavy drinkers, BPs were (significantly) lower than the remainder by up to 11 mm Hg 
systolic (men) and 4.5 mm Hg diastolic (women).
In summary, the three U.K. populations included in INTERSALT were characterised 
by relatively high BPs, sodium excretion, sodium/potassium ratio, body mass index 
and (in men) a high prevalence of heavy alcohol drinking. Applying overall findings 
from INTERSALT to the U.K. data suggests that more favourable levels of these 
variables, together with a modest increase in potassium consumption, could result in a 
shift downwards in the population BP distribution and a reduction in the prevalence 
of hypertension. These non-pharmacological approaches to BP control could be 
expected to reduce mortality from stroke and coronary heart disease.
5.4.3 Is Sodium Reduction Safe?
This question was reviewed by Dahl (1958) who concluded that the sodium intake of 
Western societies was many times physiological need, and that there was little 
evidence to suggest harmful effects of even severe sodium restriction (to below one 
gram of salt a day). Four populations in INTERS ALT were found to excrete on 
average less than 50 mmol sodium per day. Median excretion of the Yanomamo 
Indians of Brazil was only 0.2 mmol per day; they were engaged in a high level of 
physical activity, and did not have evident malnutrition or protein deficiency 
(Carvalho et al., 1989; Mancilha-Carvalho, De Oliveira & Esposito, 1989).
As with other public health measures, there will be a few individuals for whom a 
recommendation to reduce salt intake would not be appropriate (Brown et al., 1984a), 
e.g., patients with salt-losing nephritis. However reduction in average population salt 
intake by one-half would still imply a level considerably in excess of usual 
physiological need. In half of the 48 INTERSALT populations (excluding the four 
low-sodium centres) at least 15% of participants had sodium output less than 100 
mmol on the day of study, and in three of these centres, at least 15% had sodium 
output below 70 mmol.
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Restriction of sodium to around 50 mmol in individual patients, or to an average of 
70-100 mmol in whole populations, appears to be a safe procedure. Variation in 24- 
hour sodium excretion within the INTERSALT populations was surprisingly large, 
even after correction for intra-individual variability (which increases estimates of 
variance based on a single 24-hour urine collection); thus it is apparent that many 
individuals, even in Western populations, already consume diets relatively low in 
sodium.
5.4.4 Is Sodium Reduction Achievable?
The short- to medium-term trials reviewed in Chapter 1 show that reduction in 
sodium intake to below 80 mmol, or even 50 mmol, per day is acceptable and 
achievable in well-motivated patients with mild to moderate hypertension. Findings 
of the Hypertension Prevention Trial Research Group (1990) in its three year trial, 
and of the community trial in Belgium (Staessen et al., 1988) were less encouraging, 
although observational studies suggest that sodium intake in Belgium is in fact on the 
decline (Joossens & Geboers, 1985). As noted in Chapter 1, recent data from the 
U.K. suggest that discretionary use of sodium (added in cooking and at the table) may 
account for only 15% of sodium intake (Sanchez-Castillo et al., 1987) so that 
attempts to lower sodium consumption need to address the issue of salt added by the 
manufacturer in processed foods, and in particular bread, meats and cereal products 
(Bull & Buss, 1980). This would most likely require cooperation of government as 
well as the food industry to ensure adequate food labelling and to provide a wide 
variety of low-sodium and sodium-free foods.
5.5 Conclusions and Recommendations
In summary, recent controlled clinical trials o f sodium reduction, and epidemiological 
studies including INTERSALT, are remarkably consistent in their estimates of the 
size of the sodium-BP relationship. Potentially, a reduction in sodium intake is of 
benefit both to individuals with higher levels of BP, through improved BP control, 
and to the community at large through a reduction in average BP. Of the non- 
pharmacological approaches to BP management considered here (reduction in sodium 
intake, reduction in the prevalence of obesity and of heavy alcohol drinking, and an 
increase in potassium intake), it may be that sodium reduction is the most amenable 
to change: since most sodium consumed is non-discretionary, being added in food 
processing, it potentially can be lowered through population-based rather than 
individual action, e.g., government legislation, clear food labelling and greater access 
to low-sodium and sodium-free foods.
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A reduction in sodium intake is a safe and valuable measure in the management of 
patients with mild to moderate hypertension. Individual responses to sodium 
restriction vary, and adequate BP control can only sometimes be achieved by 
moderate sodium restriction alone. Nevertheless, improved BP control can be 
achieved by many patients who reduce their sodium intakes, so that they can be 
maintained on a reduced dose of anti-hypertensive drugs. At the population level, a 
general lowering of sodium intake is both desirable and feasible, but would 
necessitate a major national and community effort.
Recommendation 1: In persons with mild to moderate hypertension, a trial of 
reduced sodium intake can safely be recommended either alone or in combination 
with other dietary measures, including weight loss (for overweight individuals) and 
moderation of alcohol intake. Reduced sodium intake is also a useful adjunct to 
pharmacological therapy. To be effective, sodium intake should be reduced to less 
than 80 mmol per day, and in some cases to 50 mmol per day: special dietary 
counselling and the provision of low-sodium or salt-free foods may be required.
Recommendation 2: At the population level, average sodium intake should be 
reduced by at least one third (e.g. from 150 mmol to 100 mmol per day in the U.K.). 
This is a realistic medium-term goal. Other population measures should include a 
reduction in the prevalence of obesity, a moderation of alcohol drinking and an 
increase in dietary potassium intake. It can be expected that over time these 
population-wide measures would reduce the community burden of mortality from 
coronary heart disease and stroke.
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Appendix 1: Field Methods
This appendix gives edited versions of the INTERSALT Field Manual of Operations, 
and the Manual of Operations for the London Coordinating Centre and the Central 
Laboratory. A fuller account is available (Elliott & Stamler, 1988).
1. Field Manual of Operations
The detailed field methods which were used in the study and as the basis for training 
of investigators from the 52 centres were described in a Manual o f  Operations. The 
Manual was made available to each centre for local training and for use in the field. 
An edited version is given here. The data forms which accompany this Manual are in 
Appendix 2.
1.1 Sampling and Recruitment
The goal for each centre is the recruitment of 200 persons with complete urinary and 
BP measurements, 25 in each of 8 age-sex strata. The aim is to have this sample of 
200 as representative as possible of the base population.
First, a description of the population is forwarded to London giving available 
information on characteristics like urban/rural status; main type of economic activity; 
economic level; weather, usual diet pattern, including information on salt use; general 
level of health, ethnic composition and, if known, population size and age-sex 
distribution.
A sample of the base population is drawn, and age-eligible persons are invited into 
the study. To assess how closely those taking part in the study resemble the 
population from which they came, a detailed recruiting record is kep t
Taking the sample
There are three possible sampling situations:
1. Ideally, there is a list of those in the defined population, aged 20-59, with 
known information on the age, sex, and address of each person.
2. There is a list of names and locations (e.g., voters' list) without knowing age 
or sex.
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3. There are no names but a defined geographical location from which to sample 
(e.g., a neighbourhood, a village, etc.).
In the first situation, a random sample of 400 is drawn with 50 names of each sex in 
each 10-year age group. Allowing for refusals, this should permit recruitment of 25 
in each subgroup.
If your list has names and locations but does not specify age and sex, then a random 
sample of 600 is drawn to help account both for refusals and for any unevenness in 
age-sex distribution. As an individual is approached for recruiting, age and sex are 
determined, so as to invite 25 from each age-sex group.
If there is no list of names, then as each household is contacted, persons aged 20-59 
are identified before proceeding as above.
Recruitment
To maximise recruiting, Investigators should make more than one effort to contact 
persons in the sample. For example, if  the telephone is used to recruit participants, 
several efforts should be made to make contact before moving on to the next 
individual or household. These attempts should cover the various times of the day 
and days of the week.
The general purposes of the study should be explained (e.g., a study of life style and 
BP), but no specific mention should be made of salt, since this could lead to change 
in usual salt intake at the time of examination.
The Recruiting Record
This record serves three purposes:
1. It indicates the order in which people are to be invited into the study.
2. It helps keep count of the numbers recruited in each age-sex stratum.
3. By keeping count of contact results, it helps assess response rate and the 
representativeness of the participants.
Sequence
Investigators should attempt to recruit persons for participation in unbiased order. 
For local centres which randomly draw an age- and sex-stratified sample of 400 this 
means that investigators should attempt to recruit participants in each age-sex stratum 
in the order in which they have been randomly selected, so that the first 25 in each 
age-sex stratum are invited before the 26th. However, ensure an even spread of clinic 
appointments across the age-sex strata.
For centres who sample from a base population without knowing age and sex, this 
means starting with the first name of the 600 persons sampled and working one's way 
down, until the goal of 25 in each age-sex stratum is reached.
For those sampling from households, without a prior list o f names, the recruiting 
should be in a predetermined and systematic manner (e.g., listing all the addresses in 
a street and going to each house in order).
Where there are prior lists, names should be entered, in order, into the recruiting 
record before recruitment starts.
Where there are no lists of names, wherever feasible, household identification 
(address, etc.) should be entered, in order, into the recruiting record before 
recruitment starts.
For those centres working from a list of known names (whether or not age and sex are 
indicated), the first part of the Recruiting Record will look like this:
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RECRUITING RECORD 
(For centres with list of known names)
PART I.
Name of Person
Randomly
Selected
T.
2.
J.
Contact Results
Not Unable to Unable to Contacted
Age Contact Contact
Sex Age Eligible 1st time 2nd time Agreed Refused
400 (End list here when age-sex is known)
600 (End list here when age-sex is unknown)
(The above will take many pages)
For centres sampling either from lists of names or from  households, the second part 
of the Recruiting Record will help keep track o f  how many have agreed to 
appointments in each age-sex stratum. It needs to be updated as recruiting proceeds. 
Recruitment ends when the goal of 25 in each age-sex stratum has been reached.
PART II: (A separate form  serves as Part II o f  the Recruiting Record)
RECRUITING RECORD
Summary of recruiting, by age-sex strata 
Number with appointments
Men: Age Women: Age
Date 20-29 30-39 40-49 50-59 20-29 30-39 40-49 50-59
Special Note on Recruitment
While the aim is to recruit 25 in each age-sex group, there may be need for additional 
persons in the event (hopefully rare!) that one of the 25 either fails to attend the clinic 
appointment or fails to complete the 24-hour urine collection. Where there is a prior 
sample list, this means going back to that list for the 26th person in the appropriate 
age-sex group, and inviting that person to attend.
When there was no list at the start, you will want to return to those in the right age- 
sex group, whom you identified but did not invite in the first round, or you may need 
to return to identify other eligible people. Response to these additional invitations 
should also be entered on the Recruiting Record.
Supplementary ID Numbers
Supplementary ID numbers have been assigned to each centre to identify extra 
participants. An extra participant is to be recruited if, for a given participant 
attending the clinic appointment, at least one of the following occurs:
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1. Neither of the required BP readings (Measurement I and Measurement II, 
including the random zero) is adequately recorded.
2. The 24-hour urine collection is judged to be incomplete, that is on the 
Completeness Questionnaire, Form U (Appendix), the participant indicates 
either that urine was not always voided into one of the urine collection jars 
(Part A - "No") or that one or more jars containing urine were not returned 
(Part B - "No") or that urine was missing for some other reason (Part C - 
"Yes") and more than a few drops were lost (Part D - Box 2).
3. (For women only) The participant indicates in question 41 of the 
Questionnaire (Form Q) that she is pregnant. (Women known in advance to 
be pregnant should not be recruited into the sample).
Four ID numbers have already been set aside for extra participants, at the end of each 
age-sex stratum in the Log Book. Some centres may require additional 
supplementary ID numbers. Extra Log Book pages (with additional supplementary 
ID numbers) have therefore been drawn up:
**301 -320 Men age 20-29 
** 351 - 370 Men age 30-39 
**401 -420 Men age 40-49 
** 451 - 470 Men age 50-59 
** 501 - 520 Women age 20-29 
**551 -520 Women age 30-39 
** 601 - 620 Women age 40-49 
**651 -670 Women age 50-59 
** Centre Code
It is important that procedures for recruiting supplementary (extra) participants 
should be the same as for the main sample, e.g., repeated attempts should be made to 
contact them to ensure a high response rate.
The London Coordinating Centre should be immediately informed when an extra 
participant is to be recruited, and the reason should be given. In addition, local 
centres will be contacted immediately if review of forms in London indicates that an 
extra participant should be recruited.
In all cases, when an extra participant has been recruited, all the data (forms, urine 
aliquots) for the replaced participant should be processed and shipped in the usual
way.
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1.2 Blood Pressure Measurement
Preparation
1. Before BP is measured, the participant should be asked if he or she has 
refrained from eating, drinking anything other than water, smoking or taking 
strenuous exercise in the past half-hour. Include travelling to the clinic in the 
assessment of 'strenuous exercise'. For example, if participants have to climb 
a hill, this should be taken into account, and participants given adequate time 
to rest prior to BP measurement. The participant should not have been asked 
to fast in preparation for this visit. (Check off these items on Form G.)
2. The participant should have removed outer garments, jackets, etc. Sleeves of 
shirts, blouses, etc. should be rolled up so that the upper right arm is bare for 
the BP cuff. (If the right arm is missing, injured, or deformed, expose the left 
arm.) The shirt should not constrict, and the BP cuff should not be over the 
garment. Garments must be removed if obstructing, and a loose fitting gown 
provided.
3. BP should be measured in a quiet location.
4. The participant should be seated. When seated, the participant's right (left) 
arm should be allowed to rest, palm up, with elbow on the desk or table so 
that the antecubital fossa is level with the heart. To achieve this, either the 
position of the participant in the chair should be adjusted, or the arm may be 
raised or lowered on a comfortable support. Incorrect positioning of the 
participant's arm could introduce systematic error into the measurement.
The participant should not be placed in an uncomfortable position.
5. The participant's legs should not be crossed.
6. Three standard cuff sizes are available: adult, large adult, and child. The 
correct size of cuff is essential for accurate BP measurement. Cuffs are 
marked with two "Range Lines" on the inner surface of the cuff, and an 
"Index Line" at the end of the cuff, to indicate to the user whether the cuff is 
the correct size for a particular limb.
7. The cuff should first be used like a tape measure, to be certain that the cuff is 
the correct size for the limb: hold the end of the cuff containing the rubber 
bladder over the upper arm, and pull the other end towards the participant
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under the arm. The Index Line should lie within the Range Lines for the cuff 
size. If the Index Line either falls directly on a Range Line or outside the 
range, select the next smaller or larger cuff.
8. The centre of the pocket holding the inflation bag is marked 'O'. Once the 
correct cuff size has been chosen, palpate for the brachial artery (just above 
the cubital fossa, towards the inner side of the arm), and apply the cuff so that 
the '<!>' lies over the brachial artery. The cuff should be applied firmly enough 
to prevent slipping. The lower edge of the cuff should be 2-3 cm above the 
cubital fossa, to allow sufficient room for the bell of the stethoscope. The top 
edge of the cuff should not be restricted by clothing.
9. Before taking pulse and BP, the participant should be resting in the sitting 
position, with the cuff applied, and with no change of position for five 
minutes. Conversation should be limited. However, a brief explanation o f  the 
procedure can be repeated at this time if necessary.
10. When these preparations have been completed, be sure that Form M is filled 
out, describing these preparations. Include time of day when measuring 
began. Record time using the 24-hour clock, e.g., 1 hour after noon = 13.00.
Measurement
1. The Hawksley random zero sphygmomanometer, with random zero 0-20 mm 
is used (Figures 7 and 8).
2. It is essential, for standardised measurement, that a strict order of taking pulse 
and BP measurements is kept as a fixed routine.
3. The observer should be in a comfortable position in relation to the 
examination table. The sphygmomanometer's mercury column should be in a 
perfectly upright position, the centre of it at the eye level of the examiner.
The mercury column should face the observer and not be in the participant’s 
view.
4. Measure resting pulse. Locate the radial pulse (at the wrist) with fingers of 
your left hand, and count the number of beats for 30 seconds, using a 
stopwatch. Write this value on Form M.
5. The cuff should now be connected to the sphygmomanometer.
6. For the random zero device: turn the diaphragm tap on the front of the device 
to ’open’ and allow the mercury column to settle, then turn the diaphragm tap 
to 'close'.
7. Establish the Pulse Obliteration Pressure as follows: feel the participant's 
radial pulse with the fingers of your left hand. Inflate the cuff slowly and note 
the level (to the nearest 2 mm Hg) of the top of the meniscus o f the mercury 
column at the point at which the radial pulse disappears. Then immediately 
deflate the cuff by disconnecting the cuff and the sphygmomanometer. Write 
down this value on Form M.
8. Add 10 to the Pulse Obliteration Pressure. Calculate the Peak Inflation 
Pressure as follows: either Pulse Obliteration Pressure + 10 mm or 180 mm, 
whichever is the greater. Write down the value. The cuff should be inflated 
to this new value for each BP measurement. (Occasionally the Peak Inflation 
Pressure will need to be increased. See Technical Notes below for details.)
9. Re-connect the cu ff and the sphygmomanometer.
10. Again, locate the radial pulse with the fingers of your left hand, and count the 
number of beats for 30 seconds (using the stopwatch). Write down this value.
11. For the random zero device: turn the diaphragm tap to 'open' and leave it at 
'open', and allow the mercury column to settle. Before inflating the cuff, turn 
the thumbwheel at the right side o f the device (Figure 8) by gently spinning it 
three times with the forefinger of the right hand.
12. Place the stethoscope in the ears with the earpieces pointing forward. Ensure 
that the valve on the stethoscope head is turned to the bell position, or the 
sound will not be transmitted.
13. Using the fingers o f  the left hand, locate the brachial pulse at the point of 
maximal pulsation immediately below the cuff. The bell of the stethoscope 
should be placed here. If it is not possible to feel the brachial pulse, the bell 
of the stethoscope should be placed over the area of the upper arm 
immediately inside the biceps muscle tendon. The bell should not touch the 
cuff, rubber, or clothing.
140
Figure 7
The Hawksley random zero sphygmomanometer, front view, showing 
diaphragm tap on the left
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F igure  8
The Hawksley random zero sphygmomanometer, side view, 
showing thumb wheel
142
14. Looking at the manometer with the centre of the scale at eye level and the 
column perfectly upright, inflate the cuff rapidly to a pressure equal to the 
Peak Inflation Pressure.
15. Holding the pressure constant with the hand bulb, wait five seconds to allow 
time for the diaphragm chamber of the random zero device to fill properly. 
(Count five slowly.) Turn the diaphragm tap to the left, to the position 
marked 'close'.
16. Control the pressure fall with the valve on the hand bulb to allow the column 
of mercury to fall at a rate of 2 mm per second. Listen for the Korotkoff 
sounds with the stethoscope.
17. Record the systolic and 5th phase diastolic BP readings to the nearest 2 mm 
Hg, uncorrected for the zero. The systolic is recorded at the appearance of the 
first sound in a series of at least two sounds. The diastolic pressure Phase 5 is 
recorded at the mercury level one beat below the last sound heard. (It is not at 
the level of the last sound.) If BP sounds can be heard down to zero, record 
diastolic pressure as zero.
18. After observing and recording systolic and diastolic BP, release the remaining 
pressure by opening the bulb valve, disconnect the tube, and after allowing the 
system to come into equilibrium, note and record the 'zero' reading. Do not 
subtract the zero from systolic and diastolic BP readings on Form M as this 
will be done by computer. However, for local feedback to the participant, the 
true systolic and diastolic BP should be calculated. These may be written 
down in the left margin of the form.
19. Turn the diaphragm tap to 'open'.
20. Repeat 30 second pulse and a second BP measurement as described in 10. to 
18. above. Record on Form M, as Measurement II.
Technical Notes
1. If for any reason the observer is unable to determine (or forgets) any phase, 
write a dash in the space on the form. This is the correct way to indicate 
missed information. If an entire reading is missed, completely deflate the cuff 
and start again with a replacement reading. Always wait at least 30 seconds 
between readings.
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2. Record on Form M any difficulties in obtaining B P measurements (e.g.,
irregular pulse). If participant is in atrial fibrillation, record the pressure in 
the usual way and note "atrial fibrillation" on the form. Any problems so 
noted in measuring BP will receive special coding when the data are entered 
into the computer.
3 In reading the manometer, record at the line reached by the rounded top of the 
mercury column (the meniscus). If the top of the meniscus is exactly between 
lines, the reading is made at the line immediately above. If the mercury 
column bounces, take the reading at the lowest part of the bounce.
4. Procedure for increasing the Peak Inflation Pressure: Occasionally the
Korotkoff sounds may be heard as soon as one places the stethoscope over the 
brachial artery and begins to listen. If this happens, the observer should 
immediately deflate the cuff by disconnecting the cuff and 
sphygmomanometer, and recalculate Peak Inflation Pressure as follows:
Draw a line through the previously recorded Peak Inflation Pressure, increase 
the number by 10 and write the new number beside the original one. The new 
number includes an increase of 10 as illustrated below:
PULSE OBLITERATION PRESSURE 200
PEAK INFLATION PRESSURE =
PULSE OBLITERATION PRESSURE + 10 mm
OR 180 mm WHICHEVER IS GREATER 04« 220
Wait 30 seconds and then proceed with the BP measurement. Repeat the 
procedure if necessary.
5. The random zero sphygmomanometer has all the parts of the standard 
mercury manometer. In addition, it has a mechanism built into the box­
shaped back that changes the level of mercury in the calibrated glass tube. 
The mechanism includes a second mercury reservoir the size of which can be 
changed to hold a larger or smaller amount of mercury in the reservoir, and 
therefore allow different amounts of mercury to remain in the calibrated glass 
tube and the outside reservoir. The size of the second reservoir is changed by 
spinning the thumb wheel on the right side of the device (Figure 8). The 
second reservoir is opened and closed with a dial on the face of the 
manometer, called the diaphragm tap (Figure 7).
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1 .3  Urine Collection
Spo t (casual) urine
1. A spot urine is to be collected immediately before the start of the 24-hour 
collection. Affix the participant's receptacle label, marked SPOT 
RECEPTACLE, onto one of the large receptacles. Use spot receptacle with a 
lid, to avoid spillage. Write the participant's name on the label. Ask the 
participant to void directly into the receptacle, emptying the bladder 
completely.
2. When done, take the labelled receptacle to the laboratory area and:
Record name, ID, and split sample ID if assigned, onto the Urine Collection 
Register.
Enter the date and time as the start of the 24-hour collection and also check 
the box marked "Spot" indicating it has been received.
The time should also be entered on Form G and other relevant questions 
checked off.
3. Place one of the dipsticks provided (N-LABSTIX) into the freshly voided 
urine, completely immersing all reagent areas in the urine. Then immediately 
remove the dipstick.
Tap the edge of the stick against the side of the spot urine container to remove 
excess urine.
Hold the stick in a horizontal position to prevent possible mixing of chemicals 
from adjacent reagent areas.
Compare test areas with the corresponding colour chart on the side of the N- 
LABSTIX bottle, reading at the times specified for each area (Note: accurate 
timing is essential for reliable quantitative results), i.e., Nitrite 40 secs; Blood 
40 secs; Ketones 15 secs; Glucose 30 secs; Protein, pH time not critical. Hold 
the dipstick close to the colour chart, and match up colours carefully.
Record the results by marking an 'X' in the appropriate boxes on the 
LABSTIX form Form L.
145
4. After the dipstick procedure is completed, add a teaspoon of boric acid to  the 
urine in the receptacle and stir gently. Place labelled receptacle with the spot 
urine in the refrigerator. Aliquots from this specimen will be taken the next 
day.
24-hour collection - Start
The timing of the 24-hour urine collection starts immediately after voiding the 'spot'
urine: 'spot' urines are not to be included in the 24-hour urine collection.
1. Obtain a set of four or five 24-hour urine collection jars already prepared with 
preservative. Write the number of jars given in the space marked "Jars 
Given", on the Urine Collection Register. Obtain a funnel and carrying case.
2. Write the participant's name and ID on jar labels and affix one on each jar. 
Number the jars (e.g., from 1 to 4) as they are given to participant, writing the 
number on the jar label.
3. For 24-hour urine specimens to be used in the evaluation of daily electrolyte 
intake, it is essential to ensure as far as possible that collections are complete 
for an accurately described time period, and therefore careful instruction o f  
study participants is required.
4. Instruct the participant in the use of the funnel and jars. While use of the 
funnel is essential for women, it can be optional for men. Indicate that the jar 
should always be held during voiding.
5. All urine voided from that moment, including the remaining time spent at the 
clinic, should be collected until the same time the following day.
6. Many people when having a bowel movement involuntarily also urinate. To 
avoid loss of this urine, explain to participants that when they feel the urge to 
have a bowel movement, they should first pass urine into the collection ja r, 
emptying the bladder completely.
7. Tell participant that when any jar is about 2/3 full, a new jar should be started 
with the next voiding. This is to prevent overflow. 8
8. The participant should be given jars, funnel, carrier, and Form I, Instructions 
and asked to return to the clinic the same time the following day for 
completion of the 24-hour collection. Ensure that time of return is noted in
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the clinic's reception diary. In exceptional circumstances the final specimen 
could be passed at home 24 hours after the start of the collection provided a 
staff member is present in the home to record the time. The London 
Coordinating Centre must be informed of any such exception, by completing 
the question in Form U at the end of the collection.
Notes
1. If a participant is unable to void for the 'spot' urine, wait half an hour and ask 
the participant to try again. If the participant is still unable to void, pulse and 
BP should be measured, and then the participant given several glasses of 
water. Proceed with the remainder of the clinic visit until the participant 
indicates that he or she is able to void. Then take the 'spot' urine and start the 
24-hour collection in the usual way.
2. One-litre reusable plastic jars, with lids that screw on tightly to prevent 
leakage and which can be washed well between users, are provided by the 
Coordinating Centre. While 24-hour volume varies among individuals, each 
participant is to  be provided with the likely maximum, equivalent to a 
capacity of 4 o r  5 litres. If experience in the individual populations, which 
may differ in output based on climate, usual intake, etc., shows that this 
number is too small or too large, adjustment is to be made.
3. The carrier appropriate for each population, and even within a population, can 
be expected to  vary. Attache cases, camera bags, shopping bags can be used. 
Local customs are to help determine the type of carrier to be used. A key 
point is that the carrier is to help prevent the jars from tipping, with loss of 
some of the specimen, and with inconvenience to the participant. If possible, 
carriers should have a foam rubber lining.
Completing the 24-hour collection
1. To ensure that the end of the 24-hour urine collection is appropriately 
completed, the participant returns to the clinic shortly before the 24 hours are 
over, and the final urine specimen is collected at that time. Ask the 
participant to empty his/her bladder completely. 2
2. Do not be concerned if the collection time varies slightly from 24 hours since 
this can be accounted for in the data analysis, as long as the actual time of 
completion is recorded by the staff member.
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3. Remember that the final sample of urine voided is to be included in the 24- 
hour collection. Be sure to ask the Completeness Questions on Form U and 
the special question on menstruation for women. Check that all equipment 
has been returned (urine collection jars, funnel and carrier) and that the 
collection jars are correctly labelled.
4. Enter the end time, and day of the week, as a check, on Form U. In addition, 
the end date and time, the number of urine collection jars returned, and the 
number of jars used in the 24-hour urine collection should be recorded in the 
Urine Collection Register.
5. If the Completeness questions indicate that a jar containing urine was not 
returned, and efforts to retrieve the urine specimen were not successful, or 
urine was voided other than into the jar, or more than a few drops were 
missing, e.g., through spillage, then this will be considered an incomplete 
collection for data analysis. Nonetheless, the aliquots from this urine should 
be sent in the usual way. They can still supply some data relevant to our 
study, even if not part of the 24-hour data. As noted earlier, centres should 
recruit an extra participant in the same age-sex group to ensure that the centre 
supplies 200 complete 24-hour collections. See the sampling instructions for 
how this person is to be selected for recruitment. Use the supplementary ID 
codes for this new person.
Repeat 24-hour urine collection
1. To assess how much individuals in different populations vary from 
themselves in electrolyte excretion, (intra-individual variability) about 12% of 
the participants in each centre are to be invited to return to the clinic within 1 
to 3 weeks for a repeat collection of urine and a repeat BP measurement. 
Allowing for unwillingness or inability to return of some of those selected for 
repeats, inviting 12% should result in a repeat rate of 8-10%.
2. Those invited for the repeat visit will be the same individuals from whom split 
samples were obtained in the first visit. (Note: these individuals are identified 
in the Log Book by split sample ID codes.)
3. If a person is invited to return, the invitation must be extended when the 
participant is being seen at the end of the initial 24-hour urine collection. 
Otherwise, timely re-contact will have to be made, to ensure that the repeat 
visit is 1 to 3 weeks after the first visit.
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4. In requesting the participant to return, explain that 1 out of 8 participants is 
being asked to return to check on how much people vary over time on those 
things we have measured.
5. The repeat appointment will include pulse and BP measurement, and a further 
24-hour urine collection. Give the participant the Repeat Visit instruction 
sheet, for attending the clinic at the appointed time. Remind the participant 
that at the repeat visit, collection of urine is again to be started at the clinic 
and completed at the clinic 24 hours later.
6. All persons who participate in the repeat examination are to have a full set of 
aliquots taken and labelled with the participant's own ID, as well as a full set 
of split sample aliquots labelled with the split sample ID.
The Urine Collection Register
1. The local centre laboratory is to keep a record of all specimens received, the 
number of jars distributed, the number returned, and the number of jars used 
in 24-hour urine collections to help check on completeness. In addition, dates 
of refrigeration, freezing, and shipment o f aliquots from the clinic are 
recorded. All this information is kept on the Urine Collection Register.
2. The procedure is as follows:
a. When the receptacle containing the 'spot' urine is received in the 
laboratory area, the participant’s name, ID, and split sample ID, if 
assigned, should be entered into the Urine Collection Register.
b. Indicate that the 'spot' urine was received, and enter the start date and 
time of the 24-hour urine collection. This information should be both 
on Form G and the Register.
c. Write down the number of jars that were given for the 24-hour urine 
collection. This will generally be 4 or 5.
Twenty-four hours later, at the completion of the urine collection:
d. Record the end date and time of the urine collection. This information 
should be both on Form U and on the Urine Collection Register. Also, 
enter the number of jars returned and the number of jars used during 
the 24-hour collection. If any jars are missing, ascertain whether these 
jars contained any o f the urine passed during the last 24 hours. If a jar 
or jars were used but not returned, make every effort to retrieve the
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missing urine that day (for example, if it was left at home but is still 
intact). If this is not possible, make a note on Form U. (In any case, 
try to retrieve the missing jars since otherwise there will not be enough 
jars to meet your requirements for the study.)
e. The remainder of the Urine Collection Register is filled out as the 
specimens are prepared in the laboratory. The items to be entered 
include:
- checking the 'split' column if blinded split samples are being sent
- date of refrigeration, freezing, shipping.
f. The Urine Collection Register is a working form for the centre and 
will stay there until all collections have been completed. At that time, 
a copy of the Register is sent to the London Coordinating Centre 
without the names, which should be cut off the copy before sending it.
Measuring urine volume
The 3 values that are needed to assess 24-hour electrolyte output are:
concentration (reported, for example, as millimole per litre), determined by 
the Central Laboratory
volume (number of millilitres)
time (number of hours and minutes)
We have discussed the importance of accurate timing. The next critical step is 
correct measurement of the volume.
1. Since we are all using standard collection jars supplied centrally (1-litre 
capacity and 19 cm in height), it will be possible to measure the height of 
urine in the jars (in centimetres), which can later be converted into volume 
(ml) by the computer. This will eliminate the need to measure by pouring.
2. The height of the urine in each jar is determined using the special platform 
with vertical scale attached, developed by the London School of Hygiene and 
Tropical Medicine (Figure 9). Record the value onto Form U, in centimetres 
to the nearest 0.1 cm. Each jar is to be read and recorded separately. The 
total height of the urine for the entire specimen and hence the volume will be 
calculated by the computer. Note that each line on the measuring scale 
represents 0.1 cm.
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Each jar is numbered on the jar label when it is given out to the participant. 
Record the height of urine in each jar in  the appropriate (numbered) space on 
Form U. This is to reduce the risk of measuring the same jar twice, or missing 
out a jar. For added security, write down on Form U the number of jars 
containing urine (the same number will be recorded in the "Jars Used” column 
of the Urine Collection Register).
There is room on Form U to record height of urine in each of six 1-litre jars, 
although in most cases the number of ja rs  used will be less than 6. Put a dash 
in the space provided, for jars not used.
3. In reading the line on the scale nearest the top of the urine, the collection jar 
should be at eye level. This means either that the observer should be seated at 
a table sufficiently high to permit this, o r  that there should be an eye-level 
shelf on which the measuring platform could be placed. Jars should be 
perfectly upright when read. If the top o f  urine falls halfway between two 0.1 
cm lines, record the higher value.
4. The next step after carefully recording the height of urine in the collection jars 
is preparing the sample for aliquots.
Preparing to take aliquots
1. Remember to take aliquots from the spot and 24-hour urine collection of one 
participant at a time, to avoid confusing collections from different 
participants.
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F igure 9
Measuring scale for urine heights, and 24-hour urine collection jar
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2. Retrieve the spot urine receptacle from the refrigerator and place together 
with the 24-hour collection for that participant. Aliquots are first taken from 
the spot receptacle. Gently stir the urine in the receptacle, and take two 
aliquots. Use of a small beaker with a pouring spout, or a pipette, is 
suggested. Complete all the work on the spot urine before preparing the 24- 
hour specimens.
3. Next prepare to take aliquots from the 24-hour collection. Thoroughly mix all 
the urine from the 24-hour collection of the individual participant into a large 
bucket. Since electrolyte output may differ at different times of the day, this 
mixing is very important. The mixing should not be done too rapidly or 
vigorously, in order to avoid frothing.
4. When mixed, remove the necessary number of aliquots for the 24-hour 
collection and pour into the tubes supplied centrally. Use a pourer or pipette. 
The number of tubes and their proper labelling is described below.
Before describing further how the aliquot tubes are to be filled, etc., it is necessary to
describe the labelling procedure.
Labelling
The Central Laboratory will supply each centre with the necessary number of sticky
labels.
1. We have already mentioned the labels for the collection jars given to the 
participant. They have space for entering the participant's ID code, and say 
"JAR LABEL” on them
2. You will also receive a FILE LABEL, with space for entering the participant's 
ID code and split sample ID, if assigned.
3. All other labels for the first visit will have the ID number already printed on 
them, and also indicate how they are to be used.10 The participant's initials 
will need to be added to make up the ID code.
4. Each label has, as the last digit, a number indicating its purpose.
10 IDs will not be printed in advance on labels for the repeat visit, since these participants are also 
those with split samples.
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Label 1 = Spot urine aliquot for the Central Laboratory
Label 2 = Spot urine aliquot to freeze and store locally (this is a backup 
against possible loss in transit)
Label 3 = 24-hour aliquot - Central Laboratory
Label 4 = 24-hour aliquot - Central Laboratory
Label 5 = 24-hour aliquot - Central Laboratory
Label 6 = 24-hour aliquot - Central Laboratory
(3, 4, and 5 are for present analyses; 6 is for future analyses and will be stored 
centrally)
Label 7 = 24-hour aliquot to freeze and store locally, as backup against 
possible loss.
Two other labels are:
Label 8 = Spot urine receptacle
Label 9 = Label for the urine data form, Form U.
5. The identifying information on the labels is laid out in the following way:
Type of specimen Participant ID 
or for Form or Split-Sample ID
1st visit 
or repeat
Label
number
As an example: for a spot 
visit, the label will be:
urine aliquot going to the Central Laboratory, on a first
SPOT 66073 1 1
You will need to fill in the initials that are part of that participant's code.
A 24-hour aliquot label for local storage for this visit of this participant will look like
this:
FULL 66073 1 7
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Again, fill in the initials (first initial of first name and of last name).
6. If this participant has been assigned a split sample ID, then another complete 
set of labels with that ID will have been prepared by the Central Laboratory, 
which is printing the labels. (Of course, the Laboratory will not know these 
are split sample IDs.)
As an example, suppose the participant used in the earlier example (66073 
DK) also has a split sample ID code. Then, the label for the split sample of 
the 24-hour aliquot for local storage for this visit will look just like the above 
label, but will substitute the split sample ID code for the original one:
FULL 66092 7
(Fill in the artificial split sample initials as printed in the Log Book to complete the 
split sample ID code.)
7. The three possible entries (in letters) on the left side of the label are:
SPOT (for labels 1, 2, 8 - spot urine aliquots and receptacle)
FULL (24-hour aliquot, for labels 3, 4, 5, 6, 7)
FORM (to place on the urine form - Form U - label 9)
8. The centre o f the label is for the participant ID or the split sample ID, with 
numbers either printed in advance, or - for repeats - to be filled in locally. 
(Initials are always added locally.) The first two digits of this ID number are 
always the code for your centre.
9. The right side of the label is for indicating two other items:
Visit Number Label Number
1 (original visit) 1 to 9 (to identify type of
specimen and whether
or 2 (repeat visit) to ship or store;
see above)
10. The Central Laboratory will provide extra blank labels, for spoiled labels.
11. The Central Laboratory will also provide special labels for the 'Dry Run' (pilot 
field study) marked with the centre number = 99.
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12. When writing on labels, use the indelible waterproof marking pen provided 
centrally.
Taking aliquots
1. Prepare one set o f urine aliquots at a time to avoid confusing urine collections 
from different participants.
2. First prepare the aliquots from the spot urine receptacle before going on to the 
bucket with the mixed 24-hour sample, again in order not to confuse the two 
different types o f  specimens. EX) NOT prepare the 24-hour labels until spot 
urine aliquots are completed.
Spot urines:
3. Prepare the correct labels for the spot urine, completing the ID code.
4. Apply the labels to the tubes and secure them with transparent tape wrapped 
all the way around the tube.
5. Fill the two aliquot tubes for spot urine. Use a pourer or pipette.
6. If this participant also has a split sample ID, fill four aliquot tubes.
7. Each centre will receive aliquot tubes with push tops. Their capacity is 9 
millilitres (approximately 7 cm in height), but do not fill them to the top, since 
they will break on freezing. Leave a gap of about 2 cm at the top of each 
tube. Make sure tops are pushed firmly down into the tubes (i.e., until you 
hear a click).
24-hour urine collections:
8. Complete the correct labels (those marked "FULL", meaning the full 24 
hours, in contrast to only a spot sample). Apply them to the tubes and cover 
the label with transparent tape wrapped around the tube.
9. Next, prepare 5 aliquot tubes from the bucket containing mixed 24-hour 
specimens. Again, be sure that all jars of the collection have been measured, 
and then mixed together. (If there is a split sample ID, then 10 tubes are 
required.) Fill tubes as above, leaving 2 cm. unfilled and snap the tops in 
securely (until you hear a click).
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10. The final step prior to storage is to place the remaining label - marked FORM 
- in the space provided on page 3 of Form U, the urine data form. There is 
also space for the split sample FORM U label, if appropriate.
Storing the urine aliquots
1. Although the use of preservative to some extent protects the urine specimen 
against bacterial growth, there is nevertheless a deterioration in creatinine 
which becomes apparent within 24-48 hours at a storage temperature of -20° 
C. All aliquots must therefore be refrigerated at 4°C within 24 hours and 
frozen at -20°C within seven days.
2. On-site refrigerators (or freezers) need some back-up electrical supply, e.g., 
car batteries, to take over in case of breakdown.
3. If there is no freezing facility at the local clinic, urine aliquots will require 
local transportation for freezing. They must be transported in refrigeration 
boxes. Cooling elements (supplied from the Central Laboratory) which are to 
be placed in the refrigeration boxes should first be frozen at -20°C for at least 
12 hours. Six hours each way maximum can then be allowed for transport 
between the local storage (with freezer) and the clinic. It is essential that local 
centres are able to comply with the above requirements - if  more than twelve 
hours total elapses, the cooling elements will thaw and the temperature in the 
refrigeration boxes will rise above +4°C.
4. Refrigeration and freezing dates are to be entered in the URINE 
COLLECTION REGISTER.
Shipping urine aliquots
1. The Central Laboratory for all chemical analyses is at the St. Rafael 
University Hospital, Capucijnenvoer 33, B-3000 Leuven, Belgium. Shipment 
of urine aliquots is to be by air freight for most centres. For some European 
centres, transport by special courier services may be more appropriate. 
Railway transportation should not be used.
2. Urine aliquots must be shipped frozen (-20°C) in refrigeration boxes which 
will be provided.
3. Shipment of aliquots should be as follows:
157
The first shipment is to be after two weeks of data collection, or after 25 urine 
collections have been made, whichever is the sooner; the remaining aliquots 
and their split samples from first clinic appointments should be sent together, 
in two refrigeration boxes. The final batch of specimens should be sent at 
the end of all data collection, to comprise all urine aliquots from repeat 
appointments and all the corresponding split samples. This final batch should 
not be sent until advised by the London Centre, to ensure that all the local 
centre's first visit aliquots will already have been analysed.
Procedure for shipping urine aliquots
1. Make contact with the air freight handling department of the international 
airport nearest to the local storage site, and book the specimens on a flight to 
Brussels.
2. Notify the air freight department that samples should be kept at -20°C, both in 
the airport of departure while awaiting transfer to the aircraft and in the 
aircraft itself.
3. Arrangements should be made at least two weeks before the date of shipment. 
It is recommended that local Investigators first make contact with the airport 
freight handling department before data collection begins, to determine local 
regulations and flight procedures.
4. Two weeks before shipment, send a telex11 to the Central Laboratory and 
similarly to the London Coordinating Centre, to alert them to the coming 
shipment. The telexes should contain the following information:
INTERSALT CENTRAL LABORATORY
C/O ST. RAFAEL UNIVERSITY HOSPITAL - LEUVEN - BELGIUM
ATTN:........................................................
CENTRE:.....................................................
AIRPORT OF DEPARTURE:.......................................
DATE OF SHIPMENT:...........................................
11 A fax would now be more appropriate.
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LOCAL HOUR OF SHIPMENT:
NUMBER OF PACKAGES:.........................................
AIR FREIGHT NUMBER:.........................................
FLIGHT NO(S):...............................................
DATE OF ARRIVAL IN BRUSSELS:...............................
LOCAL INVESTIGATOR:.........................................
For the London Coordinating Centre the first three lines have to be replaced by:
INTERSALT COORDINATING CENTRE
C/O LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE
5. If no telex machine is available locally, it is critically important that the above 
information be received before shipment, so that the shipment can be picked 
up. In these circumstances, two weeks before shipment, an international 
telegram should be sent or a call made to London, and London will advise the 
Laboratory. In addition, the telexes should be sent from the airport on the day 
of shipment.
6. Enter shipping date from the clinic in the centre's URINE COLLECTION 
REGISTER.
Packing the refrigeration boxes (Figure 10)
1. Ensure cooling elements have been kept frozen at -20°C for at least 12 hours 
prior to packing.
2. Before loading the box and shipping to Leuven, fill out the SHIPPING 
FORM, listing each participant ID code and number of tubes per participant, 
in the shipment. One copy of the form should go in the box, to Belgium, and 
a photocopy should go to London. The one in the box should be in a 
waterproof jacket.
3. Place four cooling elements flat at the bottom of the polystyrene refrigeration 
box. Next place four cooling elements on their sides, so that two lie up 
against each wall of the box along its length (Figure 10).
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4. For each participant take the five aliquot tubes to be sent to the Central 
Laboratory (labels 1, 3, 4, 5, 6) and bind them together in a line with Scotch 
tape.
5. Place each set of five tubes upright in the box, parallel to the cooling elements 
along the side walls. Four sets of five tubes can be placed along the length of 
the box, and twelve sets of five tubes along its width. This will yield a total of 
240 tubes on each layer (Figure 10).
6. Place four cooling elements flat on top of the tubes below, and repeat the 
procedure above until all tubes are packed. Fill the rest of the box with 
wrapped newspaper to ensure that the tubes remain in place during transit.
7. Close the box, and wrap packing tape around the junction between the box 
and the lid, so that the lid of the box is firmly secured.
8. Place the polystyrene refrigeration box in the cardboard packing box provided 
and securely seal the latter with packing tape. Label this box as described 
below.
9. Ensure that the air freight department is aware that specimens are to be 
shipped at -20°C.
10. The following labels are to be affixed to the outside o f  the box:
A large label with the preprinted address of the Central Laboratory;
A return label with the address of the local Investigator;
Some special labels indicating the nature of the content of the refrigeration 
box:
HANDLE WITH CARE
DEGRADABLE GOODS TO BE KEPT AT -20°C
NO DRY ICE, WET ICE ONLY
NO COMMERCIAL VALUE
All these labels will be provided centrally.
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Figure 10
P olystyrene ref r igeration box
Se t of five 
urine alìquot tubes
Cooling element
Packing the refrigeration box:
Upper - cross-sectional view, Lower - top view
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Notes
1. Back-up urine aliquots should be kept locally at -20°C until clearance has 
been received from the London Coordinating Centre.
2. Do not send repeat specimens (or their split samples), until word has been 
received from the London Coordinadng Centre.
3. If dry ice is used, this needs to be cleared with the airline, and the labels 
adjusted accordingly.
Communication Procedure
On receipt of the urine aliquots in Leuven, the Central Laboratory will inform the 
London Coordinating Centre by telex of the number of aliquots received, the 
condition in which they were received, and of any discrepancy noted. For example, if 
one of the five requested urine aliquots (aliquot numbers 1 ,3 ,4 ,  5, and 6) is missing 
for a particular participant, or if the ID code is incomplete, or if samples are thawed, 
this will be reported immediately to London, so that the London Coordinating Centre 
can rapidly inform the local centre of any problems and of actions to be taken.
1.4 Possible Confounding Variables
These include items recorded on the questionnaire, height and weight 
Questionnaire (Form Q)
The main purpose of the Questionnaire is to obtain information on variables that 
could act as confounders of the true relationship between BP and sodium-potassium. 
The Questionnaire is discussed here. (See Appendix 2.)
Administration
1. The Questionnaire is given only at the first visit.
2. It is designed to be self-administered. However, assistance should be given if 
difficulty arises in interpretation. In some instances the questionnaire will be 
completely interviewer-administered. Training on interview techniques will 
be included in regional training sessions.
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3. Questionnaires have been prepared in English, but should be translated into 
local language and resubmitted to the London Coordinating Centre for back- 
translation and verification before they can be used.
4. In addition, local Investigators are to develop a four point 'social scale' (1 = 
lowest, 4 = highest) to characterise participants relative to socioeconomic 
status within their particular population. (See Appendix 3.) This may require 
additional questions, for example, on housing, water supply, etc., which 
should be inserted after question 38, the question on years of schooling.
These additional questions should be written in the local language and sent to 
the London Coordinating Centre for back-translation and approval. Based on 
answers to these questions and/or the common INTERSALT questions, the 
participant's social scale (code 1-4)  should be designated and recorded on 
Form C - Checklist for the Questionnaire. If occupation is used to derive 
social scale, code married women by their own occupation if working, 
otherwise by husband's occupation.
5. The interviewer should review all questionnaires for completeness and 
legibility. Unless specified, the answers to the questions are mutually 
exclusive (for example, Yes/No). If any queries or inconsistencies arise (for 
example, marking an 'X' in more than one box), these should be brought to the 
attention of the participant, and appropriate amendments or changes made.
6. Questionnaires will also be reviewed by the London Coordinating Centre for 
completeness, consistency, and legibility. Queries arising will be referred 
back to the local centres for urgent clarification.
Guidelines fo r  individual items
1. Date o f birth and age (Questions 1-2)
Give best estimate of date of birth/age if not known. Write 'ESTIMATED' on 
the form if exact information is not available.
2. Marital Status (Question 4)
For polygamous marriages, answer 'Now married'. Co-habitants are 
considered as 'Now married' (box 1) irrespective of legal marital status.
3. Medication (Questions 12 - 13)
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It is essential that a full list of drugs be obtained. These may be identified 
either by the generic names or the proprietary names. If the participant is 
taking medicines but cannot recall the names, these should be brought to the 
clinic the following day (when the participant returns to complete the 24-hour 
urine collection). While they should be listed here, they should also be listed 
and coded on Form C when the staff member is reviewing the Questionnaire.
4. Diet (Questions 19 - 22)
Because of the potential confounding effects on the relationship between 
sodium excretion and BP, it is essential to determine whether participants 
have changed their diets because of high BP or concern over the development 
of high BP. Both change in amount eaten and specific avoidance of sodium 
could have an important effect.
Question 22, "If you have made changes in your d iet... ", refers to answers in 
Questions 19, 20, and 21.
5. Alcohol (Questions 23 - 27)
a. Participants are asked to give information on the amount of alcohol 
consumed over the past 7 days, that is, the 7 days immediately prior to 
the day of the clinic appointment. To aid in recollection, information 
has been requested by days of the week.
b. Since the usual unit for drinks will differ in different countries, the 
question has been asked in the general form of 'how much?' Locally, 
the staff member should be sure the unit is indicated. If the answer is 
'a glass', try to ascertain the size of the glass. (If participant doesn't 
drink, enter 'NONE').
c. Obviously the size, nature, and alcohol content of different drinks will 
vary in different populations. Investigators in each local centre should 
submit to the London Coordinating Centre a list of locally available 
alcoholic drinks, with indication of 'standard' volume and alcohol 
content. The alcohol content of each drink should be expressed as the 
equivalent in millilitres of pure ethyl alcohol.
You must be sure London can translate the drinks listed into ml of 
absolute alcohol.
6. Employment (Questions 28 - 35)
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Usual work refers to the job in which the participant has been employed for 
most of his or her working life.
Present work refers to the job in which the participant is currently employed.
For example, a toolmaker who loses his job after 40 years and becomes a 
gardener, should reply that his usual job is "toolmaker" and present job is 
"gardener".
Questions 29 and 31, "Service worker" (box 6) refers to someone employed in 
service of the public, for example "waitress” or "train driver". In these 
questions, the participant is asked to mark 'X' in one appropriate box for 
his/her employment, and that of his/her spouse. If the interviewer believes, 
after referring to questions 28 and 30, that the wrong box has been marked, 
the interviewer should place an X ' in red ink alongside the correct box.
Housewives in part-time paid work should be coded according to their job 
(not housework).
Semi-skilled workers should be coded as "manual labour" (box 5).
Students should be coded as "other" (box 10) and write "student" next to box.
7. Years of Schooling (Question 38)
The aim is to determine the level of school completed. If a person took 6 
years to complete 4th grade (and this was his total schooling), the answer to 
the question is 4 years of schooling, not 6.
8. Birth Control Pills (Question 40, 40A)
Women using a depot preparation of progestogen for birth control should 
leave Yes/No boxes blank. However, write down in the margin that depot 
preparation is being used. This will be specially coded in the London 
Coordinating Centre.
The correct place to code the pill is Question 40, not Form C.
9. Menses (Question 42)
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Since potassium level in the urine could be affected by the presence of blood, 
this question is important. It is asked both on the questionnaire and, using 
Form U, at the end of the 24-hour collection.
10. General
a. If any response is written in a language other than English, please 
translate back to English. This could apply to Questions 14, 21, 24,
25, 28, 30, and 33B.
b. Form C is to be filled out by a staff member after the Questionnaire 
has been completed and reviewed. The staff member should then 
enter staff number on Form C.
Height and weight
These are measured only at the first visit, not at any repeat visit. Height is to be 
measured first, followed by weight. Height and weight should be measured twice, 
resetting the height measure or beam balance between each of the two measurements. 
If the two measures differ by 2 cm or more for height, or 1 kg (or 2 lb) or more for 
weight, then a third measurement should be taken and written down alongside the 
second measurement. (In this case, the coders at the London Coordinating Centre 
will average the two closest readings for height or weight.) Standard procedures for 
the measurement of height and weight were adopted, based on the WHO-MONICA 
protocol.
Time o f day
Since BPs vary during the day, time of measurement of BP should be recorded on the 
measurement form (FORM M), using the 24-hour clock.
Temperature
1. Ambient temperature also may influence BP and should be recorded during 
the day (FORM G).
2. There should be a reliable thermometer at the clinic site, to record indoor 
temperature.
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3 If possible, there should also be an outdoor thermometer. An alternative is to 
record the official temperature as given by the local weather bureau, via 
telephone.
4. Since the temperatures may vary markedly during the day, they should be
checked every few hours and the appropriate values entered for the individual 
participants.
1.5 Quality Control
A key reason for undertaking this study is to provide a rigorous scientific test of 
observations made earlier where there were not standardised measurements across a 
number of populations.
For INTERSALT, critical to the success o f  our joint undertaking is strict adherence to 
a detailed standardised set of procedures, with a high level of care and accuracy in all 
aspects of the work. The following steps aim at controlling and assessing the quality 
of the work.
All staff members taking part in INTERSALT must be trained, either directly at 
Regional Training meetings, or by persons who themselves have been trained at the 
Regional meetings.
Blood pressure measurement
In order to take BP measurements in INTERSALT, the observer must not only have 
been trained by INTERSALT methods, but must also pass two tests certifying 
proficiency in standardised measurement.
1. The first test is a 'test tape' prepared by the London School of Hygiene and 
Tropical Medicine, testing accuracy in hearing and recognition of the 
Korotkoff sounds.
2. The second test is evaluation of performance used in actual measurement 
(placement of cuff, operation of the random zero device, etc.). In addition, 
performance of the staff member taking systolic and diastolic pressure of a 
volunteer will be monitored by a trained and certified BP observer (e.g., the 
local Investigator, if certified), using a double-headed stethoscope.
Only staff members certified as passing both tests may take BP measurements 
in INTERSALT.
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3. When a staff member passes these tests, the local Investigator should 
complete and sign the BP Certification form and forward this to London, prior 
to involving this staff member in field work.
4. It is strongly recommended that not more than 2 staff members be given the 
task of BP measurement The larger the number doing the measurements, the 
more difficult it is to obtain good quality control.
5. Each local centre needs to forward to the London Coordinating Centre the 
names of all staff trained (and certified), and London will assign a staff 
number. This applies to those doing BP measurement and any other study 
tasks (laboratory, interview, etc.).
6. This number should be entered on all forms, as required, by the staff member 
completing that form.
Notes
1. Testing and certifying at Regional Training meetings is the first (but only the 
first) and necessary step towards proficient BP measurement. For BP 
observers to become fully familiar with the INTERSALT procedures, in 
particular the use of random zero device, it is essential that further training 
and practice sessions be arranged by local Investigators in their own centres.
2. The minimum requirement for passing the random zero test is two 
consecutive approved measurements on an individual. If one or both of the 
two required measurements is not acceptable, the entire procedure should be 
repeated on another individual.
Dry Run
While centre staff may be familiar, in general, with many of the procedures to be 
followed in INTERSALT, there is still the necessity to practice, in detail, the specific 
procedures filling out forms, the smooth running of the clinic visit in the prescribed 
order, and handling of laboratory specimens.
This test run should be organized at the end of local training and should rehearse each 
step, starting with recruiting procedures, selecting the sample, completing the 
RECRUITING RECORD, LOG BOOK. A typical visit should be simulated, 
including preparation of forms and urine jars, taking all measurements, administering
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of the Questionnaire, instructing the participant, receiving the returned 24-hour 
specimen, evaluating completeness, measuring, obtaining and labelling aliquots, 
keeping appropriate records (URINE COLLECTION REGISTER, Form U, etc.) and 
preparing for shipment.
The 'Dry Run' should last at least two days, to permit a full test of the procedure of 
ending the 24-hour collection, etc. Persons volunteering to be 'participants' may be 
other staff members, but should go through all steps, including the 24-hour collection. 
If more time is needed for the test run, it should be taken.
The progress of the Dry Run' should be reviewed with the London Coordinating 
Centre using the telephone if at all possible, to save time.
Completed forms marked 'Dry Run', should be sent immediately to London for
review.
Note
Special Dry Run' mock LOG BOOK pages, and corresponding labels, will be 
provided, but with 'centre code' of 99 as the first two digits of each D ry Run' ID 
number.
Blind split samples
Since the main independent variables in INTERSALT are sodium and potassium it is 
crucial that they be measured accurately. The quality o f  the Central Laboratory's 
functioning is critical, and the main purpose of blinded split samples is to help assess 
this. To a more limited degree, using this procedure also helps check on quality of 
local processing of specimens.
The method of handling split samples has been discussed in detail in Section 1.3.
a . As noted, specimens from participants with split sample IDs as well as their 
own ID, are to be divided and a complete double set of aliquots is to be taken. 
This set is to be labelled with split sample ID labels, while the original set is 
to have the participant's ID code.
b. It is very important that nothing should be done to 'unblind' the Central 
Laboratory as to which split sample IDs represent which participants. When 
sending the Shipping Form, the numbers should be in consecutive order, so 
that there is no indication as to which are the split sample IDs.
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Checking accuracy o f ID code
1. Each centre needs to develop its own system for checking that the right code 
has been put on each form and each tube.
2. ID codes are to be put on each page of forms, in case they become separated.
3. The participant's ID code should be entered in advance on all data forms 
assembled in the participant's file.
4. Another point where IDs need the most careful check is in the clinic 
laboratory, to ensure that the correct 24-hour specimens and correct spot 
urines are identified, as well as correct selection and labelling for split 
samples. One means of reducing error, is to process only one specimen at a 
time.
Checking by a second staff member could be useful, including checking of 
entries into the URINE COLLECTION REGISTER.
5. A final place to check ID codes is on the SHIPPING FORM, where the listing 
and quantity need to be double-checked, preferably by a second staff member.
Quality o f the data forms
1. Forms should be edited in a systematic way at the end of each day. Any 
missing information could then be obtained when the participant is seen at the 
end of the 24-hour collection.
2. Local Investigators should review the forms before they are shipped to 
London, to help ensure their quality.
3. Forms should be copied before sending the originals to London.
4. Forms should be shipped by air, first class, every week until the Field work is 
completed. If there is some means of sending them registered (as well as air 
mail first class), this would add some assurance for their delivery.
5. Data forms are heavy and bulky. They should be packed securely for postage 
to London. Ordinary brown paper envelopes are not sufficient for more than a
few forms.
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Coordinating Centres and Central Laboratory
1. Both the London Coordinating Centre and the Central Laboratory have 
developed procedures for monitoring quality of field work and of the central 
procedures (see Parts 2 and 3 below).
2. In the case of the Central Laboratory, in addition to the external control via 
blind split samples to help calculate laboratory technical error, a careful 
system of internal controls will be carried out, with results of both sent to  the 
London Coordinating Centre.
3. There will be close and frequent contact between London, Chicago (the two 
Coordinating Centres), and Leuven (Central Laboratory) to monitor progress 
and to identify any problems needing attention.
4. Frequent progress reports will be prepared by London-Chicago to keep the 
Executive Committee informed of the status of the work.
5. London will ensure that its data entry and retrieval systems function rapidly to 
permit early identification of problems. This then will be followed by timely 
and direct communication with the local Investigators, to permit appropriate 
corrective actions.
6. It is essential that every effort be made to respond promptly to these requests 
in order to ensure the integrity of the data.
1.6 Organisation of the Clinic Visit
Preparing fo r  the visit: Identifying participants
1. As noted earlier, the RECRUITING RECORD should contain the names of 
those to be invited for a clinic appointment.
2. Once an appointment is made, the name, date, and time are entered in the 
clinic's appointment diary. (To help with the next step, it would be useful to 
put age and sex next to the name.)
3. When the participant appears for the appointment, his or her name is entered 
into the LOG BOOK, on the correct age-sex page, using the next available ED 
number. The participant's initials (first letter of first and last name) are added 
to the ID number, now forming a complete ID code.
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Preparing the Participant File
1. To make the clinic visit run more smoothly and to reduce error in ID codes, 
sets of participant Hies should be prepared in advance, with ID numbers 
placed on all data forms and on the file label. (Initials, to complete the ID, are 
placed on all forms and on the file only after the participant appears for the 
clinic visit, when age, eligibility, and attendance are ascertained.)
2. The ID numbers for each centre come from the LOG BOOK pages supplied 
from London.
3. The assembled files should be kept in numerical order, and when the 
participant appears and his/her name is entered on the appropriate LOG 
BOOK page, the file with his/her number is retrieved, initials are then entered 
on the file label, LOG BOOK, and all data forms. The file then follows the 
participant through the rest of the clinic visit.
4. The visit File is to contain the following material (listed here in order of use 
during the visit):
Form F (File Frontpage, for name, address, ID)
Form G (General information about preparation of the participant for the 
measurements)
Form I (Instructions to participant on collecting urine)
Form L (Labstix form, for results of dipstick on spot urine)
Form M (Measurement of BP, pulse, height, weight)
Form Q (Questionnaire)
Form C (Checklist, about completeness of Questionnaire, social scale, etc.) 
Form U (Urine collection data form)
5. The labels for this ID number should also be placed in the file in advance. 
They include:
Urine receptacle label 
Aliquot labels
Form U label (for 24-hour collection).
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There is also a file label, which should have the ID number entered when the 
file is prepared. (The initials are to be entered when this number is assigned 
as a person appears at the clinic).
6. If the participant also has a split sample ID, the split sample labels and repeat 
visit labels should be clipped together and placed at the back of the file. The 
split sample ID code is also to be entered onto the file label.
7. Since these participants with split sample IDs are also to have a repeat visit, 
additional forms need to be numbered and entered into the file:
Form R (Repeat reminder)
Form G (General information about preparation for measurement)
Form I (Instructions to participant on 24-hour urine collection)
Form L (Labstix form, for results of dipstick on spot urine)
Form M (Measurement of pulse and BP - height and weight are not measured 
again)
Form U (Urine collection form)
(Since the Questionnaire is not repeated at the repeat visit, there is no need for 
Forms Q or C).
8. These prepared files should be stored in numerical order and be easily 
accessible in the reception area. (After the visit, they may be stored in 
alphabetic order.)
Preparing urine collection jars fo r  the 24-hour collection
1. An ample supply of urine collection jars needs to be prepared in advance, with 
a sufficient number for expected daily clinic attendance. Each clinic will have 
received 96 standard jars (sufficient for about 20 participants, estimating 5 
collection jars per participant). Since this supply is not enough for 200 
participants and 20-25 repeats, the jars must be re-used, after proper 
cleansing.
2. To prepare jars, place a heaped tablespoon of boric acid (10-15 g) into the jar 
and put the lid on.
3. Affix a jar label on each jar. No information is entered on this label in 
advance. Participant ID and name should be entered on each label, when the
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jars are given to the participant. (An indelible marking pen for this purpose is 
supplied centrally.)
4. Between collections, jars should be washed with mild detergent and rinsed
well with warm water. If jars or lids begin to retain urine odor, they should be 
discarded.
Facilities needed for the clinic visit
It is recommended that facilities for each clinic include:
1. A reception area for registering participants attending the clinic appointment 
or returning to complete 24-hour urine collections.
2. A toilet facility for passing 'spot' urine specimens and for completing 24-hour 
urine collections.
3. A quiet examination area where BP, height, and weight can be measured. 
There should be adequate space for two chairs and a table for BP 
measurement. There should be a hard, flat floor surface for measurement of 
height and weight, and room for a height rule and beam balance or other scale.
4. An area for completion of Questionnaire, and for receiving instructions for 
24-hour urine collections.
5. A 'laboratory' area for washing out and preparing urine collection jars, for 
measuring volume of 24-hour urine collections, for preparing aliquots, and for 
storing specimens on-site in a refrigerator (4°C) or freezer (-20°C).
6. Storage space for materials and equipment, and for record forms.
7. Access to a freezer (-20°C).
8. Access to a photocopying machine.
Scheduling appointments
1. When participants are contacted, they should be informed of the general
nature of the study, that BP, height, and weight will be measured, that they 
will be required to answer a questionnaire, and that a 24-hour urine collection 
will be made to help give a picture of people's diets. To ensure accuracy of 
timing of 24-hour urine collections, it is necessary that collections be both
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started and completed at the clinic. Participants should therefore be told that 
they will be required to attend the clinic for their given appointment, and 
again 24 hours later to complete the urine collection.
2. Since BPs may be higher at the end of the day than at other times, every effort 
should be made to schedule appointments during usual working hours. If 
possible, appointments should be spread equally over the day, and over the 
usual five day working week. No appointments should be scheduled for the 
sixth day or seventh (rest) day, although the clinic needs to be open on the 
sixth day, with a member of staff available, to complete 24-hour urine 
collections begun on the fifth day.
3. Because we want, as much as possible, standard conditions for measuring BP, 
we need to control for certain activities that can influence pressure.
Participants should be instructed to avoid the following activities for at least a 
half-hour before the clinic appointment: strenuous exercise, eating, drinking 
anything other than water, and smoking.
These instructions are contained in the form 'Attending the Clinic 
Appointment'. If necessary, this should be translated into the local language.
4. While the participant is not to eat for V2  hour before the visit, he or she should 
not be fasting. If there is any ancillary study involving INTERSALT 
participants that may require fasting, then this must be done on a separate 
occasion, not together with the INTERSALT clinic visit.
5. Since pregnancy may affect both BP and dietary habits, women known to be 
pregnant at the time of recruitment should not be invited to participate in the 
study. If however a woman is subsequently found to be pregnant (question 41 
of the Questionnaire), she should be included in the sample. In addition, an 
extra woman, in the same age group, should be recruited, and assigned a 
supplementary ID number.
6. A participant may fall acutely ill (for example, acute diarrhoea) at a time 
when a clinic appointment has been scheduled. Since this may affect both BP 
and urinary excretion, a new appointment should be scheduled after recovery 
from the illness.
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The Log Book12
1. When the participant arrives at the clinic, the receptionist greets him or her, 
enters the name in the LOG BOOK and adds participant's initials to complete 
the ID code.
2. The LOG BOOK is made up of pages prepared in advance centrally and 
supplied to each local centre.
3. There are approximately 250 ID numbers assigned to each centre. These 
include:
200 numbers, for the 25 participants in each of 8 age-sex groups 
25 numbers (approximate) for split sample IDs 
30 numbers, as supplementary, for extra participants
4. The LOG BOOK lists these numbers in numerical order, with 2 pages 
assigned to an age-sex group (e.g., men age 20-29).
5. When a participant enters, the receptionist should check his or her age and 
turn to the proper age-sex page in the LOG BOOK. Occasionally, because of 
a recent birthday, or incorrect census information, the participant's age will 
differ from that given in the RECRUITING RECORD. The participant 
should be allocated to the appropriate age group as of the day of the clinic 
appointment. This may necessitate adjustment of the age-sex lists derived 
from the RECRUITING RECORD.
6. The participant is then given the next ID on  the LOG BOOK page, and the 
plastic file with that number is drawn, with all its forms.
7. The receptionist aids in filling out FORM F, the first form in the file, 
providing space for name, ID code, split sample code if assigned, and Social 
Security number (or other identification appropriate to the country).
Conducting the first clinic visit
Procedure for data collection and recording is as follows and should be performed in
the order noted:
12 A more detailed description of the Log Book is available (Elliott P & Slamler R, 1988)
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1. Register participant, obtaining name and age.
2. Enter name into LOG BOOK on appropriate age-sex page, obtaining ID 
number and completing code by adding 2 initials.
3. Obtain file of forms with that ID number. Add initials to all pages.
4. Aid in filling out FORM F, with basic identification.
5. Complete FORM G, on preparation of participant for BP measurement.
6. Obtain 'spot' urine sample: affix participant ID label onto urine receptacle, 
adding initials to ID code.
7. Record participant's name, ID, etc., and time 24-hour collection begins in 
URINE COLLECTION REGISTER. Also record time on FORM G.
8. Place dipstick provided ('N-LABSTIX') into freshly voided spot urine and 
record results on Form L-Labstix.
9. Add teaspoon of boric acid crystals to the spot urine and place filled urine 
receptacle in refrigerator.
10. Instruct participant in 24-hour collection, giving FORM I.
11. Give participant 24-hour urine collection jars, filling out jar label. Give out 
funnel (for women) and carrier.
12. Make appointment for completion of 24-hour urine collection. Enter time into 
clinic appointment diary. (It should preferably be a few minutes short of 24 
hours).
13. Take measurements: complete FORM M
14. Measure pulse and BP
15. Measure height
16. Measure weight
17. Administer Questionnaire - FORM Q (Self-administered or, if needed, with 
staff assistance).
18. Review completion of Questionnaire and fill out FORM C (Checklist).
177
19. Remind the participant of his/her return the next day fo r the end of the 24- 
hour collection.
End o f the 24-hour collection
1. Receive the carrier, all jars, and the funnel.
2. Ask the participant to take one of the returned jars and use it to collect final 
specimen. Ask participant to empty bladder completely.
3. Record time of completion (FORM U).
4. Ask questions on completeness of sample size (Form U ), and, for women, on 
menstruation.
5. If any jars are missing, make effort to retrieve that day.
6. If participant is not to have a repeat visit, this ends the clinic visit
7. Bring jars to laboratory area; enter data in Urine Collection Register next to 
participant's number, on date and time 24-hour collection ended, the number 
of jars used, and the number of jars returned.
8. For those participants with split sample ID, a request to  return for Repeat 
Visit needs to be made at the time 24-hour collection is completed.
Repeat visit
One difference between procedures for the Repeat visit and the first clinic visit is that
there is no measurement of height and weight, nor is the Questionnaire repeated at the
Repeat visit. A second difference is that all persons attending the Repeat visit are to
have blinded split urine aliquots.
The procedures for the Repeat visit are:
1. Receive participant, note return in LOG BOOK, draw his/her file.
2. Fill out FORM G, on preparation for measurement.
3. Take 'spot' urine, use dipstick and record on FORM L-Labstix. Add boric 
acid and refrigerate the specimen.
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4. Record in URINE COLLECTION REGISTER the ID code, split sample ID 
code, number of 1-litre jars given for 24-hour collection, and start time.
Circle the participant's name in red ink. This will readily identify entries in 
the Urine Collection Register for Repeat visits (and avoid re-invitation after 
the Repeat visit).
5. Record 24-hour collection start time also on FORM G.
6. Give instructions for 24-hour collection (FORM I).
7. Obtain labelled 1-litre jars, fill out labels, and give to participant, together 
with funnel and carrier.
8. Make appointment for completion of 24-hour collection; enter time in 
appointment diary.
9. Take measurement of pulse and BP (FORM M: do not repeat height and 
weight).
10. Remind participant to return in 24 hours.
11. End of 24-hour urine collection:
a. Procedures are the same as for the first visit.
b. Receive participant, check completeness of collection, using FORM 
U.
c. Receive all jars. If any are missing, try to retrieve.
d. Give participant one of his/her jars and ask to void final specimen of 
the collection into that jar.
e. Record time of completion on FORM U.
f. Bring all the jars to the laboratory area and complete entry in URINE 
COLLECTION REGISTER, remembering to include split sample ID 
information.
Remember that specimens must be refrigerated within 1 day and frozen (-20°C) 
within 7 days.
Notes
1. If a participant does not appear within l/2 hour of the appointment for ending 
the 24-hour collection, on either first or repeat visits, every effort should be
made to contact him/her for completion of the collection. Even if the end is 
then 1 or 2 hours after the 24-hour point, the computer can take this into 
account as long as actual time of the collection is recorded.
2. Local criteria for responding to elevated BP or abnormal urine findings need 
to be determined in advance, and the appropriate place in the clinic schedule 
for any action should be decided.
1.7 Forms
Three types of forms are to be used in a standard way: data collection, instructions to
participants, records and administration.
1. All forms have been drafted jointly by the London and Chicago Coordinating 
Centres. Each local centre will receive a master copy of each form, for local 
reproduction.
2. The exception is the LOG BOOK, whose pages have been produced centrally, 
containing all ID numbers assigned to each individual centre. This simply 
needs to be placed in a binder and used as is.
3. Certain forms may need translation into the local language. All translated 
forms need to be sent to the London Coordinating Centre for back-translation 
into English, to assure that meaning is identical. This must be done prior to 
use in the field.
4. If forms are produced in a language other than English and therefore are 
retyped locally:
a. Please make sure that layout and coding are like the original form, to 
facilitate entry into the computer. This is especially true for the 
Questionnaire, where questions need to be lined up properly for coding 
in the right-hand column.
b. Where responses appear in a language other than English, be sure 
English translation is written (in capital letters) next to the other 
language.
5. Be sure participant ID appears on each page of each form, in case pages 
become separated.
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6. There is only one form to be sent to London on which the split sample ID is 
identified as such, and that is the 24-hour urine collection form (FORM U).
It also appears on the Frontpage file form, identifying the participant, name, 
address, etc., but that form is not sent to London. It is for local use only.
The split sample ID appears on the Shipping Form but is not identified there 
as a split sample ID, otherwise the Laboratory will be unblinded as to split 
samples.
7. Be sure the forms indicate whether the visit is a first appointment or a repeat 
visit.
8. Be sure the number of the staff member completing the form is on each form. 
Only data collected by a staff member certified to collect those data will be 
included in the study.
9. All forms should be edited prior to shipment and every effort made to correct 
errors or obtain missing information. The local Investigator should keep close 
and timely surveillance on how well forms are being completed.
10. Completed forms should be photocopied and the original sent to London.
11. Completed forms should be shipped to London once a week.
12. Send all forms from a participant's visit together. If there is no Repeat visit, 
the forms may be forwarded in his/her plastic file after the first visit. List in 
numerical order on the sheet provided all the participant IDs included in the 
shipment o f  forms to London. Include this list together with the shipment of 
forms and send a photocopy to London under separate cover. A copy of the 
list should also be kept locally.
13. If a Repeat visit is scheduled, the forms from the first visit should be stapled 
together and sent to London. After the Repeat visit, the remainder of the 
forms should be sent together in the participant's plastic file.
14. Forms received in London will be reviewed rapidly, and any errors will be 
brought to the attention of the local centre as soon as possible.
Note: When entering numbers, be sure all dashes are filled, using leading Os where
necessary, e.g., 0 0  1.
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1.8 Ethical Concerns
Abnormal blood pressure
In the course of measuring BP, you are likely to come across individuals with 
pressures above normal. A persistent diastolic pressure o f 95 mm Hg or higher has 
been designated 'abnormal' by the World Health Organization, and a persistent 
pressure 90-94 mm Hg is considered above normal in many countries.
If BP is above normal, local Investigators should be guided both by local practice and 
by the following suggestions:
1. If the diastolic pressure is 90-104 mm Hg, the pressure could be re-measured 
when the participant reports next day for completion of the 24 hour urine 
collection, or at the Repeat visit for participants with such visits.
2. If the pressure remains in this range, it is suggested that the participant should 
be referred to the usual source of medical care, and, with the participant's 
permission, the BP data should be forwarded.
3. If diastolic pressure is 105 mm Hg or higher, more vigorous steps to pursue 
referral should be taken.
Urinary screen (dipstick)
Urine dipsticks ('N-LABSTIX') will be provided centrally. Each dipstick records 6 
measures - nitrite, blood, ketones, glucose, protein, and pH. The following findings 
are noteworthy and merit attention: a positive reading for nitrite (which may be 
indicative of urinary tract infection); more than trace positive for blood in men or 
non-menstruating women; more than trace positive for glucose or protein; and 
positive for ketones, in the presence of glycosuria.
If any of the results mentioned above are recorded, it is suggested that the participant 
be referred to the normal source of medical care, and, with the participant's 
permission, the urinary dipstick data should be forwarded.
Confidentiality
Neither the London Coordinating Centre nor the Central Laboratory should receive 
the names of study participants. Only the ID code should be forwarded.
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The London Coordinating Centre will at a later date review the URINE 
COLLECTION REGISTER, RECRUITING RECORD, and LOG BOOK. Names 
should be removed from the copies forwarded to London.
In all respects, confidentiality of the data regarding individuals will be maintained.
Assurances on safeguarding the rights o f  INTERSALT participants
INTERSALT centres will follow a common set of procedures in regard to protecting 
and safeguarding the rights and welfare of all examinees in the study. These include: 
informing participants of the nature and aims of INTERSALT (an investigation of 
multiple factors possibly influencing BP); the above described guarantee of 
confidentiality, and the timely transmission to participants of clinically relevant 
findings.
In keeping with common practice in ethical research worldwide, there should be local 
review by an independent body of the INTERSALT protocol and local research 
plans, including any proposed ancillary studies. This body, which could be an 
existing Institutional Review Board or an ad hoc committee established for this 
review, should consist of a group of competent men and women independent of the 
local research team. Their assurances, based on their review on safeguarding and 
protection of the rights and welfare o f  the human beings at the local centre, should be 
forwarded to the Chicago Coordinating Centre.
1.9 Equipment and Materials
To be provided centrally
1. All forms (to be reproduced locally).
2. Participant files (plastic).
3. Jars for 24-hour urine collection: 96 1-litre plastic reusable jars with screwtop 
lids (4-5 per participant).
4. Funnels: 20 large reusable plastic funnels for use during urine collection (1 
per panicipant for 24-hour collection, mainly for women).
5. Sticky labels, printed, for spot urine receptacle, collection jars, File, aliquot 
tubes, FORM U.
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6. Marking pens: black indelible oil-based pens for use on labels.
7. Aliquot tubes and tops: push-top leakproof, 9 ml polypropylene.
8. Refrigerated packing boxes and cooling elements.
9. Measuring platform and scale for urine jars.
10. Transparent tape and packing tape.
11. Dipsticks: 300 N-Labstix for testing in freshly voided spot urines.
To be provided locally:
1. Clinic appointment diary.
2. Outdoor/indoor thermometer.
3. Large reusable receptacles for collecting spot urine samples (with lid to 
prevent spillage when placed in refrigerator before taking aliquots).
4. Loose-fitting gown for BP measurement, if participant's clothing restricts arm.
5. Littmann stethoscopes: two of model 2100 or 2101 (3M Company).
6. Stopwatch for measurement of pulse.
7. Height ruler (plus short ruler for extreme heights).
8. Beam balance or other weighing scale.
9. Boric acid crystals analytic reagent quality (minimum 99.5% pure), for 
preserving urine; 10 to 15 kg.
10. Carrier bags or cases (or equivalent) for use during urine collection (1 per 
participant for 24-hour collection). Number of bags or cases should be 
sufficient for the number of participants expected over 3-4 days.
11. Pair of rubber gloves for handling urine specimens.
12. 5-litre bucket for mixing 24-hour urine collection prior to taking aliquots.
13. Stirring rod for mixing urine.
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14. Small beaker or pipette for transferring urine to aliquot tubes.
15. Scissors.
16. Laboratory racks for storing aliquots upright for freezing.
17. Refrigerator (4°C) or freezer (-20°C) on site at clinic. This should have a 
backup electric supply.
18. Access to a freezer (-20°C) if none on site.
19. Access to photocopier.
Ordering by local centres from a central supplier
In addition to the material being supplied centrally (forms, LOG BOOK, etc. from 
London, equipment for standardised urine collection from  the Central Laboratory), 
standardised equipment for measuring BP is essential.
1. The machine to be used is the Hawksley random zero sphygmomanometer, 0- 
20 mm variation in the random zero, without the constant release valve. Two 
machines per centre are required.
2. A selection of different size Baumanometer Calibrated V-Lok cuffs with latex 
bags, bulb and valve:
Number and sizes: 2 adult (Number: 1820)
1 large adult (Number: 1825)
1 child (Number: 1821)
3. The above items are to be ordered by the individual centres, directly from 
Hawksley who will advise as to total cost (including shipping), which is 
dependent on whether mercury is shipped together with the 
sphygmomanometer.
2. Methods for the London Coordinating Centre
This section summarises the methods of the London Coordinating Centre and is an 
edited version of the London Coordinating Centre Manual. It was used to document 
procedures of the Coordinating Centre and to train its staff.
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2.1 Summary of Coordinating Centre Responsibilities
The functions of the London Coordinating Centre can be summarised as follows:
Joint responsibility with the Chicago Coordinating Centre
1. Standardise methods so that data are collected in a similar manner by all 
centres.
2. Organise and conduct regional training meetings to train each centre in 
INTERSALT methods, to hold individual consultations with local 
investigators, and to ensure that all documentation has been received and is 
up-to-date.
3. Plan and carry out site-visits to selected centres.
4. Take urgent policy decisions as necessary between meetings of the Executive 
Committee.
5. Periodically review finances, staffing levels, and progress of the study to 
enable a high level of supervision and quality control to be maintained.
6. Prepare the main final paper for publication, and advise on further 
publications.
London Coordinating Centre responsibilities
1. Allocate the centre code and staff numbers for each local centre.
2. Distribute Log Books, Dry Run material, documentation and forms, and up­
date them where and when necessary (for example "corrections and additions" 
to the Field Manual of Operations), based on training meeting and field-work 
experience.
3. Back-translate and approve questionnaire and forms for local use.
4. Receive necessary documentation from each centre prior to data collection, 
including population description, social scale, alcohol equivalents, and 
education levels.
5. In conjunction with the Central Laboratory, arrange for the bulk purchase of 
INTERSALT supplies and materials and ensure that payment is made.
6. Invoice local centres for the costs of the INTERSALT supplies, or 
alternatively ensure that these costs are met from central funds.
7. Ensure that all supplies and equipment are shipped to local centres in time.
8. Receive and review completed Dry Run forms and feed-back urgently to local 
centres.
9. Approve local ancillary study requests.
10. Communicate with local centres before and during data collection, and clarify 
problem areas that may arise.
11. Set up and maintain a computer file for each centre.
12. Ensure that forms are sent regularly to London, and that urine aliquots are 
shipped as required to Leuven.
13. Review forms as they arrive for important errors and omissions, and take 
appropriate action.
14. Advise centres when necessary on the need to recruit supplementary 
participants.
15. Monitor progress so that the exact status of each centre is known as to the 
number of forms and urine aliquots shipped and processed.
16. Communicate regularly with the Central Laboratory and monitor the arrival, 
completeness, and integrity of urine shipments.
17. Receive and review copies of the daily working sheets from the Central 
Laboratory.
18. Oversee Central Laboratory procedures, including internal quality control, 
making site visits as necessary.
19. Carry out data handling procedures: receive, edit, code, punch, verify, and 
check completed forms.
20. Prepare a weekly report of the number of forms received, edited, coded, 
punched, verified, and checked.
21. Hold regular staff meetings to discuss progress and problems.
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22. Communicate regularly with all centres, in the form of Newsletters, reports, 
etc.
23. Inform the Executive Committee and funding agencies of the progress of the 
study.
24. Carry out data quality control procedures: re-code a random sample of forms, 
and determine error rate in coding; verify (double punch) all forms, or a 
random sample of forms, and determine error rate in data entry; carry out 
range and consistency checks on the data; and monitor the technical error of 
the Central Laboratory (12% of the samples will be split and sent blind to the 
Central Laboratory for analysis).
25. Receive the necessary documentation from each centre after completion of 
data collection, including the Recruiting Record, Recruiting Summary, Log 
Book, Urine Collection Register, and local centre Report.
26. Prepare a summary of data received (excluding urine data) for each local 
centre.
27. Arrange transfer of computerised data from the Central Laboratory, and 
merge the data for each centre with the appropriate computer file in London.
28. Transfer data to the University mainframe computer for analysis.
29. Perform the data analysis in preparation for the main INTERSALT 
publication, in consultation with the Chicago Coordinating Centre.
30. Suggest and perform other data analyses, in collaboration with the Chicago 
Coordinating Centre and other INTERSALT investigators.
2.2 Central Training
Venue
The central training of investigators was organized jointly by London and Chicago, in 
a series of regional training meetings. In all, 5 regional meetings were held and 105 
investigators were trained centrally. The regional meetings were held in London (2), 
Houston, East Berlin, and Singapore. The first took place in December 1984, and the 
last in September 1985.
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Content
The training sessions were held over 3 days (4 days in Singapore) and consisted of 
lectures and slide presentations in the mornings, and practical sessions and individual 
consultations in the afternoons. Training was based around the Manual of 
Operations, and covered all aspects of the Study, from sampling and recruiting, BP 
measurement, instruction on the 24-hour urine collection, etc., to the role o f  local 
Principal Investigators, and ethical concerns.
The practical sessions involved filling out of all forms, including the questionnaire 
(with feedback), and detailed instruction, training, and certification in BP and the 
urine collection, the key variables under study.
Overall, BP training consisted of:
1. Slide/lecture presentation, outlining the INTERSALT BP procedures, and 
introducing the forms and equipment to be used.
2. Lecture giving definitions of the BP sounds (phase I - systolic; phase V - 
diastolic) and introducing the London School of Hygiene and Tropical 
Medicine BP - audio tape.
3. Recognition and timing of the BP sounds on the audio training tape, using 
individual cassette recorders and headphones.
4. Certification on the audio test tape, by defined criteria.
5. Practice (in groups of three, and under supervision) in the use of the random 
zero sphygmomanometer, application of cuffs, etc.
6. Use of double-headed stethoscopes to train and test investigators against the 
INTERSALT BP trainers. Investigators were certified by defined criteria 
using live readings on the random zero sphygmomanometer.
7. Instruction on the maintenance of the random zero device, and on emptying 
and filling with mercury.
Training in the urine collection was as follows:
1. Lectures and slide/lecture presentations covering all aspects of the urine 
collection, including timing, participant instruction, ensuring complete 
collections, labelling procedure, aliquoting, refrigerating, and shipping.
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2. Collection for 24 hours and aliquoting of investigators' own urine during the 
meeting:
a. Jars had to be prepared (with boric acid) and labelled.
b. Spot urines were collected, the dipstick test carried out, boric acid 
added, and the urines refrigerated overnight.
c. Instructions for the 24-hour urine collection were given.
d. Relevant forms were filled out (Form G - General, Form U - Urine 
Collection, Urine Collection Register).
e. Urine volume (heights) was measured.
f. Aliquots were taken, labelled, and taped together in the prescribed 
manner.
g. The refrigeration box was packed ready for shipping, and the shipping 
form was filled out.13
2.3 Review o f  Local C en tres
Centre Identification
Each centre is identified by name and unique 2-digit centre code, assigned at one of 
the regional training meetings. The centre code is incorporated as the first 2 digits of 
each ID number listed on the LOG BOOK and on the corresponding pre-printed 
labels sent from the Central Laboratory.
Back translation o f  forms
The questionnaire and data forms for the Study were prepared in English by the 
London and Chicago Coordinating Centres. For languages other than English, local 
translations of the forms were made and sent for approval to London (and to Chicago, 
for a few centres). Native or fluent speakers of the language (usually from within the 
University) are contacted to back-translate the forms into English without reference 
to the original. Comparison is then made with the original English version, and 
discrepancies referred back to the local centre for clarification.
13 Urine aliquots from the meetings were analysed and individual results were sent to panicipaling 
investigators. At the end of each training meeting, the training materials (including the training 
slides and the BP audio tape) were made available to investigators to allow them to train their own 
staffs locally.
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All approach letters to participants, extra questions, etc. must also be translated and 
back-translated, and local field work should not begin until all the necessary forms 
and documentation have been approved.
To minimize errors in coding, it is particularly important that translated versions of 
the forms and questionnaire maintain the structure of the English originals, and 
efforts are made to ensure that questions line up correctly with the boxes in the right- 
hand coding columns. Where possible, common versions of the forms and 
questionnaire are agreed for centres which share a common language (for example, 
Italian, Spanish, German). Translations into 22 languages and dialects are approved 
for use in the INTERSALT study.
Preliminary information (See Appendix 3)
Before data collection begins, each centre is asked to send preliminary information to 
the London Centre. A check-list is filled out by one of the London coding staff, to 
document whether the following has been received from each centre:
1. Population description. A detailed account to characterise the base population 
is prepared: urban/rural status; main type of economic activity; economic 
level; weather; usual diet pattern, including any information on salt use; 
general level of health; ethnic composition; and, where available, size of the 
population and age-sex distribution.
2. Social scale. Where possible, a four-point social scale (1 = lowest, 4 = 
highest) is constructed to classify participants broadly into social groups. The 
scale chosen might be based on accepted national criteria (for example, 
Registrar General's social class in England and Wales), or be particular to the 
population under study.
3. Alcohol equivalents. A list of alcoholic drinks consumed in the population 
and the equivalent volumes (in ml) of absolute alcohol are necessary to allow 
data on alcohol intake to be quantified. During the study, centres need specify 
only the type of alcohol consumed (beer, wine, whisky, etc.) and the volume 
(in ml); conversion to ml of absolute alcohol is then calculated by computer.
4. Education levels. A brief description of the education system, and the 
expected time spent at each level (primary, secondary, higher education) is 
needed to interpret answers to questionnaire queries on education.
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5. Clinic hours. Days and times that local clinics are open are entered on to the 
computer, and checked against those filled out on the data forms.
6. Certification of local staff. At least one member of staff from each centre is 
trained at a regional training meeting. If other members of staff are taking 
part in the study (in any capacity) they are trained locally, and certified in the 
appropriate tasks by the local Principal Investigator. For BP, observers not 
trained at regional training meetings must be certified against an INTERSALT 
trained and certified observer.
The local Principal Investigator completes and returns a "Certification of Staff 
Member" form for each o f his or her staff, indicating those aspects of the 
Study for which each staff member is certified. Staff numbers (starting at 
"01" in each centre) are assigned by London, and a computer check of staff 
number against study tasks (as recorded on the data forms) is carried out.
7. Methods of sampling. Sampling in each centre is achieved by one of three 
methods:
a. Age-sex stratified random sampling when age and sex are known.
b. Simple random sampling if names and locations are known, but not 
age and sex.
c. House-to-house contact, if there is no list of names.
These are to be discussed with London in advance. During the study, 
London is on hand to advise on sampling where necessary (for 
example, if a shortfall is apparent in one of the age-sex groups).
Ancillary studies
INTERSALT policy is to encourage ancillary studies by local centres, providing that: 
funding is arranged locally; an INTERSALT investigator is a principal investigator 
or co-investigator on the ancillary study, and is responsible for presenting it to the 
INTERSALT Executive Committee; and that the ancillary study does not interfere 
significantly with the conduct and goals of the main study. Interference may take a 
variety of forms, for example, the collection of fasting blood samples, too much 
additional examination time, o r the inclusion of procedures which would make the 
examination less acceptable to participants.
The local Investigator submits the "Ancillary Study Approval Request Form” and any 
relevant documentation to London for approval. In general, requests meeting the 
conditions above are approved.
Communications
It is the responsibility of the London Centre to maintain close contact with 
participating centres throughout the study. This takes the form of regular general 
communications (e.g., updates to the Manual of Operations, Newsletters, etc.), and 
direct contact at different stages of the study locally. Two separate files and a "local 
centre book" are kept to record details of communications with each centre.
1. Planning for the Study. Once initial contact is made, letters are exchanged on 
details of the local study, and relevant INTERSALT documents are sent out, 
including the Protocol and Manual of Operations .
2. Regional Training Meeting. Local investigators were sent invitations to 
attend one of the regional training meetings, and were required to fill out and 
return Registration Forms for the meeting. Any missing documentation, and 
the training and Dry Run materials, were distributed at training meetings.
3. Preparation for the Study. Prior to data collection, contact is established with 
each centre by letter, telephone, and if possible by telex, and the preliminary 
materials are requested, including translations of the data forms and 
questionnaire. A date is set for the Dry Run and the study proper, and 
despatch of the central supplies is organized.
4. Dry Run. Where possible, the Dry Run is discussed with the local 
investigator by telephone after review of the completed Dry Run forms in 
London. Arrangements for the study proper are also discussed, and a follow­
up letter is sent.
5. Data Collection. Lines of communication between London and local centres 
are established in advance of data collection to allow for early detection and 
correction of errors. In all cases, London is on hand to answer queries arising 
in the field. Urgent problems discovered during the edit procedure are dealt 
with by telephone, telegram, or telex (including the need to recruit 
supplementary participants). Other queries are normally made by air-mail 
letter, and a standard form for this purpose has been prepared. London also
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advises local centres on whether shipment o f forms and urines are received in 
London and Leuven, and whether back-up urines are required.
6. Completion of the local Study. After completion of data collection, a request 
is made for copies of the Log Book, Urine Collection Register, Recruiting 
Record, and Recruiting Summary (without the names) together with answers 
to any outstanding queries. The local Investigator is also asked to make out a 
report of the centre's experiences during data collection, along the lines of a 
pro-forma prepared in London. Once all data have been entered onto the 
microcomputer in London, checked and verified, a summary report of data 
received (excluding urinary data) is prepared and sent to the local 
Investigator.
7. Publications. The main paper by the INTERSALT Cooperative Group is to be 
circulated for comment to local investigators in advance of publication.
Site visits
The INTERSALT Protocol made provision for site visits to be made to selected 
centres to coincide with local training and the Dry Run. The size of the study and the 
distances involved do not permit this to be a primary means of contact.
2.4 Review of the Central Laboratory Procedures
Delivery o f central supplies
Central supplies (tubes, tops, etc.) for the INTERSALT study are purchased in bulk 
by Leuven for shipment to local centres, and a set o f  numbered and blank labels are 
printed for each centre. After receiving word from London (for example, once 
payment for central supplies has been made), boxes of supplies and labels are packed 
and despatched, and the details discussed with London so that local centres can be 
informed.
London and Leuven have worked closely together to  ensure that central supplies have 
been delivered to centres in time. This has necessitated overcoming many local and 
international difficulties in the shipping of supplies around the world, including 
airline and customs regulations.
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Notification o f  local shipments
According to protocol, both the London Coordinating Centre and the Central 
Laboratory are to be advised of incoming shipments from local centres at least 2 
weeks in advance. This has not always been feasible, and occasionally contact with 
either London or Leuven has not been made until near the time of shipment. In all 
events, London and the Central Laboratory discuss the shipping details by telephone, 
and arrangements are made in Leuven to collect the shipment as soon after arrival as 
possible.
Once the shipment has been retrieved, the boxes are opened, an inventory of the 
aliquots is taken and compared with the shipping list from the local centre, and an 
assessment is made of the state of the urines (whether thawed, whether the aliquot 
tubes are cracked, etc.). Details are discussed with London by telephone, and 
appropriate feedback to the local centre (usually by London) is agreed. Forms 
documenting the date of arrival of each shipment, the IDs of urines received, and the 
state of the urine samples are sent on to London by post.
The shipment of the first 25 urines from each centre is analyzed quickly by the 
Central Laboratory and the results discussed with London by telephone. This 
identifies any problems in labelling (particularly of the split samples) or in the 
allocation of ID numbers, and if necessary the local centre is contacted urgently by 
London for a review of local procedures.
Receipt o f laboratory data
Photocopies of the laboratory working sheets are sent regularly to London by post. In 
addition, plots of the internal quality control samples and addition curves for sodium 
and potassium are periodically reviewed. Computerised laboratory data are being 
sent on 8" floppy disks (one or two per centre), and are transferred onto 
microcomputer in London. Thus both uncorrected data (working sheets) and data 
corrected to baseline control values (floppy disks) are being received.
Communications
Regular site visits are being made to the Central Laboratory enabling laboratory 
quality control procedures, transfer of data, etc., to be reviewed. Several visits to the 
London Coordinating Centre have also been made by Central Laboratory staff, with 
detailed Minutes of such meetings.
195
A close working relationship has been established with the Central Laboratory, and 
frequent communications are made by telephone, telex, and letter. Details of 
telephone conversations are recorded in a separate book for the Central Laboratory, 
and files are maintained for correspondence, for invoices related to central supplies 
and shipping costs, and for routine Laboratory data received in London.
Quality control procedures
An extensive system of internal quality control for the INTERSALT Study has been 
developed by the Central Laboratory in collaboration with the London Coordinating 
Centre. Regular review of the quality control procedures is carried out by post and on 
the telephone, and during site visits. External quality control is by means of the split 
samples.
1. Quality Control Charts and Addition Curves. Results of the daily quality 
control samples (High, Medium, and Low for each analysis of interest) are 
displayed and outliers investigated. Addition curves for Na and K are also 
produced to check for systematic errors in the Laboratory.
2. Laboratory Working Sheets. Copies of the daily working sheets for the 
Central Laboratory are sent to London by post. These are reviewed and kept 
as a working record of Laboratory performance.
3. Participant IDs. Participant initials from the aliquot labels are entered onto 
the Laboratory working sheets when the urines are analyzed. They are 
entered onto computer in Leuven and checked against initials listed on the 
urine Shipping Forms.
A list of IDs (with initials) is prepared in London for each centre, and 
comparison is made with the IDs received in Leuven. Any discrepancies are 
investigated in London and in Leuven, and if necessary checked with the local 
centre. Finally, the full 7-character ID for each participant in the Study is 
agreed, so that Laboratory data can be merged with the data file in London.
4. Split Samples. The analysis of split samples is reviewed in London, and any 
discrepancies are checked first for mislabelling in the Laboratory and then for 
mislabelling in the field. A formal analysis of laboratory technical error is 
undertaken once computerised laboratory data have been received in London.
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Finances
Bulk purchase of the INTERSALT central supplies sent from Leuven is organised by 
the Central Laboratory. The Laboratory is also liable for the costs of shipping 
supplies and for customs duties when incoming shipments are picked up from 
Brussels airport. Detailed invoices are sent periodically to London for payment from 
central INTERSALT funds.
2.5 Processing Data from Local Centres
Introduction
The London Coordinating Centre has several microcomputers for use in 
INTERSALT. Data are stored on double-sided double-density (720 K) 3.5" diskettes 
with one diskette per centre. Each diskette contains participant data from the data 
forms, laboratory data, and data characterising the local centre. Data are additionally 
stored on hard disk (10 Mb) which is used for up-dating the data set and copying 
local centre data back to the corresponding diskette. Some data analyses are also 
carried out on microcomputer.
Participant and local centre data are entered on computer in London, while laboratory 
data are entered and checked in the Central Laboratory in Leuven and transferred to 
London on 8" floppy disks. The data are then merged in London using the 7- 
character participant ID as identifier.
Planning the workload
The workload of the London Centre is unpredictable from week to week, depending 
on a variety of factors beyond control of either London or the local centre 
(availability of photocopying facilities, the state of the postal services, etc.). 
Nevertheless, efforts are made to plan ahead and keep abreast of the workload (for 
example, by employing part-time coding staff). Regular timetables are produced of 
expected starting dates of centres not yet in the field, and a summary is made each 
week of the number of data forms received, edited, coded, entered onto the computer, 
checked, and verified.
Local centre data
A number o f general files are prepared for each local centre. These contain identity 
numbers of participants and staff and information on the centre's working hours and
rest days. Further files contain coding information on alcohol use and dietary 
changes.
Logging in data forms
When a shipment of forms is received, the Shipping List is date-stamped, and the 
shipment passed onto the appropriate staff member for editing and coding. In most 
cases, one coder will be responsible for a centre until the completion of the study 
locally. The Field Coordinator or Data Manager decides (usually at the time of the 
Dry Run or first shipment) which member of staff to allocate to a given centre; their 
decision depends on the current and expected workload of each staff member.
When a Shipping List is not enclosed and a copy has not been received under 
separate cover, a list of IDs included in the shipment is prepared by the coder and 
date-stamped. The Shipping Lists are kept together with the data forms during 
editing and coding. They are then filed along with copies of the Urine Shipping
Forms.
The coders keep a tally of the number of forms received, edited, and coded each 
week, and this is passed on to the Data Manager or Computer Operator. A weekly 
summary for the London Centre is then prepared.
Initial edit procedure
As soon as possible after receipt of a shipment of forms, the initial edit procedure is 
carried out. The purpose of the edit procedure is to check that all the forms have been 
received for each participant included on the Shipping List, and that no systematic 
errors are being made on the variables of most interest (BP and the urine collection). 
In addition, a decision is taken as to whether supplementary participants are required.
Following the initial edit procedure, the local centre is contacted by telex or telegram. 
In urgent cases, where the protocol has not been followed or has been misunderstood, 
the Field Coordinator gets in touch with the local investigator by telephone. Follow­
up letters are also sent where necessary. Once the initial edit is complete, forms are 
ready for coding.
Coding o f data forms
L Training and instruction of coders. Instruction of full-time INTERSALT
coding staff was organized by the Field Coordinator and Data Manager, using
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a detailed schedule of coding rules. Part-time coding staff are trained by one 
of the full time coders, but problem areas and areas of disagreement are 
referred to the Field Coordinator for clarification.
The Field Coordinator is on hand to advise on interpretation of existing 
coding rules or on new rulings, and decisions are recorded in a book kept for 
this purpose. In addition, regular meetings are held at the London Centre 
during which coding problems can be discussed and new coding rules can be 
communicated to other INTERSALT staff.
2. The Dry Run. A full coding of the Dry Run is made as soon as possible after 
the forms have arrived in London, and the local centre file and check-list are 
inspected to see whether all the preliminary information has been received. A 
complete list of errors, inaccuracies, and omissions on the Dry Run and a note 
of any missing documentation, are recorded in the local centre book, which is 
passed to the Field Coordinator. Efforts are then made to contact the local 
Principal Investigator by telephone to discuss the Dry Run and any 
outstanding problems or queries. In all cases, a follow-up letter is sent.
3. Coding Methods. While INTERSALT data forms are in general precoded, 
some variables need central coding (e.g., ml of alcohol, type of diet change). 
Coding boxes are located in the right-hand coding column. In addition, mock- 
up data forms with prompts and coding boxes have been set up on the 
computer using dBase II.
4. Coding Quality Control. A 5% sample of forms from each centre (excluding 
repeats) has been randomly selected for double-coding. Staff who code the 
forms the first time round are unaware of which forms have been selected.
The second coding is carried out by a different member of staff, but to ensure 
that the second coding is "blind" to the first, the forms are photocopied with 
blank boxes substituted into the right hand coding columns. Both sets of 
forms are entered onto the computer and compared. Any discrepancies are 
investigated, and an "error rate" (for the first coding) is calculated. Feedback 
on the double-coding is given to the coding staff, and action is taken if error 
rates are too high or if a systematic error by one of the staff is detected. 
Double-coding is also used to train part-time staff, and their performance is 
compared with that of the established coders.
5. Data Entry. Data are entered either directly from the forms (without a 
separate coding stage) or from coded information in the right hand coding
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boxes. If the data do not need coding, the digits are transferred to the right 
hand coding boxes, to enable the data entry technician to proceed efficiently. 
Whether data in the right hand column are from direct transfer or from coding, 
the data are verified by double entry (by the same individual, on a separate 
day), and an entry "error rate” is established. Double entry is also used when 
data are corrected and up-dated.
Data checking
Checking programs are run once data have been entered onto the computer and 
verified. These test whether identity numbers are valid, missing, or duplicated; 
whether fields are within acceptable ranges, and whether data are internally 
consistent. In addition, a list of unknown or missing fields (coded 9 and 7) is 
produced.
Communication o f errors to local centres
Local centre errors are detected by the London Centre at various stages of the review 
procedure. These include the Dry Run, the initial edit, the coding stage, and 
computer checking of the data. All errors detected in the Dry Run are reported back 
to the local centre, by telephone if possible. In addition, a telex or telegram is sent 
after the initial edit to advise centres on whether supplementary participants are 
required.
In general, errors are of two types:
1. Major (systematic) errors. These arise from misinterpretation of the protocol, 
and result in incorrect recording of the data. They are usually discovered 
either at the Dry Run, or during the initial edit procedure. In all cases, contact 
with the local centre is made immediately by telephone, telegram, or telex, so 
that corrective action can be taken.
2. Minor errors. These occur when information is missing, incorrectly entered, 
out of range, or illegible on particular forms. They are generally found at the 
coding stage or by the data checking program, and are reported to the local 
centre by air mail. A standard form for this purpose has been prepared. A list 
of outstanding problems is stored on computer until a response has been 
received from the field.
Error correction
When corrections are received from the local centre, the necessary amendments are 
made to the data set using the data entry program. The disk file with the problems 
outstanding for the centre is also amended, so that an updated list of queries is kept 
on file. Corrections are verified by copying the original file and updating it twice 
(double entry).
Additional procedures
When data correction in a centre is complete, a number of additional procedures are 
carried out.
1. Local Centre Documentation. Copies of the Log Book, Recruiting Record, 
Recruiting Summary, and Urine Collection Register are requested, with 
names removed to preserve confidentiality. They are checked for 
completeness and examined to determine whether the protocol was carried our 
correctly (for example, in recruiting the sample in the order of the age-sex 
lists). In addition, ID numbers and initials from the Log Book and Urine 
Collection Register are compared with those received in London and Leuven. 
Any queries are referred back to the local Principal Investigator for 
clarification.
Response rates in each age and sex group are calculated from the Recruiting 
Record and Recruiting Summary, where possible. The numerator is all age- 
sex eligible participants (including supplementaries), with eligible participants 
plus refusals as the denominator. (Noneligibles and those above the required 
numbers per age-sex group from the initial lists are excluded from the 
calculations.) A printout of those participants for whom supplementaries 
were required is also made.
2. Computer Checks. In addition to the range and consistency checks of 
participant data, programs are run to check that only certified staff carried out 
clinic tasks and that clinic opening times were consistent with those indicated 
in the preliminary information received from each centre.
3. Summary of Data Received. Once all the data from a local centre have been 
entered onto computer, verified, and checked, and replies have been received 
to outstanding queries, a report is prepared of data received in London 
(excluding urinary data) and sent to the local investigator.
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2.6 Processing Central Laboratory Data
Introduction
Definitive data from the Central Laboratory are sent to London in computerised form 
on floppy disks. The laboratory records results, enters them into its computer, and 
verifies the data (by 10% random double entry). In addition, a number of checking 
programs are run to give range and consistency checks on the data, and to detect 
transcription errors by laboratory technicians.
In addition, for day-to-day management of the study, a variety of non-computerised 
data are received from the Central Laboratory.
1. Results on first 25 urine aliquots. The first 25 urine aliquots from a centre are 
analysed soon after receipt in Leuven, and results are transmitted to London 
by telephone. Split samples are identified by London and if gross 
discrepancies are apparent, the Laboratory is asked to reanalyse the samples to 
help determine whether the error was in analysis, recording, or mislabelling.
2. Laboratory working sheets. These are filed for reference and are periodically 
reviewed (for results on split samples, to check participant initials, etc.).
3. Quality control charts and addition curves.
4. Inventory of urine aliquots. Lists of urine aliquots received in the Central 
Laboratory, giving date of arrival, state of arrival, etc., are sent to London as 
shipments arrive. A comparison of IDs is made with those on the data forms, 
and any discrepancies are investigated.
Processing computerized data
When a floppy disk from the Central Laboratory is received, it is read on an 8" disk 
drive within the Department of Epidemiology and the data are transferred to 
microcomputer. The data are merged on hard disk with the corresponding participant 
data, using the seven-character participant ID as identifier, and copied onto the local 
centre's diskette.
At the end of the Study, a magnetic tape of all the Central Laboratory results will be 
prepared and transferred to London. Comparison will be made with the data received 
on floppy disk.
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External quality control
External control of the Central Laboratory is being monitored by computation of the 
technical error. This is calculated by analysing paired results on the split samples, as 
follows:
TE = £N.=/ (Xj, - Xi2)2 
2N
where TE = technical error
N = number of paired split samples, 
and Xi|( Xj2 , X21, X22, etc are split-sample pairs.
The technical error is also expressed as a percentage o f the mean:
%TE = 100 x TEW*im,  (X,,+ Xa)/2N
2.7 Other Procedures
Staff meetings
Meetings of London Coordinating Centre staff are held regularly to review the day- 
to-day running of the Coordinating Centre. In addition, meetings are held from time 
to time with staff from the Chicago Coordinating Centre and the Central Laboratory, 
and progress and policy issues are discussed. Detailed minutes of the meetings are 
distributed to INTERSALT staff.
Interim reports
INTERSALT Newsletters are sent regularly by the London Coordinating Centre to all 
participating investigators and to members of the Executive Committee. In addition, 
it is the responsibility of the London Centre together with Chicago to provide updated 
reports as necessary for the Executive Committee and funding agencies.
Filing
Two filing systems are in use in the London Coordinating Centre: a working file and 
a permanent file. As forms are received from a local centre, they enter the working 
filing system. Data forms for a given participant are kept within the participant's
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plastic file, and all the files for a given centre are filed together in five or six filing 
boxes per centre. Once all the data for a centre have been coded, punched, entered 
into the computer, verified, and checked (i.e., the data set is complete and correct), 
the centre's filing boxes and data forms are transferred to permanent storage.
Data security
To preserve confidentiality of the individuals participating in INTERSALT, 
identification is made by means of the study ID only and names are not held in 
London. Efforts are made to ensure that no data are mislaid or go missing. As forms 
are received in London, they are checked against the Shipping List prepared in the 
local centre and discrepancies are queried. Data forms, microcomputers, and 
diskettes are locked up outside working hours.
Once data have been entered into the computer, a number of copies are kept to guard 
against loss through faulty media. One copy is kept on hard disk, a second copy on 
diskette, and a third copy on a diskette stored in a safe place outside the building. 
This is locked up, and provides a backup should the others be lost through fire, etc.
3. Methods for the Central Laboratory
This section summarises the methods and procedures of the Central Laboratory 
(excluding biochemical procedures) which were developed jointly by the Laboratory 
and the London Coordinating Centre. It was part of a larger Laboratory Manual used 
by the Laboratory staff and technicians.
3.1 Procedures for Shipping Urine Aliquots
There is one Central Laboratory for all chemical analyses, at the Sint-Rafael 
University Hospital, Capucijnenvoer 33, B-3000, Leuven, Belgium.
Local centre to Brussels airport
These procedures are described in detail in Section 3, Field Methods.
Brussels airport to Central Laboratory
As urine shipments arrive at Brussels airport, the Central Laboratory makes contact 
with the appropriate air freight handling department (either Sabena or Belgavia, 
depending on which airline is used for the shipment). If the samples arrive before 6
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p.m. on a weekday, they are collected on the day of arrival in Brussels. Shipments 
arriving after 6 p.m. are collected the next morning.
The local centres have been advised not to send any shipments scheduled to arrive in 
Brussels over a weekend. In the event that this occurs, however, shipments can be 
collected only on the Monday morning, since there is no customs service over the 
weekend. If shipments have to stay overnight at the airport, the airline handlers are 
advised to store them in a deep-freeze until collection. Import duties are invoiced to 
the London Coordinating Centre.
Upon arrival in the Central Laboratory, the urine aliquots are unpacked, counted, 
checked, and stored in a deep-freeze at -30°C (aliquot numbers 1, 3, 4, and 5), and at - 
80°C (aliquot number 6). Aliquot numbers 1 (spot) and 3 (full, 24-hour) are analyzed 
for cations and creatinine; numbers 4 and 5 are stored for future analyses and number 
6 is kept for long-term central storage. If for some reason less than four aliquots of 
the 24-hour urine collection are received, the following priority rules apply: 
irrespective of the aliquot number, the first aliquot is taken for immediate analysis, 
the second one for long-term central storage, and the remainder for future analyses.
Shipping information is entered on the Urine Inventory. This information includes 
the local centre number, airway bill number, invoice number, import duties, date of 
shipment, date of arrival in Brussels, whether first or repeat collection, whether or not 
the aliquots are backups, and whether or not aliquots are thawed (s= only spot 
thawed; f= at least one full sample thawed; a= both spot and full samples thawed). 
The participant initials are also copied onto this form from the urine Shipping List 
sent by the local centre.
The Central Laboratory informs the London Coordinating Centre by telephone of the 
number of samples received, the ID numbers, the condition in which they were 
received, and of any discrepancies noted (e.g., when at least one o f  the five urine 
aliquots for a given participant is missing). The London Coordinating Centre informs 
the local centre accordingly and instructs the Central Laboratory o f  actions to be 
taken.
As far as possible, the Central Laboratory analyses the first shipment of urine from a 
centre on the first working day after arrival in Leuven. Results of these analyses are 
immediately telephoned to the London Coordinating Centre, and the labelling, the 
allocation of ID numbers, and the results for any split samples are checked there.
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At the end o f each week, the Central Laboratory sends copies of the Inventory Forms 
(if any shipment arrived during the preceding week) and of the laboratory working 
sheets (crude data) to the London Coordinating Centre. Once all the aliquots for a 
particular centre have been analysed, data are transferred to London on a 3740 
formatted 8" floppy disk; separate data files are used for first and for repeat 
collections.
3.2 Quality Control Procedures
An extensive quality control programme is used to ensure high-quality urine analyses. 
This includes internal control by analysis of a commercially available urine standard, 
addition curves, procedures for monitoring daily laboratory performance, and 
external control by means of split samples.
Internal quality control
1. INTERSALT Reference Samples. At the beginning of the study, before any
sample had been analysed, a number of urine pools were collected and 
subdivided into 4 ml aliquots. They were stored in a deep-freeze at -30°C for 
use throughout the study for internal laboratory control.
For each of the analyses of interest (sodium, potassium, calcium, magnesium, 
chloride, and creatinine) two low, two medium, and two high concentration 
pools of urine were prepared.
For a given substance and concentration (i.e. sodium, medium) the two pools 
were designed to differ by about 2.5%. This was done in order to blind the 
technicians as to the "true" value of concentration for a given quality control 
sample.
About 250 aliquots were taken from each pool. Assuming that the chemical 
analyses will last about 2.5 years, that is 500 working days, a sufficient 
number of aliquots were prepared for the duration of the study.
Each working day is randomly assigned an INTERSALT reference sample 
from either pool for each substance and concentration and the technicians 
have no prior knowledge of which of the two pools a specific INTERSALT 
reference sample has been drawn.
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Analysis of the INTERSALT reference samples is by visual display and 
control charts.
2. Visual display. Plots of the INTERSALT reference samples Low (1,2), 
Medium (1,2), High (1,2) are made periodically and reviewed with the 
London Coordinating Centre. Oudying points are investigated.
3. The Levey-Jennings Control Chart. For each INTERSALT reference sample, 
estimates of the mean (X), the standard deviation (s) and the range (R) were 
calculated from results obtained over a period when the laboratory was judged 
to be at a good level of control. Each day, the average of repeated estimates 
of a given INTERSALT reference sample is calculated to determine whether 
it lies within a 3 standard error (S.E.) confidence interval of X. Points lying 
outside 3 S.E. give a warning of a possible out-of-control situation. Such a 
warning also occurs when at least seven consecutive values fall either below 
or above the nominal value, or when seven consecutive values show a positive 
or negative trend.
4. Commercially Available Urine Standard. Throughout the study, a 
commercially available urine standard is analyzed periodically for external 
comparison of results obtained in the Central Laboratory with target values as 
given by the company from which the standard is obtained. The primary 
objective here is to test whether or not the analytical system provides accurate 
results.
For an analytical system to be accurate, the obtained results should fall within 
the designated range.
5. Addition Curves. This method is also applied for testing the accuracy of the 
analytical system, and may provide more reliable conclusions than by 
analysing commercial standards.
This method consists of analysing a set of urine samples obtained by mixing 
specified amounts of an unknown sample (jc), of a urine standard (y) with 
known concentration, and of distilled water (z), according to the formula:
x + n*y + z = t(n = 0,..., 10)
If the samples are prepared carefully following detailed instructions, the 
results obtained after analysis should follow a straight line.
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The accuracy of the analyzing system is evaluated using linear regression 
techniques. Empirically, the linear correlation coefficient r should be at least 
0.999 for the accuracy to be acceptable. The slope b should not be 
significantly different from one (p<0.01). The intercept a is to be interpreted 
as the concentration o f the unknown urine sample.
Addition curves are made periodically throughout the study.
External quality control: split samples
External validation of the Central Laboratory is through analysis of the 12% split 
samples.
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Appendix 2: Forms and Questionnaire 
Data Collection Forms
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GENERAL PREPARATION FOR MEASUREMENT Z 2 ™  g :
OBNERAL rLRASl DO WOT MRITE M X I
• l U t t  C B flR I
M u »
PARTICIPANT ID
a p p o in t m e n t . f i r s t  |~ ~ [  l  r epea t  [ j 2
q P
P
r r x r r  number or perso n  com pleting  t h is  porm gg
1 . MRS PARTICIPANT ASKED TO PAST IN PREPARATION FOR
THIS V ISIT ?
" ° D J □
13
(IP  YES, RE-SCHEDULE CLINIC APPOINTMENT)
2 .  DATE /  /
Day Month Yaar □ □ □ □ □ □1 4 -1 9
3 . DAY or MEEK MON I TUES 2 MED 1 1 3
THUR [ ^ )  4 PRI 5  SAT 6  SDN 1 1 7 P
4A. IS  TEMPERATURE RECORDED IN:
DEGREES 1— 1 DEGREES -------
CENTIGRADE? 1 1 1 FAHRENHEIT? | |  2 P
4B. OUTSIDE TEMPERATURE ____ (DEGREES) ngp
ABOVE EERO? | |  1 BELOW EERO? [ |  2 p
4C. ROOM T E M P E R A T U R E ______________(DEGREES) □□□
2 6 -2 6
ABOVE EERO? |~~J 1 BELOW EERO? |-----1 2 P
(CONTINUED ON NEXT PAGE)
210
211
LABST1X
FORM L .
STUDY C D f m
(M M )
PARTICIPANT ID □ □ □ □ □ □ □
1 -7
B Q
h r r o o m f a r r  ran  J |  i u p z a t  |  1 2
. .  □
10
MOTES: OSE DIPSTICK IN PAESHLY VOIDED SPOT URINE ONLY
IN THE URINE, THEN IMMEDIATELY REMOVE THE STICK. TAP EDGE
HORIZONTAL POSITION. COMPARE THE TEST AREAS WITH THE
AT THE TIMES SPECIFIED POR EACH AREA.
l .  « r a m  E H  i  1 1 3 □
(40  M C I) N tg P o* 11
2 .  »LOOD E H  i  2  n  3 E H  4 S □
(4 0  M C I) Nag T r a c t  4 44 444 12
3. m a m s  1 i l  I” - 1 2 1 Is I ] *  I | s  I ) o □
(1 5  M C I) Nag T r a c t  Sm all Mod L •  r  g • 13
« .  glooose E H »  D *  E H » E H 4 E H *  E H * □
(30  m c i ) N«g T r a c t  4 44 444 4444 14
S . PROTEIN* EH  1 1 1 3  [^) 3. E H  4 □  * E H  * □
N tg T r a c t  4 44 444 4444 15
« .  p«* EH  > E H 2 E H j E H 4
5 .0  6 . 0  6 . 5  7 .0
□  * E H *  □ ’ □
7 . 5  8 . 0  8 .5 16
•T lM t n o t  c r i t i c a l
STATT NUMBER
T O
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MEASUREMENTS
APPOINTMENT: FIRST | | REPEAT [~~~[
PH*« 2 —  PORK H.
PARTICIPANT ID
2 .  PULSE AND 1LOOD PRESSURE
PLEASE DO NOT W ITT NERE
RESTINO PULSE (3 0  • • c o n d ì)  ______________ DQP
PULSE ORL ITERATI ON PRESSURE __ DQP
PEAK INFLATION PRESSURE 
(PULSE OBLITERATION PRESSURE +  10 H i 
OR 180 mm, WHICHEVER IS  CREATER) □□□
2 8 - 3 0
HEASUREMENT J: PULSE (JO • e c o o d s )  ____ ngp
RZ SYSTOLIC ___________ ogp
RZ DIASTOLIC _______ □gp
RZ ZERO □□
4 0 - 4 1
MEASUREMENT I I :  PULSE (3 0  • • c o n d ì ) ________ □  □ □  
4 2 - 4 4
RZ SYSTOLIC ________ □  □ □  
4 3 —4 7
RZ DIASTOLIC _________ □  □ □  
4 8 - 3 0
RZ ZERO
WAS BLOOD PRESSURE MEASUREMENT DIFFICULT?
□  □  
3 1 - 3 2
TES Q  )  NO Q  2 
IF YES, GIVE DETAILS BELOW
( p i e n e  v r l t e  l e g i b l y .  In  E n g l l i h .  i f  p o n l b l e )
□
33
IF FIRST APPOINTMENT, PROCEED TO MEASURE HEICUT AND WEICHT 
(neit pipe). IF  REPEAT APPOINTMENT. THIS ENDS THE MEASUREMENTS.
(C O N T IN U E D  OH H EXT P A C E )
KEASUKEMEMTS
PABTICIFAirT ID 
3 .  n i c r r  aito v e ic h t
r * a  l  —  r o * x  « .
PLEASE DO DOT VHITE BERE
D I G I T  AMD VEICHT 0 » SEIVE* H U K B E *_________
■ATI PASTI CI PAIfT ' S SBOCS I E U  HZMOVED?
'  □□
T t s  □  t  mo d )  2 □
3«
h e ic h t  i __________ ( c u T i x r r u s ) ag.p
n i c v r  i l __________ □□□
4 0 - 6 2
v e ic h t  i __________ .  ____  ( k il o s , t o  thè  h e a ie s t  half e i l o ) □□DD
6 3 - 6 6
VEICHT I I __________ .  ____ aagg
OD I __________ (POUHDS, TO THE HEAJtEST ODE POUHD)
I I __________ ngg
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QUESTIONNAIRE FCUH 0 .
PLEASE DO NOT WRITE HERE
STUDY CENTRE
( H u t )
PARTICIPANT ID □ □ □ □ □ □ □
□ g
Q U E S T I O N N A I R E P A G E  2  F O R M  Q .
P A R T IC IP A N T  I D P L E A S E  DO N O T  W R IT E  H E R E
P L E A S E  ANSW ER A L L  Q U E S T IO N S  T H A T  A P P L Y  TO
Y O U . MARK A N  'X *  I N  T H E  B O X  O R P R I N T  IN F O R M A T IO N  W H E R E
R E Q U E S T E D . ASIC T H E  IN T E R V IE W E R  FOR
A S S IS T A N C E  I F  R E Q U IR E D
1 .  W A T  I S  T O U R  D A TE  O F  B I R T H ?  /  / □ □ □ □ □ □
( D a y )  ( M o n t h )  (  Y e a r ) 1 0 - 1 5
2 .  W A T  WAS TO UR A C E L A S T  B IR T H D A Y ? □ □
1 5 - 1 7
3 .  « H A T  S 3  A R E  T O U ?  H A L E  J 1 1  FE M A L E  |  1 2 Q
A . A R E  YOU:
» 0 «  H A R R IE D  |____ |  1  D IV O R C E D  OR S E P A R A T E D ?  | ____ |  2
W IDOW ED? |  |  3  N E V E R  M A R R IE D ?  1 1 N □
1 9
5 .  DO YOU NOW 9 4 0 K E  C I G A R E T T E S ?
I E S  1  I F  Y E S ,  P L E A S E  ANSW ER Q U E S T IO N S  6  AND 7
NO 2  I F  N O , P L E A S E  S K I P  Q U E S T IO N S □
6  AND 7  AND T H E N  ANSWER 2 0
Q U E S T IO N S  8 ,  9  AND 1 0
ON LY  F O R  C U R R E N T  C IG A R E T T E  S M O K E R S
6 .  A BO U T HOW MANY C IG A R E T T E S  A  DAY DO YOU S O K E ?
□ □
( N u m b e r ) 2 1 - 2 2
7 .  A R E T H E S E :
M A N UFA CTU RED  C I G A R E T T E S ?  |____ |  1
•R O L L  YOUR OWN’ C I G A R E T T E S ?  1 1 2 □
2 3
3 0 Œ R S ,  P L E A S E  S K I P  Q U E S T IO N S  8 , 9  AND 1 0  AND P R O C E E D
T O  Q U E S T IO N  1 1
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QUESTIONNAIRE PAGE 3 -  FORM 0
PARTICIPANT ID PLEASE DO N O T  WRITE HERE
ONLY FOR PEOPLE NOT NOW CIGARETTE SOKEPS
8 . IF  YOU ARE NOT A CIGARETTE 90K ER NOW, DID YOU 
EVER »CKE 5 OR HD RE CIGARETTES A DAY?
TES | | 1 N o [ ^ ]  2 •Q
9- DO YOU NOW 3 0 C E  A PIPE?
*e s [ 1 1  wo |  |  z Q
10. DO you NOW SMOKE CIGARS OR CIGARILLOS?
1 '  wo 1 1 2 g
FOR EVERYONE
11. HAVE YOU EVER BEEN TOLD BY A DOCTOR (OF HEALTH WORKER) 
THAT YOU HAVE HIGH BLOOD PRESSURE?
r a l  I 1 wo | 1 2 □
27
12. ARE TOU NOW TAKING AN! MEDICATION FOR HIGH BLOOD PRESSURE?
IEs Q  1 HO [ | p Q
IF  TOU ARE TAKING SUCH MEDICINE, WRITE THE NAME (OR NAMES)
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Q U E S T I O N N A I R E P A G E  4 -  F O R M  Q .
P A R T I C I P A N T  I D P L E A S E  DO N O T  W R IT E  H E R E
1 3 -  P L E A S E  W R IT E  T O E  N A > C S  O F  ANY O T Y C R  
M E D I C I N E S  YOU A RE NOW T A K IN G
i l T  Y O U  A R E T A K IN G  ANY ► C D IC IN E S  NOW BUT
YOU D O N ’ T  R D C M B E R  T H E IR  N A M 3 ,  P L E A S E
SHOW  U S  T O E  M E D IC IN E S  T H E  NEXT T D C  WE S E E  Y O U )
1 * .  A S  F A R  A S  YOU KNOW, D O E S  YOUR M O T H ER , F A T H E R  O R  A N Y  
S I S T E R S  O R  B R O T H E R S NOW HA VE H IG H  BLO O D  P R E S S U R E ,
OR D I D  T H E Y  HAVE H IG H  BLO O D  P R E S S U R E  I N  T H E  P A S T ?
tesQ i HO I I2
I F  Y E S .  P L E A S E  L I S T  W I C H  FA M IL Y  M > te E R S  W ERE A F F E C T E D
□29
1 5 .  HA VE Y O U  EV E R  B E D J  T O L D  BY A D O CTOR T H A T  YOU 
HAVE H A D  A H E A R T  A T T A C K ?
□30
r e s  I  I t  HO I L
1 6 .  HA VE Y O U  E V E R  B EEN  T O L D  B Y  A D OCTOR T H A T  YOU H A V E  
HAD A S T R O K E ?
□31
» Q ,  N O  l I 2
1 7 .  O V ER  T O E  L A S T  TW ELVE M O N T H S , H A S YOUR 
W E IG H T  G E N E R A L L Y  B E E N :
□32
T H E  S A R E 7  1 1 1 IN C R E A S IN G ?
F A L L IN G ? □  3 □33
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Q U E S T I O N N A I R E PAGE 5  ~ FORM Q.
PARTICIPANT I D _____________________
CHLT FOR THOSE OVER 25 TEARS OLD
1&A. DO YOU WEIGH MORE
ml 11
18B. ABOUT HOW HUCH DIE IOU WEIGH WEN TOO WEHE 25? ______
IS  THIS IN: P L Q s l |  1 POUNDS | 1 2 POUNDS * |  |  3
NOW THAN T O U  D I D  W E N  YOU W E R E  2 5 7  
WO I  I  2  D O N ’ T  KNOW  n  1
F O R  E V E R Y O N E
T H E  N E X T  FEW Q U E S T IO N S  A R E ABOUT W HAT YOU U SU A LLY  E A T ,  
A N D  ANY CH A N GES YOU MAY HAVE M A D E.
1 9 .  H A V E  YOU CHANGED HOW MUCH YOU U S U A L L Y  E A T ?
Y E S ,
Y E S ,
I  E A T  
I  E A T  L E S S
MORE |  |
□
3
<4
I F  - Y E S " ,  ABO U T HOW LO N G  A 0 0  D ID  YOU M AKE T H I S  C H A N G E ? 
2 0 .  H A V E  YOU CHANGED T H E  AMOUNT O F  S A L T  I N  YOUR F O O D ?
NO I |  2  Y E S , I  E A T  M O R E S A L T  f H  3  
Y E S , I  E A T  L E S S  S A L T  Q  A
I F  " Y E S " ,  ABO U T HOW LO NG  AGO D ID  YOU M AKE T H I S  CH A N G E ?
PLEAS DO KJT WRITE HERE
Q
□ □ □
35-37
Q
g
qg
g
qg
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Q U E S T I O N N A I R E
P A R T IC IP A N T  I D
2 1 .  D ID  YOU HA KE SCM E O T H E R  C H A N C E S  I N  YOUR D IE T ?
- □ l
2 7  Y E S , P L E A S E  L I S T  CH A N G E S H E R E
P A G E  6  -  F O R M  Q .  
P L E A S E  DO N O T  W R IT E  H ERE
-Q
□ □
U 6  M7
g
2 2 .  I F  YOU HAVE MADE C H A N G E S I N  YOUR D I E T ,  H E R E  ANY O F  
T H E S E  MADE ON T H E  R E C O M E H D A T IC N  O F  A  DOCTOR 
(O R  H EALTH W O R K E R )?
|  1 |  1 NO C H A N G E S  I 1 
Y E S  |____ |  1 NO |_____|  2  MADE |____ |  3
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QUESTIONNAIRE
P A R T I C I P A N T  I D ___________________________
FOR EVERYONE
2 3 .  I N  T H E  L A S T  FEW  T E A R S , HA VE YOU M ADE ANY C H A N C E S I N  
T O E  AMOUNT O F  A L C O H O L  YOU U SU A LLY  D R IN K ?
NO Y E S ,  I  D R IN K M O RE A LCO H OL 1 1 ]
L E S S  A L C O H O L [ ( *Y E S ,  I  D R IN K  :
2U. T H I S  P A S T  W E E K E N D , HOW MUCH A L C O H O L  D ID  YOU D R IN K ?  
T Y P E  ( B E E R ,  W IN E , W H IS K Y , E T C )  HOW MUCH?
SU N .
PAGE 7 -  FORM Q. 
PLEASE DO NOT WRITE HERE
□ □ □ □ □ □ □
1 - 7
□
□ □ □ □ □ □
11-16
□ □ □ □ □ □
1 7 - 2 2
□ □ □ □ □ □
□ □ □ □ □ □
□ □ □ □ □ □
3S-A0
□□□□qg
□□□□qg
□ □ □ □ □ □
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QUESTIONNAIRE
PAGE 8 -  FORM Q. 
PT-TXSE DO NOT WRITE HERE
PARTICIPANT ID □□□□□□□
25. POP WEEKDAYS THIS PAST WEDC, HOW MUCH ALCOHOL DID YOU DRINK?
8-9 mrti
HON. nnnnnn
1 0 -1 5
□□□□□□
1^121
□□□□□□
2 2 -2 1
TUES. □□□□□□
2 8 -3 3
□□□□□□
3 * -3 9
□□□□□□
40 —4 5
WED. □□□□qg
□□□□□□
7HUR. □□□□qg
□□□□□□
7 0 -7 5
nnnnnn
7É3T i
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2 6 .  FO R  A L L  O F  L A S T  WE E X , N A S  T H E  AMOUNT O F A L C O H O L  YOU W A N K
ABOUT A V E R A G E  F O R  A W EEX? |  1 1
L E S S  TH AN  A V E R A G E  TO R  |  I 
A W EEX ? '  | ____ |  2
H D  R E  TH AN  A V E R A G E  F O R  )  |
A WEEX? ___ 3
QU ESTIONNAIRE
PARTICIPANT ID ________________
2 7 .  HAVE YOU H A D  A N  A L C O H O L IC  D R IN K  W IT H IN  T H E  L A S T  
T W E N T Y -F O U R  H O U R S ?
a
TH E  F O L L O W IN G  Q U E S T I O N S  ARE A BO U T YOUR VtoRK . 
2 6 .  WHAT I S  YOUR U S U A L  W ORK, O R J O B ?
2 9 -  W H IC H  O F  T H E  F O L L O W IN G  B E S T  D E S C R IB E S  YOUR U S U A L
W ORK, OR J O B ?  
(MARK ’ X ’ I N  O N E BOX O N LY )
HOUSEWORK □  o, FA RM  0 2
O F F I C E ,  C L E R I C A L □  ° 3 S A L E S  |  |  t »
MANUAL LA BO U R □  « S E R V I C E  W ORKER |  |  0 6
F O R E M A N  ,  
S U P E R V I S O R □  or S K I L L E D  W ORKER ( 1 0 8
M A N AG ER, P R O P R I E T O R  ! |  
P R O F E S S IO N A L  (____ |  0 9 O T H E R  |  1 1 0
PAGE 9 - FORM Q.
PLEASE DO NOT WRITE HERE
T O
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QUESTIONNAIRE
ONLY FOR MARRIED PEOPLE
PARTICIPANT ID ___
3 0 .  WHAT I S  T H E  U SU A L WORK O R J O B  O F  YOUR H U SB A N D  
OR W IF E ?
3 1 .  W H IC H  O F  T H E  F O L L O W IN G  B E S T  D E S C R IB E S  Y O U R  HUSBAND 
OR W I F E 'S  U SU A L  W ORK, O R J O B ?
(M ARK 'X *  I N  O N E BOX O N L Y )
HOUSEWORK □  o , FA JW  □  0 2
O F F I C E ,  C L E R IC A L  1 1 0 3 S A L E S  1 1 0 <
MANUAL LA B O U R 1____ |  0 5 S E R V IC E  W O R K ER |____ ]  0 6
F O R EM A N  , 
S U P E R V I S O R □  o f S K IL L E D  W O R K ER 0 8
M A N A Œ R , P R O P R I E T O R l  I 
P R O F E S S IO N A L  |_____|  0 9 OTHER 1 1 1 0
F O R  EV ERY ON E
3 2 .  A R E YOU NOW E M PL O Y E D ?
Y E S N O , U N EM PL O Y E D  1 1 2
N O , R E T IR E D □ 3 N O , O THER 1 1 <
ON LY  FO R  P E O P L E  NOW EM PLO Y ED
3 3 -  I F  YOU A R E  NOW E M P L O Y E D , I S  T H I S  YOUR U S U A L  W ORK, OR J O B ?
5 1 I 1 wo I 12
3 3 B .  I F  N O , D E S C R IB E  YOUR P R E S E N T  WORK O F J O B .
PAGE 10 -  FORM Q.
PLEASE DO NOT WRITE HERE
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Q U E S T I O N N A I R E
p a r t i c i p a n t  i d
P A G E  1 1  —  F O R M  0 .  
PL E A SE  DO N O T W R IT E  HERE
3 * .  I N  REG A RD  T O  T O U R  P R E S D f T  W O R K . I S  I T  M O ST L Y  D ID O O R S  OR 
O U TD O O R S ?
» D O O R S  j  1 1 O U TD O O R S 1 1 2  K T T H > 1  1 3 □
9 0
3 5 . ROW MUCH P H Y S IC A L  A C T IV T T T  O R  HEAVY LA BO U R I S  
IN V O L V E D  I N  TO UR P R E S E N T  W O R K ?
V ER Y  H E A V Y . L O T S  C T  |  ]  « D I U M  P H Y S IC A L
P H Y S IC A L  A C T IV IT Y  | ______|  1 A C T I V I T Y  | _____|  2
L I G H T  O R  V ER Y  L I T T L E  1 I 
P H Y S IC A L  A C T !  V i n  I_____|  3 □
9 1
P O P  E V E K Y C K E
3 6 .  I N  Y O U R  L E I S U R E  T I M E .  H O W  M U C H  P H Y S I C A L  « m v i ' I Y  
A R E  Y O U  niGMXD  I N ?
A  L O T  Q  1 M O D E R A T E  |  [ 2 O P ^ N C Y JE  j ~ J  3 Q
3 7 .  WHAT T Y P E  O F  S C H O O L  (O R  C O U R S E  O F  E D U C A T IO N ) 
D ID  YOU L A S T  A T T D iD ?
» 0  S C H O O L  A T T E N D E D  1 1 1 E L E M E N T A R T  SC H O O L  2
SEC O N D A R Y  O R H IO H  SC H O O L  |  1 3  H IO H E R  E D U C A T IO N  |  |  A
3 8 .  ABO U T HOW M A N ! T E A R S  O F  S C H O O L IN G  OR FORM AL E D U C A T IO N  
HAVE YOU C O M P L E T E D ?
□
9 3
□□
9 4 - 9 5
FO R  K E N : T H I S  E N D S  T H E  Q U E S T IO N S .  TH AN K  YOU 
FO R  W CMEN: P L E A S E  TU R N  T O  T H E  N FD fT  P A C E .
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CHECKLIST
PARTICIPANT ID
4 .  D . OTHER ANTTHTPERTENSI VET
i n  i no n  ;
P«Re 2— PORN C.
PLEASE DO NOT WRITE HERE
( S e e  M A N U A L  O P  O P E R A T I O N S .  A p p e n d i x )
5 .  R E F E R  T O  Q U E S T I O N  1 3  O F  Q U E S T I O N N A I R E .
I S  T H E  P A R T I C I P A N T  T A K I N G :
A .  O E S T R O C E N S .  O T H E R  T H A N  T H E  ’ P I L L ’ ?
n s  □  i
1 .  S Y S T E M I C  S T E R O I D  P R E P A R A T I O N ?
TES □  >
C .  O T H E R  M E D IC A T I O N  A F F E C T I N G  B L O O D  P R E S S U R E ?
T E S  O H  1
S p e c i f y  ________________________
• a
D .  A M T  O T H E R  M E D I C A T I O N ?
Sp«cify ___________
; □  1 no □
( S e e  M A N U A L  O F  O P E R A T I O N S .  A p p e n d i x )
6.  S O C I A L  S C A L E  O F  P A R T I C I P A N T :
(L O W E S T  -  1 *  H I G H E S T  - 4 )
□  >
□  is
1 I 20
□  »
□  »
□
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U R I N E  C O L L E C T I O N  I N F O R M A T IO N
2 4  h o u r  u r i n e  c o l l e c t i o n
F O R K  u .
b t u d t  a m i  ( b * m )
P L E A S E  D O  N O T  W R I T E  H E R E
F A I T  I C I P A K 7  I D
1 - 7
B E
8 - 9
a p p o i n t m e n t :  f i r s t  1 1 1  r e p e a t  1 1 2
1 .  E N D  o r  2 4 - H O U R  C O L L E C T I O N
A . DAT or  W E E K : H O N  I  T O E S  |  |  2  W ED  J ^ J  J
- □
10
E H U R S  [ Z ]  4  m i  Z D  5  B A T  H D  6  B U N  Z D  7  
B .  T I K E  o r  D A T  ( R i g h t  A f t e r  V o i d i n g  F l n e l  S n n p l e )
□
1 1
( 2 4 —H O U R  C L O C K ) _____________t  ______
l o u r «  M i n u t e *
C .  W A S  T H E  C O L L E C T I O N  C O M P L E T E D  A T  T H E  C L I N I C T
1 2 - 1 5
Y E S  Z D  1  WO 1 1 2  
E X P L A I N
2 .  C O M P L E T E N E S S
A S K  T H E  P A R T I C I P A N T  T H E  F O L L O V I N C  Q U E S T I O N S  
A F T E R  C O M P L E T I O N  O P  T H E  U R I N E  C O L L E C T I O N
A .  " D U R I N G  T H E  2 4 - H O U R  P E R I O D ,  D I D  Y O U  A L W A Y S  V O I D  
I N T O  O N E  O F  T H E  U R I N E  C O L L E C T I O N  J A R S ? "
□
1 6
T E S  Q  1  B O  Q  2  
1 .  'W E R E  A L L  JAMS C O N T A IN I N G  H E I N E  E E T U M E D T *
□
1 7
T E S  Q  l  H O  1 | 2
I F  M O ,  E V E R T  E F F O R T  S H O U L D  B E  M A D E  
T O  R E T R I E V E  H I S S I N C  U R I N E
□
1 8
( C O  N T  I  MlJ E D  O N  N E X T  F A C E )
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Participant Instruction Forms
P R E P A R I N G  P A R T I C I P A N T  F O R  V I S I T
FROM:
C L I N I C  A D D R E S S :
T E L E P H O N E :
A T T E N D IN G  T H E  C L I N I C  A P P O IN T M E N T
T h a n k  y o u  f o r  t a k i n g  p a r t  I n  t h i s  s t u d y  o n  b l o o d  p r e s s u r e .  A n  a p p o i n t m e n t  h a s  
b e e n  s i a d e  f o r  y o u  t o  a t t e n d  t h e  c l i n i c a l  c e n t r e  ( a d d r e s s  a n d  t e l e p h o n e  n u m b e r  
a b o v e )  a t  ___________ a n  /  p m  o n  _____________________________ .
For at least one-half hour before your appointment, please avoid strenuous 
exercise, and refrain from eating or drinking anything other than water, or 
Booking.
B l o o d  p r e s s u r e ,  h a i g h t ,  a n d  w e i g h t  w i l l  b e  a e a s u r e d ,  a n d  y o u  w i l l  b e  a s k e d  t o  
a n s w e r  a  q u e s t i o n n a i r e .  Y o u  w i l l  a l s o  b e  a s k e d  w h i l e  a t  t h e  c l i n i c  t o  s t a r t  
a  c o l l e c t i o n  o f  u r i n e .  T h i s  w i l l  b e  c o m p l e t e d  2 4  h o u r s  l a t e r .  Y o u  w i l l  b e  
a s k e d  c o  r e t u r n  t o  t h e  c l i n i c  t o  c o m p l e t e  t h e  u r i n e  c o l l e c t i o n  a t  t h e  s a m e  
t i m e  t h e  d a y  f o l l o w i n g  y o u r  f i r s t  c l i n i c  a p p o i n t m e n t .
I f  f o r  a n y  r e a s o n  y o u  f i n d  t h a t  y o u  a r e  u n a b l e  t o  a t t e n d  y o u r  c l i n i c  a p p o i n t m e n t ,  
o r  t h e  r e t u r n  v i s i t  2 4  h o u r s  l a t e r ,  p l e a s e  l e t  u s  k n o w  i n  a d v a n c e  s o  t h a t  
s u b s t i t u t e  c l i n i c  a n d  r e t u r n  a p p o i n t m e n t s  c a n  b e  m a d e .
T h a n k  y o u  o n c e  a g a i n  f o r  y o u r  c o o p e r a t i o n .
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I N S T R U C T I O N S  F O R  2 4 - H O U R  U R I N E  C O L L E C T I O N
1 Y o u  w i l l  b e  a s k e d  t o  c o l l e c t  a l l  u r i n e  p a s s e d  d u r i n g  o n e  d a y  ( 2 4  
h o u r s ) .
Y o u  w i l l  b e  g i v e n  u r i n e  c o l l e c t i o n  J a r s ,  a n d  a  c a r r i e r .  Y o u  m a y  a l s o  
r e c e i v e  a  f u n n e l .
T h e  J a r s  h a v e  s c r e w - t o p  l i d s  t o  a v o i d  s p i l l a g e .
Y o u  w i l l  a l r e a d y  h a v e  b e e n  a s k e d  t o  p a s s  a  s a m p l e  o f  u r i n e .
T h i s  w a s  t h e  s t a r t  o f  t h e  2 4 - h o u r  c o l l e c t i o n .
C O L L E C T I O N  S T A R T E D  O N i  _______________________________  ________________________________
( D a y )  ( D a t e )  ^
A T :  _______________________________  ( a m  /  p m )
2  C O L L E C T  A L L  ( E V E R Y  D R O P ! )  O F  Y O U R  U R I N E  f o r  t h e  c o m p l e t e  2 4  h o u r s .  I f  
y o u  f e e l  t h e  n e e d  t o  h a v e  a  b o w e l  m o v e m e n t ,  f i r s t  t r y  a n d  p a s s  u r i n e  
i n t o  o n e  o f  t h e  c o l l e c t i o n  J a r s  s o  t h a t  n o  u r i n e  i s  l o s t  d u r i n g  t h e  
b o w e l  m o v e m e n t .
3  I f  y o u  h a v e  b e e n  g i v e n  a  f u n n e l ,  a l w a y s  u s e  i t  t o  a v o i d  s p i l l a g e  o r  
l o s s  o f  u r i n e .
4  A l w a y s  h o l d  t h e  J a r  w h i l e  u r i n a t i n g ,  t o  a v o i d  t i p p i n g .
5  O n c e  t h e  J a r  i s  t w o - t h i r d s  f u l l ,  s t a r t  a  n e w  J a r  t o  a v o i d  r u n n i n g  
o v e r .
6  D o  n o t  a d d  a n y t h i n g  b u t  u r i n e  t o  t h e  J a r ,  a n d  d o  n o t  r i n s e  I t .
7  B E F O R E  L E A V I N G  T H E  C L I N I C  m a k e  s u r e  y o u  h a v e  a n  a p p o i n t m e n t  t o  r e t u r n  
t o  t h e  c l i n i c  A T  A B O U T  T H E  S A M E  T I M E  T O M O R R O W  t o  c o m p l e t e  t h e  2 4 - h o u r  
c o l l e c t i o n .
8  B R I N G  W IT H  Y O U  a l l  c o l l e c t i o n  J a r s ,  t h e  f u n n e l  ( i f  g i v e n ) ,  t h e  c a r r i e r ,  
a n d  t h i s  f o r a  w h e n  y o u  r e t u r n  t o  t h e  c l i n i c  t o m o r r o w .
O U R  N E X T  A P P O I N T M E N T  W I T H  Y O U  I S  T O M O R R O W * 
a t  ____________________________________________________ ( t i m e )
B E  S U R E  T O  U S E  T H E  J A R S  T O  C O L L E C T  A L L  U R I N E  V O I D E D  U N T I L  W E  S E E  Y O U  
A G A I N .
T H A N K  Y O U  F O R  Y O U R  C O O P E R A T I O N I
F O R M  I
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P R E P A R I N G  P A R T I C I P A N T  F O R  
R E P E A T  V I S I T
F R O M :
C L I N I C  A D D R E S S :
T E L E P H O N E :
A T T E N D I N G  T H E  R E P E A T  C L I N I C  A P P O I N T M E N T
T h a n k  y o u  f o r  t a k i n g  p a r t  I n  t h i s  s t u d y  o n  b l o o d  p r e s s u r e .  A n  a p p o i n t m e n t  
h a s  b e e n  m a d e  f o r  y o u  t o  a t t e n d  t h e  c l i n i c a l  c e n t r e  ( a d d r e s s  a n d  t e l e p h o n e  
n u m b e r  a b o v e )  a t  __________________  a m  /  p m  o n  _______________________________.
F o r  a t  l e a s t  o n e - h a l f  h o u r  b e f o r e  y o u r  a p p o i n t m e n t ,  p l e a s e  a v o i d  s t r e n u o u s  
e x e r c i s e ,  a n d  r e f r a i n  f r o m  e a t i n g  o r  d r i n k i n g  a n y t h i n g  o t h e r  t h a n  w a t e r ,  
o r  s m o k i n g .
B l o o d  p r e s s u r e  w i l l  b e  m e a s u r e d  a g a i n .  Y o u  w i l l  a l s o  b e  a s k e d  w h i l e  a t  
t h e  c l i n i c  t o  s t a r t  a n o t h e r  c o l l e c t i o n  o f  u r i n e .  T h i s  w i l l  b e  c o m p l e t e d  
2 4  h o u r s  l a t e r .  Y o u  w i l l  b e  a s k e d  t o  r e t u r n  t o  t h e  c l i n i c  t o  c o m p l e t e  
t h e  u r i n e  c o l l e c t i o n  a t  t h e  s a m e  t i m e  t h e  d a y  f o l l o w i n g  y o u  f i r s t  c l i n i c  
a p p o i n t m e n t .
I f  f o r  a n y  r e a s o n  y o u  f i n d  t h a t  y o u  a r e  u n a b l e  t o  a t t e n d  y o u r  c l i n i c  
a p p o i n t m e n t ,  o r  t h e  r e t u r n  v i s i t  2 4  h o u r s  l a t e r ,  p l e a s e  l e t  u s  k n o w  I n  
a d v a n c e  s o  t h a t  s u b s t i t u t e  c l i n i c  a n d  r e t u r n  a p p o i n t m e n t s  c a n  b e  m a d e .
T h a n k  y o u  o n c e  a g a i n  f o r  y o u r  c o o p e r a t i o n .
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Records and Administration
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R E C R U I T I N G  R E C O R D
(For Centres with List of Known Names)
PART I.
Name of Person
Randomly
Selected Sex Age
Not
*9«
e l i g i b l e
Contact Results
Unible to 
Conttct 
1st Time
Unibit to
Conttct Cont.cted 
2nd Time Aqreed Refused
‘
»
|
!
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RECRUITING RECORD
(For Centres Without List of Known Names)
Household 
Identification 
(Address, etc.)
Spoke with No One 
Age Eligible
Age Eligibles Invited - Results
Occupant
Age Sex Refused AgreedYes No
RECRUITING RECORD
SUMMARY OF RECRUITING, BY AGE-SEX STRATA
Nianber with Appolfitments 
Men: Age Women: Age
D a te 2 0 -2 9 3 0 -3 9 4 0 -4 9 50 -5 9 j  2 0 -2 9 3 0 -3 9 4 0 - 4 9 5 0 -5 9
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O n t  re  Haar
URINE COLLECTION REGISTER
*  1 M u t t i
M K P a r t i c i p a n t
10
S p lit 
Sanple ID 
I f  a t t lp e f
S p i l t
d o n a
S p o t IJ a rt 
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Start H  Rr 
date fine
I«« ?*  hr 
Date lin e
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SHI PP 1 WG FORM
THIS FORM IS TO BE SENT TOGETHER WITH SPECIMENS LISTED BELOW, TO CENTRAL LABORATORY.
BE SURE SHIPPING CARTONS ARE CORRECTLY ADDRESSED, AND MARKED PROPERLY FOR PRESERVATION. 
A COPY OF THIS FORM IS TO BE HAILED TO LONDON AND A COPY KEPT IN THE LOCAL CLINIC.
LIST ID CODES IN NUMERICAL ORDER 
D O  N O T  I N D I C A T E  W H I C H  A R E  S P L I T  S A M P L E  I D »
ID
CODE
NUMBER 
OF TUBES
ID
CODE
NUMBER 
OF TUBES
ID
CODE
NUMBER 
OF TUBES
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Appendix 3: Description of Study Centres
.Study c e n tre : Argentina, Buenos Aires
Principal Investigators: E, Balossi, J Hauger-Klevene
Study dates: 18.11.85-17.2.86
Study population and sampling;
The population was staff of the National Institute of Agricultural Research (INTA), 
located 26 kms. from Buenos Aires. The staff work on major agricultural research. 
Offices are located throughout the country, but the study was done in the Castelor 
Centre where there are 612 employees aged between 20-59 years.
A complete list of names, age and sex was available and random sampling was done. 
People were contacted at work by telephone and asked to participate.
Social scale: 1 = ) Based on education and income,
There are also private schools organised by religious groups, community groups and 
non-profit organisations. These can teach subjects other than those indicated by the 
State.
2 = ) e.g., no or incomplete education and
3 = ) unemployed is social scale 1, and higher
4 = ) or university education with large income
) is social scale 4.
Education: State schools:
Primary school from 6-12 years 
Secondary school 13-18 years 
University 18-25 years
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Study centre: Belgium, Charleroi
Princinal Investigator: M Komitzer
Study dates: 10.12.85- 13.1.87
Study population and sampling:
Charleroi is a city located in the south, and part of the French speaking community. 
On 1.1.1983 the population was 216,144 people.
A random sample was selected from the MONICA Study register dated January 1984 
(ages 25-59) and a random sample of the population of Charleroi added for those 
aged 20-24.
A home visit and three telephone calls were made before the contact was considered 
as a refusal.
Social scale: Based on level of education:
1 = No school
2 = Primary
3 = Secondary
4 = Higher
Education: Elementary school, age 6-12 years 
Secondary inferior, age 12-15 years 
Secondary superior, age 15-18 years 
Secondary professional, age 15-19 years 
Secondary technical, age 15-19 years 
University, age 18-25 years 
Technical superior, age 18 to 22 or 23 years
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Study  centre: Belgium , G hent
Principal Investigator: G de Backer
Study dates: 4.11.85-22.5.86
Study population and sampling:
A sex/age stratified random sample was selected from the population register of the 
city of Ghent which is in the north, and is part of the Dutch speaking community. 
Except for those aged 20-24, all participants were also eligible for the MONICA 
study.
Sampling was undertaken centrally for the Ghent and Charleroi Centres at Brussels 
University. Eligible subjects were informed by letter requesting a home visit (at least 
3 attempts were made to establish contact).
Social scale: Based on level of education:
1 = No school
2 = Primary
3 = Secondary
4 = Higher
Education: Elementary school, age 6-12 years
Secondary inferior, age 12-15 years 
Secondary superior, age 15-18 years 
Secondary professional, age 15-19 years 
Secondary technical, age 15-19 years 
University, age 18-25 years 
Technical superior, age 18 to 22 or 23 years
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Study cen tre : Brazil, Y anom am o Indians
Principal Investigator: J J Mancilha Carvalho
Study dates: 3.6.86 - 8.7.86
Study population and sampling:
Yanomamo Indians, Amazon Jungle: Approximately 18,000 individuals occupy a 
region of 100,000 square miles located between Brazil and Venezuala. Four villages 
were chosen for study, in the Surucucu Plateau area. Sampling was o f  all adults 
identified by house-to-house survey. The Yanomami live under primitive conditions, 
with banana as the main staple, no access to alcohol and a salt-free diet. The diet is 
supplemented by game, fish, insects, sugar cane, roots and wild vegetable foods. 
Access is from the Funai Health Station, 30-40 kilometres or 5-10 hours walking 
distance through the jungle. A Funai interpreter was used by the Portuguese speaking 
investigators. Adults use ’penene' (leaves of tobacco and ashes).
Social scale: 1 = All women
2 = All other men (not 3 or 4)
3 = The Xamens (Xabores)
4 = The Chiefs (Tuxquas)
Education: Not applicable
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.S tudy  c e n t r e : B raz il, X ingu Indians
Principal Investigator: R G Baruzzi
Study dates: 17.7.85 - 5.5.86
Study population and sampling:
Native tribes o f  the Parque Indigena do Xingu (PIX) in Central Brazil, 1600 km from 
Sao Paulo, were studied; access to the region is only by air. There is a complete 
medical file on every Indian - including age, sex and village.
Random sampling was done, stratified by age, sex, and Indian group to get 
proportional representation of the 3 Indian groups; Upper Xingu, Je Indians and 
"other" Indians.
Social scale: 1 = ) Based on degree of leadership
2 = ) within the tribe.
3 = ) Not concisely defined.
4 = )
Education: Not applicable
Study centre: C a n a d a ,  Labrador
Principal Investigator: M Baikie
Study dates: 22.4.85 - 21.5 85
Study population and sampling;
Three villages were chosen in Labrador, Newfoundland, Canada's most easterly 
province.
Nain is an isolated community with an air strip and a good telephone service. Total 
population is 938, predominantly Innuit. Major employment is fishery. In summer, 
300 people go north to the fishing grounds. In winter, there is dependence on 
insurance, welfare, and government projects. Fresh food is in short supply in winter. 
Half of calorie intake is 'native food', i.e., fish, caribou, partridge, berries.
Northwest River The population is 515 (35% under 20), mainly white settlers 
speaking English only. There is limited local employment: hunting, trapping, fishing. 
The majority of the workforce travels to Goose Bay daily to government related jobs. 
Alcohol abuse is a problem.
Sheshashit The population is 550, almost exclusively Innuit. Housing is in poor 
repair. There is no running water or sewage facilities. Many are fluent in English. 
The standard of living is one of the lowest in the area. Alcohol abuse is a problem.
Names of all men and women aged 20-59 were extracted from the census list and sent 
to the University of Newfoundland for random sampling. Recruitment was by a 
public health aide, fluent in English and Innutituk, undertaken partly by telephone 
and partly by 'skidoo' visiting subjects at home.
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Canada, Labrador, corn.
Social scale: 1 = Unskilled, unemployed, low income,
poor housing
2 = Partly skilled, occasional manual,
seasonally employed or traditional 
employment, low income, adequate 
housing
3 = Skilled manual, involved with and well
regarded in the community, good income 
and housing
4 = Professional, skilled, community leader
or elder, good income and housing
Education: Grades 1-9
Grades 9-13 with or without secondary certificate 
Trade schools/vocational centres do not require 
secondary school graduation.
Nain 55% of those over age 15 years have less than grade 9 education, but there are 
30 people with university degrees and 15 with a university education but no degree.
Northwest River Aged over 15 years, 28% have less than grade 9. 29% have some 
secondary and 16% some university education.
Sheshashit Most have not completed secondary school.
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Study cen tre: C a n a d a ,  St Johns
Principal Investigators: J Martin, G Fodor
Study dates: 16.4.85-21.6.86
Study population and sampling:
Inhabitants of 3 coastal fishing villages with harbours on the west coast of 
Newfoundland. The climate is subarctic with the sea frozen from January to May. 
Random sampling was done using a census based on a household census drawn up 10 
years earlier for a different study. It was updated by age and reference to the 
electoral polling list of 1983. A letter about the study was posted to each householder 
and also put up in the local community centre. Two attempts were made to contact 
potential participants before considering them as refusals. There are only a few 
surnames in this region - hence a number of participants had the same first and 
surname (but had different ages).
Social scale: 1 = Seasonally employed
2 = Permanently employed
3 = Skilled
4 = Professional
Education:
Education became compulsory in 1949 when Newfoundland joined Canada. Until 
1969 every religious denomination had its own school system, but now only 3 remain 
(Roman Catholic, Pentecostal and non-religious integreated). Each "grade" is one 
academic year.
Kindergarten
Elementary school grades 1-7
High school grades 8-11
Grade 12 was added in 1984
University, or college of trades and technology
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Study centre: Columbia, Tuquerres
Principal Investigator: G Montes
Study dates: 9.7.86-5.12.86
Study population and sampling:
Participants were randomly selected from the population of the small town of 
Tuquerres (30,000 people). The urban zone with 13,000 inhabitants and rural zone 
with 17,000 were both included in the study. It is in the Andes mountains 3,051 
metres above sea level, and therefore cold. There is no large industry - most of the 
people are involved in agriculture or small family craft workshops. Most inhabitants 
are mixed race ("mestizo") and indigenous ethnic groups with few white people. 
Approximately 70% are graded 1 in the social scale below.
Social scale: 1 = Occasional jobs - small plot owners
2 = Field work, crafts traders
3 = Farmers, store owners, transport workers
4 = Professionals, large landowners with cattle
Education: Elementary school for 5 years 
Secondary school for 6 years 
University for 5 years
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Study centre: D enm ark , G lostrup
Principal Investigators: K Klarlund, M Schroll
Study dates: 11.3.85-14.5.85
Study population and sampling:
Random sampling was done from the Central Registry of all inhabitants o f the town 
of Glostrup aged 20-59 years old. Non-responders were contacted twice and some 
three times.
Social scale: 1 = Unskilled workers
2 = Semi-skilled workers, smallholders
3 = Skilled workers, farmers, employees
with degrees (non-professional), subordinates
4 = Professionals, landed proprietors
Education: Primary education for less than 7 years
Secondary education for less than 7 years 
University or Institute of Dentistry/Engineering etc.
Education is interwoven with work and training in Denmark. Apprenticies in the 
winter attend school for 3-4 hours each afternoon. Many young skilled workers 
attend one year of school at the start of apprenticeships.
254
Study cen tre: Finland, Joensuu
Principal Investigators: P Pietinen
Study dates: 6.11.85-22.1.86
Study population and sampling;
A stratified random sample was selected from the 'population' register of the Health 
Centre in Joensuu, a town in North Karelia.
Social scale: 1 = Unskilled
2 = Semi-skilled
3 = Skilled
4 = Professional
Education: Pre-school care for 5 and 6 year olds
Primary school from age 7
Lower secondary for 3 years
Upper secondary for 3 years
University or higher education, 4-6 years
Vocational or in-service training after secondary school
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Study cen tre : Finland, Turku
Principal Investigator: O Impivaara
Study dates: 3.9.85 - 13.11.85
Study population and sampling;
A stratified random sample was drawn from the population register of Turku City 
(situated on the SW coast of Finland). Subjects were contacted by letter and extra 
participants recruited to allow for refusals and cancellations. Main areas of 
employment are in industry, public services, commerce, transport and construction. 
The general educational and economic level are relatively high.
Social scale: 1 = Unskilled
2 = Semi-skilled
3 = Skilled
4 = Professional
Education: Pre-school care for 5 and 6 year olds
Primary school from age 7
Lower secondary for 3 years
Upper secondary for 3 years
University or higher education, 4-6 years
Vocational or in-service training after secondary school
Study centre: G e rm a n y , Bem ried
Principal Investigator: H Hofmann
Study dates: 9.9.85 - 28.7.86
Study population and sampling:
An urban population was selected in Bemried, Bavaria. The sample was drawn from 
a municiapl list of all men and women aged 20-59, giving sex, age (decades only) and 
addresses of each person.
The first attempt to contact individuals was by home visit. Refusals at this stage were 
contacted by letter from the local Investigator, followed by another visit or telephone
call.
The study was publicised in the local press.
Social scale: 1 = Blue collar
2 = White collar
3 = Employed in family shop
4 = Self-employed, professionals
Education: From ages 3-6, attendance at kindergarten is voluntary
Primary school 6-9 years
Grammar school for 4 years
Common school for 5-6 years, or
"Gymnasium" which usually leads to university.
Usually there is a 3-year apprenticeship
after common school with "part-time" lessons as well.
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Study cen tre : G erm a n y , Cottbus (formerly in the G .D .R.)
Princinal Investigator: L Heinemann
Study dates: 6.11.85 - 28.1.86
Study population and sampling:
Cottbus is a County Capital town in East Germany, population 120,000; main 
industries are open-cast mining, engineering, and textiles. In co-operation with the 
local Registration Office an initial list was drawn up of names and addresses of 700 
Cottbus inhabitants, bom on certain days of the year. A stratified random sample was 
then selected from this list.
Subjects were approached by letter (answer letter pre-paid), and two follow-up 
reminders were sent if necessary.
Social scale: Based on years of education:
1 = 0-10 years
2 = 11-13 years
3 = 14-15 years
4 = 16+ years
Education: The system was introduced in 1965 but was not a 
major change from the old system:
Creche
Kindergarten from about 4 years 
Primary school from 7-9 years 
Intermediate from 10-12 years 
Secondary from about age 13-16 
Vocational training leading to:
Adult education, technical school,
University or college
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Study cen tre: G erm an y , H eidelberg
Principal Investigator: U Laaser
Study dates: 23.9.85 - 27.2.86
Study population and sampling:
A random sample was selected from a list of staff at the Rehabilitation Centre in 
Heidelberg, and young men (20-29) who were doing their "civil service" in the
Centre. 
Social scale: 1 = Manual workers
2 = Tradesmen
3 = Office workers
4 = Professionals
Education: From ages 3-6 attendance at kindergarten is voluntary 
Primary school 6-9 years 
Grammar school for 4 years 
Common school for 5-6 years; or 
"Gymnasium" which usually leads to university. 
Usually there is a 3-year apprenticeship 
after common school with "part-time" 
lessons as well.
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Study centre: Hungary, Porcsalm a village
Principal Investigator: J Kishegyi
Study dates: 25.11.85 -9.1.86
Study population and sampling:
A stratified random sample of the population of Porcsalma village in N.E. Hungary 
was selected - most are agricultural workers but 60% of them also work part-time in a 
shoe factory or canning factory; 40% work in an agricultural co-op. A population list 
by age and sex was compiled by the local council in 1985. Invitations were delivered 
to participants by the local council messenger. Non-responders were sent a second 
letter, but generally residents were keen to take part.
Social scale: l = )
2 = )
3 = )
4 = )
Dependent on 5 factors: occupation 
income, housing circumstances and 
positions held in organisations like 
trade union or youth club.
Education:
Until 1947 elementary schools had 6 grades (now 8 grades). People who did not aim 
at higher education went through all grades. Those who worked to become clerks 
and sales personnel went to a 4 grade lower middle school (i.e., higher elementary 
school) after finishing the 4th grade of elementary school. Children aiming for 
universiy went to a lower plus upper middle school, 8 grades altogether, taking 12 
years until university.
S tu d y  c e n tre : Ice land , R eykjavik and district
Principal Investi gator J Ragnarsson
Study dates: 12.2.85-28.1.86
Study population and sampling:
A random sample for the study was drawn from the MONICA population, which 
includes the city of Reykjavik and its 5 surrounding towns. Two letters were sent to 
each person and where there was no response the person was telephoned before 
registering a refusal. There were problems recruiting the youngest age group (20-29) 
of both sexes because the MONICA population had tended to move away, often out 
into the country. Therefore a new additional sample in this age range was selected 
randomly from the National Register using pre-defined birthdates.
Social scale: 1 = Manual workers without higher training,
e.g., drivers/cleaners, invalided workers 
and the unemployed
2 = Salaried workers - e.g. clerks,
waiters, nurses
3 = Workers with higher education, professionals
scientists, registered nurses
4 = Managers, doctors, judges, those with an
education of 18 years or more
Education:
At age 15, students can choose technical schools, business schools or marine school; 
there are also 4-year apprenticeships. Some people in the oldest age group could 
have had only 3 years total formal schooling if they lived in the remote areas.
Elementary school from age 6 to 15 years 
High school from age 15 to 19 years 
University from age 19 years
Study centre: In d ia , Ladakh
Principal Investigator: K S Reddy
Study dates: 14.7.86-30.7.86
Study population and sampling:
A stratified random sample was selected from a list of the residents of Stok 
(population 857), Ladakh, situated on a high altitude plateau 11,600 ft above sea 
level. The people of Ladakh are mostly Buddhist, linked ethnically and culturally to 
the people of Tibet but Asian-Indian in terms of geo-political integration into India. 
The people are mostly farmers (men and women) - there is periodical movement to 
the mountains with livestock for grazing. Additional work includes bricklaying, 
civilian labour for army construction projects and a travel camp for tourists. There 
are few other forms of employment - school teachers, medical/paramedical personnel, 
revenue clerks etc. (although these people still tend to farm part-time). The Lamas 
(Buddhist monks) reside in monasteries and lead a life of prayer, worship and 
religious teaching. They are literate, as they undergo 8-15 years training in Buddhist 
schools of religion. The staple crops are barley and wheat. Fresh vegetables are not 
available in winter and fresh meat is scarce. Salted tea, prepared with tea leaves, 
milk, yak butter and salt is drunk often during the day, up to 30 or more cups per day.
Social scale: Based on yearly income:
1 = Less than RS 6000 per year
2 = RS 7600-12000 per year
3 = RS 12000-18000 per year
4 = More than RS 18000 per year
Education:
The majority of the people have no formal education, being mostly farmers. The 
Lamas are trained Buddhist monks (and have no formal education in the usual sense 
but they have between 8-15 years of religious education and are therefore highly 
literate). However, there is primary, secondary and high school education. There is 
now a school in Stok for primary and secondary education. High school is only 
available in Srinagar, the capital city.
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Study cen tre: India, New Delhi
Principal Investigator: K S Reddy
Study dates: 10.3.86 - 9.6.86
Study population and sampling:
The population of study was employees of the All India Institute of Medical Sciences 
(A.I.M.S.) including medical/professional, administrative, engineering (technical) 
staff and their families, resident on campus. Lists were compiled from the 1984 
electoral rolls, housing records and registration records of A.I.M.S. health service. 
Age/sex stratified groups were randomly selected using random number tables.
Social scale: Based on monthly income:
1 = Less than RS 500 per month
2 = Between RS 500-999 per month
3 = Between RS 1000-1999 per month
4 = More than RS 2000 per month
Education:
There are usually 10 years of education from 5 to 15 years of age, class 1 to class 10, 
often preceded by 1 or 2 years of nursery pre-school. Then:
Junior college (pre-university) for 2 years 
(class 11-12)
University education - 3 years, bachelors course 
Professional course (medicine, engineering, etc.)
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Study cen tre : Ita ly , Bassiano
Principal Investigator: G Urbinati
Study dates: 18.2.86-23.4.86
Study population and sampling:
Bassiano is a small hill town, 500 metres above sea level, 60 miles south of Rome, 
with 1535 inhabitants. Main activities arc agriculture, stock-raising, and services. 
Commuters represent a substantial percentage of the male working population. The 
economic level is lower than the average for Italy.
A stratified random sample was selected from the Bassiano electoral register. 
Potential participants were invited by letter to a general meeting organised by clinical 
and municipal staff to explain the study aims and procedures. A letter was sent 
confirming the invitation to attend the clinic; some contacts were made by telephone.
Social scale: Based on employment and education:
1 = Manual and unemployed - illiterate
2 = Farming/skilled/services - primary school
3 = Sales/office/clerical/craftsmen - secondary
high school
4 = Managers/students/professional
-university or postgraduate
Education: Elementary school 6-20 years 
Junior school 11-13 years 
High school 14-18 years 
University 19-22 years
Study cen tre : Ita ly , G ubbio
Principal Investigators: M Laurenzi
Study dates: 10.4.86-4.7.86
Study population and sampling:
Stratified random sampling was done from the census list of the population of the 
historical centre of the town of Gubbio. At least 3 attempts were made to contact 
individuals before considering them as refusals.
Social scale: 1 = ) No detailed information on income,
2 = ) therefore based on educational
3 = ) achievement and job. For housewives and
4 = ) students, social scale of spouse or parents
) was used.
Education: Elementary school 6-20 years 
Junior school 11-13 years 
High school 14-18 years 
University 19-22 years
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Study cen tre : Italy, Mirano
Principal Investigators: C Dal Palu, S Zamboni
Study dates: 1.4.86-4.6.86
Study population and sampling:
Stratified random sampling was done among the population of Mirano, a small town 
in the Veneto region, 30 kilometres from Padua, population approximately 25,183. 
Sampling was compiled from the cesus list of the Mirano Health District. Letters 
were sent to general practitioners advising them of the INTERSALT aims and the 
proposal to recruit patients. Explanatory letters were then sent to individuals inviting 
them to attend the clinic; some were contacted by telephone.
The Chernobyl nuclear accident affected the diet during the study since the 
radioactive cloud passed over Italy in early May. Sale of leafy vegetables was 
stopped. Many people refrained from using fresh milk for the whole period of risk.
Social scale: Based on education:
1 = Illiterate, or primary school only
2 = Secondary school 1st level
3 = Secondary school 2nd level
4 = University
Education: Elementary school 6-20 years
Junior school 11-13 years 
High school 14-18 years 
University 19-22 years
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Study centre: Italy , N aples
Principal Investieator: E Farinaro
Study dates: 29.5.85- 17.10.85
Study population and sampling;
Stratified random sampling was carried out from the list of employees at the Olivetti 
factory. Since few women are employed at the factory, wives and daughters were
also included in the study. 
Social scale: Based on employment:
1 = Unemployed
2 = Retired/housewife
3 = Employed
4 = Professional/manager
Education: Elementary school 6-20 years 
Junior school 11-13 years 
High school 14-18 years 
University 19-22 years
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Study cen tre: J a p a n , O saka
Principal Investigator: H Ueshima
Study dates: 1.4.85-23.10.85
Study population and sampling:
Employees of the Daidon Life Insurance Company, Osaka, and their wives were 
selected by stratified random sampling. Participants live in Osaka City and 'satellite' 
cities in the Osaka area, and were mainly white office workers and their wives 
(mostly housewives). Osaka is the second largest city in Japan. Diet is typically 
middle-class Japanese: older people eat more fish; younger people eat more meat.
Social scale:
This was based on age and work experience, which is indicated by job number. 
Wives have the same job number as their husbands. The social scale is confounded 
by age, since jobs become more senior with age.
1 = Lowest class (newcomer to job, job no. 1-2)
2 = Middle class (job no. 3-4)
3 = Upper middle class (job no. 5-6)
4 = Highest class (job no. 7-9, executives)
Education: Primary school at age 6 years (until 12 years old)
Junior high school for 3 years (until 15 years old) 
Senior high school for 3 years
University for either 4 years or (mainly for girls) 2 years, or after senior high school 
students go to a professional school to be trained for jobs in computing, nursing, etc. 
There are also cramming schools to prepare for university entrance.
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Study centre: J a p a n ,  T o ch ig i
Principal Investigator: T Hashimoto
Study dates: 26.8.85 - 9.12.85
Study population and sampling:
A stratified random sample was selected of inhabitants of Minamikawachi-machi 
town and its surrounding communities, in Tochigi prefecture. The list was drawn 
from people who have national insurance, but some non-insured people in the 
youngest age range (20-29) were accepted. Tochigi is a rural area; 50% of the 
participants were farmers.
Social scale: Based on bicycle/car ownership:
1 = No bicycle or car
2 = One bicycle
3 = One car
4 = Two or more cars
Education: Primary school at age 6 years (until 12 years old) 
Junior high school for 3 years (until 15 years old) 
Senior high school for 3 years
University for either 4 years or (mainly for girls) 2 years, or after senior high school 
students go to a professional school to be trained for jobs in computing, nursing, etc. 
There are also cramming schools to prepare for university entrance.
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Study cen tre: Japan , Toyama
Principal Investigator: S Kagamimori
Study dates: 21.10.85-4.12.85
Study population and sampling:
The study population was all employees of a zip fastener company - YKK. Stratified 
random sampling was done from a complete list o f employees.
Social scale: Based on occupation:
1 = Manual worker
2 = Non-manual
3 = Foreman and supervisor - manual
4 = Manager
Education: Primary school at age 6 years (until 12 years old) 
Junior high school for 3 years (until 15 years old) 
Senior high school for 3 years
University for either 4 years or (mainly for girls) 2 years, or after senior high school 
students go to a professional school to be trained for jobs in computing, nursing, etc. 
There are also cramming schools to prepare for university entrance.
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Study centre: Kenya, Rambugu and Ndori villages
Principal Investigator: N Poulter
Study dates: 13.1.85 - 14.2.85
Study population and sampling:
The study population was inhabitants of Rambugu village, Western Kenya, which has 
a population of about 1500 persons, from 320 households. Five men aged (50-59) 
were also randomly selected from Ndori, a similar village nearby. The study 
population was exclusively from the Luo tribe. Approximately 90% of adults are 
engaged in subsistence farming.
Sampling was carried out using a pre-exisitng census list (by individual and 
household). Households were randomly selected and eligible subjects listed. 
Subjects were studied at home.
Social scale: 1 = Subsistence farmer
Begins at age 5. Primary school until the "Kenyan Primary Exam" is passed. 
Secondary education leads to O and A levels which are (or were) based on the 
English system. Fees are paid in secondary schools. In practice, children are often in 
primary school until their late teens although secondary school begins at about age 12 
years.
2 = Subsistence farmer & sells produce
3 = Subsistence farmer and urban source of funds
4 = Other
Education:
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S tudy  centre: M alta, D ingli village
Principal Investigators: J M Cacciottolo, A Amato Gauci
Study dates: 3.6.86-11.7.86
Study population and sampling:
A stratified random sample was drawn from inhabitants of the village of Dingli, using 
the latest electoral register (October 1985). People were recruited by a Health 
Inspector calling at their homes to give an invitation and explain the procedures. 
Those who failed to attend were contacted by telephone. Those who were working 
were given a letter for their employers written by the Chief Medical Officer.
Social scale: 1 = ) Based on the
2 = ) Registrar General's
3 = ) classification
4 = ) of England and Wales.
Education:
Education has changed radically in Malta over the last 30 years. Malta was a colony 
until 1964 when a full scale education system began, on U.K. lines, with 
comprehensive schools, etc. This system has since been adapted several times. Prior 
to 1964, it was not compulsory to stay at school until age 16. There was a literacy 
campaign in the 1950s when people were obliged to attend a government scheme 
"school" for three years to learn reading and writing. It is therefore possible for 
people such as nurses to have only 3 years education and yet do important skilled 
jobs. Now, nurses are educated to age 16 and then follow a 3 year training course.
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Study cen tre: M exico, Tarahum ara Indians
Principal Investigator: W E Connor
Study dates: 6.6.85 - 25.6.85
Study population and sampling:
The study was conducted among the Tarahumara Indians of Sierra Madre in 
Chihuahua. The altitude is about 2240 metres above sea level. The recruitment 
method was to invite participants by radio, through bilingual school teachers and 
through local authorities to a local meeting place in the main school where the study 
was explained and participants recruited.
Social scale:
Depends on economic situation of the head o f the household together with the 
education level and and social standing of both husband and wife (includes the ability 
to read, write, travel and take part in religious ceremonies).
Education: Kindergarten (not obligatory)
Primary school for 6 years 
Secondary school for 2 or 3 years 
Several types of high school depending on pupils 
Options: preparation for natural sciences,
Correra Tecnica, technical training, etc. 
for 3-4 years
University for minimum of 4 years
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Study centre: T he N e th e rlan d s , Zutphen
Principal Investigator: D Kromhout
Study dates: 18.3.85 - 8.5.85
S t u d y  p o p u l a t i o n  a n d  s a m p l i n g :
Stratified random sampling was carried out among the population of the small 
commercial town of Zutphen. The sampling list was provided by the Department of 
Population. Several attempts were made to contact non-responders by letter and 
telephone.
Social scale: Based on employment:
1 = Manual/unskilled
2 = Lower administrative professions/
skilled manual
3 = Small businessmen/shopkeepers/students
4 = Professionals/managers
Education: Primary school for 6 years 
Lower vocational training 3-4 years, or 
Lower level high school for 4 years, 
leading to vocational training; or 
Higher level high school 5 years, leading 
to high vocational training, or 
Grammar school for 6 years, leading to University.
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Study cen tre: P ap u a  New G u in ea , Asaro Valley
Principal Investigators: P Howard, M Alpers
Study dates: 18.11.85-20.2.86
Study population and sampling:
The study population comprised two groups of villages in the Asaro Valley of the 
Eastern Highlands Province, about 18 miles from Goroka:
the Kamus group is more traditional and depends on subsistence agriculture. 
Few women attend school.
the Gimisave group are more acculturated - more women attend school and 
more "store food" is eaten. There is a primary school in the village.
In June/July 1985 a complete census of the communities was drawn up allocating 
house numbers and drawing maps. Few adults knew their year of birth, therefore it 
was estimated (and is probably accurate to within 5 years). Data from the census 
forms were entered onto computer and two population listings drawn up, stratified by 
age and sex. Because of the differences in lifestyle and economy of the two 
communities, the two populations were sampled separately and slightly more weight 
was given to the more traditional community (Kamus).
Social scale:
Education:
1 = Immigrants, subsistence farmer, unskilled
workers, income less than K500
2 = Subsistence farmer with income K500-K1000/
salaried workers/average villager with low 
income from small coffee holdings
3 = Younger average villager with primary
education or a salaried job or with a 
bigger coffee holding
4 = Owners of extensive coffee estates/
other business interests/ 
professionally qualified people
Some schooling was available in the village
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Study centre: P eop le 's  R epub lic  o f  C h in a , N anning
Principal In vestiga tor Z Long
Study dates: 1 7 .4 .8 6 - 12.5 .86
Study population and sampling:
Participants were residents/staff of Guangxi Medical College. A list of names, sex, 
and ages (20-59 years) was obtained from the security section of the college and a 
stratified random sample was drawn.
S o cia l scale: 1 = Manual worker, farmer
2  = Skilled worker
3 = Nurse, technician, teching assistant
4 = Teacher, doctor, official
Education: Elementary school for 6 years 
Middle school for 3 years 
High school for 3 years 
Higher education for 5 years
Technical school after middle school for 3 years. Graduate program after university 
for 3 years for Masters degree.
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Study cen tre: People 's R e p u b lic  o f  C h ina , Tianjin
Principal Investigator: L Liu
Study dates: 20.3.86 - 4.4.86
Study population and sampling;
The study was done in Zhao Ku Li village, east of Tianjin. The population includes 
both peasants working in agriculture and people in industry, mostly working 7 days a 
week. A complete list of names with age/sex was available and a random sample 
selected.
Social scale: 1 = ) Based on work type, education
2 = ) and living conditions.
3 = )
4 = )
Education: Elementary school for 6 years 
Middle school for 3 years 
High school for 3 years 
Higher education for 5 years
Technical school after middle school for 3 years. Graduate program after university 
for 3 years for Masters degree.
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Study centre: P o land , Krakow
Principal Investigator: J Sznajd
Study dates: 15.4.86- 12.6.86
Study population and sampling:
The study population was the 2500 employees of the POLKABEL cable factory in 
Krakow. A stratified random sample was taken from the list of employees. The 
factory officer was responsible for scheduling the clinic appointment times.
Social scale: 1 = Unskilled
2 = Skilled, farmers, craftsmen
3 = Clerical, administration
4 = Executives, professionals, managers
Education: The education system was ill-defined between 1939-45 
Before 1939
Elementary school 7 years 
Gymnasium 8 years 
University 4-6 years
After 1945
Elementary school 7 years (8 years after 1960) 
Secondary school (4 years)
Engineering school (5 years) or 
Technical schools (3 years)
College (2 years), for those not going to university 
University 4-6 years
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Study cen tre: P o la n d ,  W arsaw
Principal Investigator: S L Rywik
Study dates: 16.4.86- 11.6.86
S t u d y  p o p u l a t i o n  a n d  s a m p l i n g :
This was a study of the general population of Warsaw, based on the MONICA 
survey. A list of 32,629 people aged between 20-59 was obtained from the 1985 
voters' list and a stratified random sample was selected.
Social scale: 1 = Unskilled
2 = Skilled, farmers, craftsmen
3 = Clerical, administration
4 = Executives, professionals, managers
Education: The education system was ill-defined between 1939-45 
Before 1939
Elementary school 7 years 
Gymnasium 8 years 
University 4-6 years
After 1945
Elementary school 7 years (8 years after 1960) 
Secondary school (4 years)
Engineering school (5 years) or 
Technical schools (3 years)
College (2 years), for those not going to university 
University 4-6 years
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S tu d y  centre: P o rtu g a l, C artaxo Village
Principal Investigator: J G Forte
Study dates: 2.5.86 - 23.7.86
S t u d y  p o p u l a t i o n  a n d  s a m p l i n g :
A random sample was drawn of inhabitants of the town of Cartaxo, about 65 kms east 
of Lisbon, using the electoral census list. The population is about 10,000, half of 
whom work in rural activities (farming, vineyards and cattle farming).
Social scale: 1 = ) Based on income and
2 = ) education.
3 = )
4 = )
Education: Primary school 4 years 
Ordinary level 5 years 
High level 3 years 
University level 4-6 years
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Study centre: Sou th  K o rea , Pusan
Principal Investigator: B C Park
Study dates: 27.6.86- 11.8.86
S t u d y  p o p u l a t i o n  a n d  s a m p l i n g :
Personnel of the Kosin Medical College (excluding medical doctors) were studied, as 
well as some relatives of patients in the hospital.
Social scale: Based on household income:
1 = Monthly household income
under 300,000 won
2 = Monthly household income between
300.000- 500,000 won
3 = Monthly household income between
500.000- 900,000 won
4 = Monthly household income
above 900,000 won
Education: Kindergarten 5-7 years old 
Primary school 7-13 years old 
Middle school 13-16 years old 
High school 16-19 years old 
University or college 19-23 years old
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Study centre: S o v ie t  U n io n ,  M oscow
Principal Investigator: R Oganov
Study dates: 5.3.86 - 30.6.86
Study population and sampling:
The study population comprised blue and white collar workers in the automobile 
industry, Moscow. Employees of 3 engineering plants were studied, including 
engineers, technicians, lab personnel, foremen, managers and service staff. A random 
sample was drawn from  the list of employees.
Social scale: 1 = Blue collar
2 = White collar
3 = Foreman
4 = Manager
Education: Elementary school age 6-10 years 
Secondary school age 10-17 years 
Higher education 17+ years
Secondary specialised school can be attended after secondary school or as its 
continuation instead o f  high school. Higher education means a completed university 
or institute course after the age of 17.
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Study cen tre: S p a i n ,  Manresa
Principal Investigator: S Sans
Study dates: 9.5.85 - 30.7.85
S t u d y  p o p u l a t i o n  a n d  s a m p l i n g :
A random sample was drawn from the general population of Manresa, an industrial 
town of 66,000 inhabitants 60 kilometres north of Barcelona, using an updated 1981 
municiapl census list.
Personal letters were sent to individuals inviting them to participate in the study. 
Two nurses paid domicilliary visits to participants who did not keep their 
appointments after a letter of telephone call. (An average of 4 contacts was
attempted.) 
Social scale: 1 = Unskilled
2 = Skilled
3 = Services
4 = Professionals
Education: From age 6 to 16 years:
Primary school 
Secondary school
Polytechnic/high school, age 14-16 years 
University at age 17
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Study centre: S p a i n ,  Torrejon
Principal Investigator: M Luque-Otero
Study dates: 19.2.86 - 22.4.86
S t u d y  p o p u l a t i o n  a n d  s a m p l i n g :
A stratified random sample was selected from the population of Torrejon de Ardoz, 
an industrial town 20 km to the west of Madrid. There are 80,000 inhabitants, most 
of whom migrated there in the 1960s from the south and central parts of Spain. The 
main employment is a factory in the town.
Social scale: Based on monthly income:
1 = Unemployed
2 = Salary up to 50,000 pesetas a month
3 = Salary up to 51-100,000 pesetas a month
4 = Salary more than 100,000 pesetas a month
Education: From age 6 to 16 years:
Primary school 
Secondary school
Polytechnic/high school, age 14-16 years 
University at age 17
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Study centre: T aiw an , San Chilo village area
Principal Investigator: W P Tseng
Study dates: 19.9.85-25.10.85
Study population and sampling;
The population sample was the San Chilo village, one hour from Taipei. Total 
population is 17,000, 40% of whom are farmers.
Social scale: 1 = ) Devised on a points-system based on
2 = ) education, occupation and economic status.
3 = ) The higher the number of points scored,
4 = ) the higher the social scale.
Education: Elementary school for 6 years 
Junior school for 3 years 
Senior high school for 3 years 
College/university for 4 years 
Law school for 5 years 
Medical school for 7 years
Study centre: T rin id ad  an d  T obago , P lym outh-B ethesda
Principal Investigator: A Patrick
Study dates: 14.3.85 - 10.8.86
Study population and sampling:
The 1976 censused adult population of Plymouth-Bethesda in Tobago of 826 
respondents was used. The population was aged 20 and over in 1976 and so was now 
aged 30 years or more. Therefore, 149 people aged 20-29 also were sampled. Many 
people from the 1976 census had migrated. Many additional house visits were 
necessary. A second survey was carried out to repeat the 24-hour urine collections, 
because of problems in the first survey.
Social scale: Based on employment:
1 = Unemployed
2 = Labourer
3 = Clerk, waiter, sales o r service
4 = Professional, landowner
Education: Preparatory school, ages 3-6 years 
Elementary school, ages 7-10 years 
Secondary school system, ages 11-19 years
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Study centre: United Kingdom, Belfast
Princinal Investigator: G Scally
Study dates: 17.6.85 - 10.4.86
Study population and sampling:
The study was based on the MONICA project in Belfast. Patients were selected 
randomly from the age-sex lists of general practitioners practising in Belfast, obtained 
from the Central Services Agency.
Social scale: Based on Registrar General's classification:
1 = Farming/manual
2 = Foreman supervisor
3 = Office, public service, sales
4 = Managerial, professional
F.ducation: Kindergarten
Primary school, ages 5-7 years 
First/junior school, ages 7-11 years 
Secondary school, ages 11-18 years 
College/University, age 18+years
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Study cen tre: U n ited  K ingdom , Birmingham
Principal Investigator: G Beevers
Study dates: 1 8 .4 .8 5 -2 6 .1 1 .8 5
S t u d y  p o p u l a t i o n  a n d  s a m p l i n g :
A stratified random sample was selected from the workforce o f Lucas Electrical 
(manufacturer of car headlights), Hockley, Birmingham. There are over 3000 
employees of whom approximately 1000 are office workers. The women are mostly 
office workers, clerks and cleaners. About 90% of the workforce are white, but there 
are also Caribbean blacks and Asians (Indian or Pakistani born).
Social scale: Based on Registrar General's classification:
1 = Farming/manual
2 = Foreman supervisor
3 = Office, public service, sales
4 = Managerial, professional
Education: Kindergarten
Primary school, ages 5-7 years 
First/junior school, ages 7-11 years 
Secondary school, ages 11-18 years 
College/University, age 18+years
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Study c e n tre : U nited  K ingdom , South W ales
Principal Investigator: P El wood
Study dates: 26.3.85 - 19.4.85
S t u d y  p o p u l a t i o n  a n d  s a m p l i n g :
A stratified random sample was selected from the age/sex register of a general 
practice in Bridgend, a market town in mid-Glamorgan. Letters of invitation were 
sent out and telephone calls and home visits made as necessary.
Social scale: Based on Registrar General's classification:
1 = Farming/manual
2 = Foreman supervisor
3 = Office, public service, sales
4 = Managerial, professional
Education: Kindergarten
Primary school, ages 5-7 years 
First/junior school, ages 7-11 years 
Secondary school, ages 11-18 years 
College/University, age 18+years
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Study cen tre : U nited  S tates, Chicago
Principal Investigator: J Ständer
Study dates: 20.11.85-5.6.86
Study population and sampling:
A stratified random sample was drawn from the list of employees aged 20-59 o f  the 
Chicago Peoples Gas Co (about 1200 people were eligible). Letters of invitation 
were sent and if no reply was received within ten days, the person was contacted by 
telephone and the invitation repeated.
Social scale: 1 = Unskilled labourer/service worker
2 = Skilled labourer/semi skilled/secretary, clerk
3 = Foreman, salesman, supervisory
4 = Executive, managerial, professional, technical
Education: Elementary school 1-8 years 
High school 9-12 years 
Higher education 13+ years
A college graduate would have 16 years of education; a masters degree student, 17 or 
18 years; an MD, 20 years and a PhD, 19-20 years of education or more.
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Study centre: U nited  S ta te s , Goodman (2 centres)
Principal Inv esti gators: D A  Frate, H  Langford
Study dates: 24.4.86 - 27.8.86
Study population and sampling;
The population sampled was a rural settlement, 51% black and 49% white. There 
were two centres: one for black, and one for white participants. The sample was 
drawn from a pool o f age, sex and race eligible individuals identified from a series of 
5% random population surveys conducted in the project area. Home visits and 
telephone calls were used to recruit people from the sample. Refusal on initial 
contact or one missed appointment constituted a "refusal".
Social scale: Based on employment, income and home ownership:
1 = Unemployed or wage under $5000,
none home owner
2 = Unemployed or wages under $5000, but
owns home, and/or garden, livestock
3 = Employed, salary over $5000,
rents or owns home
4 = Employed, professional or agricultural,
income more than $25000, owns home
Education: Elementary school 1-8 years
High school 9-12 years 
Higher education 13+ years
A college graduate would have 16 years of education; a masters degree student, 17 or 
18 years; an MD, 20 years and a PhD 19-20 years of education or more.
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Study cen tre : U n ited  S tates, Hawaii
Principal Investigator: D Curb
Study dates: 13.6.85- 1.8.85
S t u d y  p o p u l a t i o n  a n d  s a m p l i n g :
The study was conducted on the island of Molokai. 250 people (67% of population) 
20-59 years old were seen. These people live in extended family dwellings or small 
groups of houses on "homestead" lands which are allocated by state law for long term 
low-cost housing for native Hawaiians. It is a mobile community, but a census of 
individuals was completed and thought to be reasonably accurate. There were 
difficulties getting people to come to the clinic. One solution was to have the clinic 
and the study itself blessed by a local religious figure, a Kahuna.
Social scale: Based on education:
1 = Elementary school
2 = Secondary/high school
3 = College
4 = Advanced degree
Education: Elementary school 1 -8 years 
High school 9-12 years 
Higher education 13+ years
A college graduate would have 16 years of education; a masters degree student, 17 or 
18 years; an MD, 20 years and a PhD 19-20 years of education or more.
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Study centre: U n ite d  S tates, Jackson (2 centres)
Principal Investigators: H Langford, R Watson
Study dates: 7.3.86- 17.12.86
S t u d y  p o p u l a t i o n  a n d  s a m p l i n g :
A stratified random sample was selected from the list of employees of the University 
of Mississippi Medical Center (about 4000 people). There were two centres: one for 
black and one for white participants.
Social scale: Based on the highest grade completed in high school: 
Black White
1 = 1-8 grade 1-11 grade
2 = 9-11 grade 12 grade
3 = 12 grade 13-16 grade
4 = 13+grade 17+grade
Education: Elementary school 1-8 years 
High school 9-12 years 
Higher education 13+ years
A college graduate would have 16 years of education; a masters degree student, 17 or 
18 years; an MD, 20 years and a PhD 19-20 years of education or more.
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Study centre: Z im babw e, Harare
Principal Investigators: J Matenga
Study dates: 10.12.85-25.2.86
Study population and sam pling;
A stratified random sample was selected from the list of non medical workers of 
Parirenyatwa Teaching Hospital (secretaries and hospital clerks were excluded).
Social scale: 1 = Unskilled, semi-skilled
(no training), servants, labourers
2 = Semi-skilled (some training)
police, lorry drivers, etc.
3 = Skilled (requiring 0 levels)
4 = Professional
Education: Based on the British system except for a change in 
number of years at primary school in 1970: 
Primary school for 7 years (was 8 years) 
Secondary education:
Zimbabwe Junior Certificate, 2 years 
British 0 levels, 2 years 
A levels, 2 years
University, same as the British system
After secondary education it is also possible to do
technical training in various colleges.
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Appendix 4: INTERSALT Methods and Main Results 
(Published Papers)
INTERSALT Co-operative Research Group. INTERSALT Study. An international 
co-operative study on the relation of blood pressure to electrolyte excretion in 
populations. 1. Design and Methods. J Hypertens 1986; 4: 781-787.
INTERSALT Co-operative Research Group. INTERSALT: an international study 
of electrolyte excretion and blood pressure. Results for 24-hour urinary sodium and 
potassium. Br MedJ 1988; 297: 319-328.
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